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The development of novel methods to incorporate fluorine and fluoroalkyl groups into 
organic molecules is highly desirable, as these substituents can impart unique stability, 
reactivity and biological properties. Over the past decade, tremendous efforts have 
been expended to develop transition metal-catalyzed aromatic fluorination 
methodologies. Nevertheless, carbon–fluorine bond formation remains challenging, 
especially in the context of general, functional group-tolerant late-stage fluorinations of 
arenes. Ultimately, gaining direct accessibility to highly functionalized and complex 
fluorinated pharmaceutical and radiopharmaceutical precursors is a central objective of 
this field.  
Chapter 1 describes the key challenges in the field C–F bond formation key 
considerations in industry, as well as the relevant history and precedent for the work 
detailed herein. 
Chapter 2 begins with our initial development of the copper-catalyzed fluorination 
of unsymmetrical diaryliodonium salts with KF. This transformation proceeds with high 
chemoselectivity and yields. Detailed computational and experimental mechanistic 
analyses established the key role of the solvent in catalysis and rationalized the 
chemoselectivity in Cu-catalyzed reactions of unsymmetrical iodonium salts. 
Chapter 3 describes detailed efforts into the translation of the Cu-catalyzed 
fluorination of diaryliodonium salts to radiofluorination.  The fluorine-18 radionuclide is 
the most widely utilized for in vivo imaging by positron emission tomography. However, 
the lack of rapid, practical radiofluorination methods hinders newly developed 
radiotracers entering into clinic. We have identified conditions that rapidly incorporate 
fluorine-18 into electron-rich arenes in 20 minutes under mild conditions. Importantly 
this chemistry can be further applied to synthesize clinically important radiotracers.  
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Chapter 4 details the exploration of the Cu-mediated radiofluorination of aryl 
boronates and aryl halides.  Extensive studies on developing a new elution method 
allowed operationally simple, highly reproducible means to make anhydrous 18F– 
effective for Cu catalysis.  
Chapter 5 investigates a novel Pa-catalyzed decarbonylative fluorintion method 
to incorporate a carbon-fluorine bond. The protocol aims to utilize aroyl fluorides as both 
the fluorine and arene source that oxidatively adds to metals in a single step, thereby 
minimizing the complexity and waste in this step of the synthesis. This work was further 




CHAPTER 1. INTRODUCTION 
1.1 SIGNIFICANCE OF FLUORINE  
     Fluorinated organic compounds, particularly aryl fluorides, have found numerous 
applications in pharmaceuticals, agrochemicals, radiopharmaceuticals and polymeric 
materials.1 The replacement of C–H bonds with C–F bonds can lead to improvement of 
the stability, reactivity, and/or biological properties of organic molecules (Figure 1.1). 
Approximately 40% of agrochemicals and 20% of pharmaceuticals contain at least one 
fluorine atom, often located on aromatic rings. In addition, fluorocarbon based polymers 
(PTFE, PVDF, FEP and fluoroelastomers) are widely used in automotives, electronics, 
chemical processing, and industrial equipment. By 2019, the global fluoropolymer 
market is projected to reach approximately 8 billion dollars in revenue.2 Additionally, 
fluorine-18 (18F) tagged radiotracers are abundant in radiopharmaceuticals. Positron 
Emission Tomography (PET) is a minimally invasive imaging technique that provides 
physiochemical information. Greater than 90% of PET scans are performed annually 
using 18F-labeled molecules. Due to the ideal half-life of 18F (110 minutes), 18F 
radiotracers are broadly useful for monitoring in vivo metabolic processes that are 
critical for drug discovery and disease diagnosis. For these reasons, chemists have long 








Figure1.1. Prevalence of Aryl Fluorides in Various Fields and Representative Examples 
 
 
1.2 KEY CONSIDERATIONS FOR SUCCESSFUL FLUORINATION PROCESS 
     For the successful development of new fluorination methods, it is important to 
consider differences in scale between pharmaceuticals, agrochemicals and PET 
imaging techniques and incorporate these considerations into the design of a new 
transformation (Figure 1.2). In agrochemicals and pharmaceuticals (especially for 
applications in process chemistry), the total cost, the availability of reagents, and the 
yield of the fluorinated products are the key factors sought in a fluorination method. In 
contrast, medicinal chemistry or PET imaging has other priorities for choosing an 
appropriate fluorination method. Generally radiopharmaceuticals and lead drug 
molecules are only synthesized in miligram to nanogram quantities. Therefore, speed, 
operational ease, and late-stage derivatization are often the key considerations for 
these transformations. When using the short-lived [18F]fluoride radionuclide, the speed 
and operational ease of the radiofluorination are particularly critical for 
radiopharmaceutical synthesis. Due to the limited lifetime of [18F]fluoride, it is ideal to 




































especially important in medicinal chemistry (even in agroscience) to evaluate fluorinated 
molecules in structure activity relationship (SAR) studies.3  The SAR studies are to 
determine the relationship between chemical structures and their biological activities 
that evokes target biological effects. Therefore, enabling late-stage derivatization of 
substituents in architecturally complex molecules will provide ease of such testings.  
  Figure 1.2 Comparisons of Fluorination Methods in Industry4 
 
1.3 CLASSIC FLUORINATION PROCESSES THAT ARE STILL IN USE  
The most common nucleophilic aromatic fluorination methods today were 
developed in the late 19th to 20th centuries and are still widely utilized in industrial 
chemistry. 5  The two conventional fluorination processes are the Balz-Schiemann 
reaction (eq. 1, Scheme 1.1)6 and halex fluorination reactions7 (eq. 2, Scheme 1.1). The 
Balz-Schiemann reaction involves the thermal decomposition of diazonium 
tetrafluoroborates/fluorides, synthesized by the diazotization of the corresponding 
aromatic amine.5 The halex fluorination method converts activated chloroarenes into the 
corresponding fluoroarenes in the presence of alkali-metal fluorides (eq. 2).  
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Scheme 1.1 Conventional Nucleophilic Fluorination Routes3-5 
 
A number of electrophilic aromatic fluorination methods are also well-known 
(Scheme 1.2).1,5 However, the use of toxic fluorine gas,8 poor regioselectivity, and/or the 
requirement for expensive electrophilic fluorinating reagents (i.e. Selectfluor) make 
these methods less economical for industrial scale synthesis (Figure 1.3).9  
Scheme 1.2 Representative Electrophilic Fluorination Method6,7 
 
 





















































Importantly, both the nucleophilic and electrophilic methods described in this section do 
not meet key considerations for methods suitable for pharmaceutical or 
radiopharmaceutical synthesis. These conventional methods require forcing conditions 
and possess poor functional group tolerance. As a result, one typically has to resort to 
de novo syntheses in order to evaluate fluorinated molecules in SAR studies in 
pharmaceuticals or agrochemicals. 
1.4 CHALLENGES WITH THE FLUORINATION PROCESS 
Despite the wide utility of fluorinated compounds, there are a limited number of practical 
synthetic methods for aromatic fluorination. One of the challenges associated with C-F 
bond formation is the low nucleophilicity of the fluoride (F–). 10 Common, inexpensive 
fluoride salts (e.g. KF and CsF) are poorly soluble in organic solvents and even traces 
of water can attenuate the nucleophilicity of fluoride by strong hydrogen bonding 
interactions (38.6 kcal mol-1 for bifluoride, HF2–). Thus these methods require rigorously 
anhydrous conditions to achieve high yields, which can be a drawback in terms of 
practical synthesis (Scheme 1.3).11  
Scheme 1.3 Hydrogen Bonding Energy of F----HF11 
 
1.5 EARLY STUDIES ON AR–F BOND FORMATION FROM METAL FLUORIDE 
COMPLEXES 
Over the past decade, there has been tremendous progress in the development of 
transition metal-catalyzed cross-coupling reactions to form C–F bonds.12 Such reactions 
are believed to proceed via the simplified catalytic cycle shown in Scheme 1.5 
Stoichiometric studies were carried out to gain insight into the C-F bond formation event. 
In theory, the carbon-fluorine bond is a thermodynamically favorable process as a CAr–F 
bond possesses the highest bond dissociation energy (F > Cl > Br > I) (Table 1.1). 13 
Being thermodynamically allowed, transition-metal catalyzed fluorination of aryl halides 
would initially seem a suitable target for catalysis. However, early attempts at examining 





the fluorination of aryl halides/pseudohalides catalyzed by low-valent transition metals 
(i.e. Ni, Pd, Pt, Ru, Co and Rh) were unsuccessful (Scheme 1.4). 14 
Scheme 1.4 Simplified Proposed Catalytic Cycle for Metal-Catalyzed C–F Bond 
Formation 
 
Table 1.1 Ph–X Bond Strengths for X = F, Cl, Br, I13 
X Ph–X Bond Strengths (kcal/mol) 





For example, in 2002, Grushin reported the synthesis and characterization of the first 
palladium fluoride complex (PPh3)2PdPhF.15 However, this PdII complex did not undergo 
reductive elimination to form the desired Ph–F upon heating (Scheme 1.5). This study 
identified reductive elimination of aryl fluoride from PdII as the challenging step of this 
transformation. 
Scheme 1.5 Grushin’s First Isolated Pd(II)PhF Complex
 
Mechanistic studies by Hartwig and coworkers revealed the relationship between 
electronegativity of halogens and activation energy in the context of CAr–X bond 
formation from {Pd[P(o-tol)3](Ar)(μ–X)}2 (X = Cl, Br and I) (Scheme 1.6). 16  First, 
increasing electronegativity of the reacting halide increases the thermodynamic driving 
force but decreases the rate (i.e. increases the activation energy) for reductive 
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of the resultant product Ph–X, while the rates of reductive elimination of aryl halides 
showed the opposite trend. Faster rate of reductive elimination for bromoarene and 
iodoarenes were attributed to the higher polarizability and greater electron-donating 
ability of these halogens. This explains why the reductive elimination to form a 
thermodynamically feasible CAr–F bond is kinetically challenging. Second, in their study, 
the reductive elimination of haloarene occurs via a three-coordinated arylpalladiumII 
halide monomer by cleaving the starting dimer, accompanied by the ligation of P(t-Bu)3. 
Therefore, since the starting dimers were shown thermally stable unless the addition of 
ligand to facilitate the cleavage of M–F bridge, it suggested the fluoride-bridged dimer 
can be similarly a resting state of PdIIArF complex before reductive elimination to occur.  
Scheme 1.6 Csp2–Halogen Bond Formation: Kinetics vs. Themodynamics  
 
Table 1.2 Comparision of Thermodynamics and Kinetics Involving Csp2–Halogen Bond 
Formation 
X Keq Ph–X (kcal/mol) kobs (s-1) 
Cl 9.0 x 10-2 96 1.28 x 10-4 
Br 2.3 x 10-3 81 1.42 x 10-4 
I 3.7 x 10-5 65 -- 
In 2007, Yandulov computationally and experimentally studied aryl fluoride reductive 
elimination from PdII. 17   His computational studies revealed that the monomer 
LPdII(Ar)(F) forms a fluoride-bridged dimer that is stable to reductive elimination. 
Experimentally, it was shown no reductive elimination of 4-fluoronitrobenzene was 
observed from {Pd[P(o-tol)3](p-NO2Ph)(μ–F)}2 after stirring at 60 °C for a week (Scheme 
1.7). Thus, the stable PdII dimer formation was identified as the key remaining obstacle 




















Scheme 1.7 Thermal Reactivity of Pd-F Dimer  
 
Shortly after, Buchwald and coworkers disclosed the Pd-catalyzed nucleophilic aromatic 
fluorination of aryl triflates using CsF as a fluorinating reagent. A bulky monodentate 
biarylphosphine ligand, BrettPhos, was found to stabilize a three coordinate 
intermediate that subsequently underwent reductive elimination. This was the first 
example of nucleophilic fluorination achieved through a Pd0/II catalytic cycle.18 Despite 
this advancement, this fluorination method still has a limited substrate scope, results in 
the formation of undesirable regioisomers,19 and requires long reaction times. More 
recent efforts have demonstrated Pd-catalyzed fluorination of aryl triflates and aryl 
bromides under milder conditions.20 
Scheme 1.8 Pd0/II-catalyzed Nucleophilic Aromatic Fluorination18-20 
 
Collectively, these examples demonstrate that reductive elimination of haloarenes from 
PdII center is a challenging transformation. As an alternative approach for CAr–F bond 
formation, the Sanford lab has employed electrophilic fluorinating reagents (F+) to 
access high-valent PdIV(Ar)F complexes.21,20 This high-energy intermediate can then 
undergo facile reductive elimination to form the desired CAr–F product (Figure 1.4).22 
The thermodynamic instability of PdIV is believed to be a driving force for this difficult 
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Figure 1.4 Conventional Pd0/II vs. High-Valent PdII/IV Catalytic Cycles 
 
In 2006, the Sanford lab disclosed the first PdII/IV catalyzed aryl fluorination of C–H 
bonds using N-fluoropyridinium oxidants as the electrophilic fluorinating oxidant.23 More 
recently, the Yu lab further extended our initial work in CAr–F bond formation.24 Another 
closely related example is Ritter’s Ag-catalyzed electrophilic fluorination of aryl 
stannanes, 25,26  aryl boronic acids27 and aryl silanes28 using Ag catalyst and Selectfluor. 
In all cases, the current limitations are the use of electrophilic fluorinating reagent as an 
oxidant in conjunction with use of noble metals (Scheme 1.9). Although our group has 
demonstrated reductive elimination of aryl fluorides from putative PdIV intermediates, 
these above oxidative C-F bond forming processes are unfortunately not readily 
amenable to integration into alkali MF-based catalytic fluorination cycles. This 
transformation requires the use of expensive F+ reagents in stoichiometric amounts. 
Hence, for a scale-up synthesis, it remains cost-prohibitive and it is unsuitable for PET 
chemistry,29 as nucleophilic fluoride is preferred for this application.  
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1.6 TRANSITIONING TO NOVEL, MORE COST-EFFECTIVE APPROACH  
The goal of my thesis is to develop novel nucleophilic fluorination methods that are 
practical and efficient. A key unmet need in the field is a mild and general aryl 
fluorination protocol, allowing CAr–F bond formation at a late stage of syntheses of 
complex molecules, using nucleophilic fluoride (Scheme 1.10). In order to solve this 
long-standing challenge, we have considered two approaches towards nucleophilic 
fluorination: Cu-catalyzed fluorination and Pd-catalyzed decarbonylative fluorination.  
Scheme 1.10 Transition Metal-Catalyzed Fluorination 
 
Cu-catalyzed Nucleophilic Fluorination. In order to target a milder reaction that is more 
functional group compatible and inexpensive, one strategy is to find a means to oxidize 
a metal center to access high-valent intermediates in the presence of oxidant and 
nucleophilic fluoride. We hypothesized that such an approach might be feasible with Cu 
catalysis.30 The use of ‘high-valent’ organometallic copper intermediates has recently 
been used to achieve difficult bond formations (Scheme 1.11). The development of 
copper and palladium catalysis has been closely related as both metals have been used 
extensively in the construction of similar types of carbon–carbon and carbon–
heteroatom bonds.30 Therefore, one of my thesis goals is aimed towards developing a 
novel, more cost-effective fluorination approach utilizing nucleophilic fluoride sources 
(F–) and copper, an inexpensive and earth-abundant first row transition metal (Scheme 
1.14). High-valent CuIII, like PdIV, should facilitate the formation of challenging bonds 















Scheme 1.11 Moving Towards More Cost-Effective Approach: High-Valent 
Organometallic Copper Chemistry for Achieving C–F Bond Formation 
 
This investigation was further inspired by work from the Ribas lab in which C–F 
bond formation at CuIII was demonstrated utilizing a macrocyclic ligand (Scheme 1.12). 
Although Riba’s report only shows a single substrate for such transformation, 
computational studies revealed low activation barriers for the reductive elimination step. 
Their excellent work fueled our interest in the use of Cu for developing more general 
fluorination methods. The low cost of Cu compared to other noble metals renders it a 
particularly attractive alternative. Hence, copper mediated fluorination has become a 
rapidly developing field of research. However, when my investigation first started, there 
was no general Cu fluorination method that used substoichiometric/catalytic amounts of 
Cu.  
Scheme 1.12 Riba’s Cu-catalyzed Halide Exchange 
 
The first objective of my thesis was to develop a general Cu-catalyzed/mediated-
fluorination method that proceeded via high-valent CuIII intermediates. This 
transformation would be highly cost effective and could extend the current scope of 
























valent Cu intermediate (Scheme 1.13). While we are investigating our Cu-mediated 
fluorination, many including Hartwig and Ritter, have contributed to the field.32  
Scheme 1.13 Premise of My Thesis Objectives 
 
Pd-Catalyzed Decarbonylative Fluorination. The second aim of my thesis was to 
develop a transition metal catalyzed nucleophilic fluorination utilizing non-alkali metal 
fluoride sources. One drawback of the fluorination is the poor solubility of alkali metal 
fluorides. The ideal fluoride reagent is KF because of its abundant availability and low 
cost, but the rate of reaction can be hindered by the low solubility of fluoride in organic 
solvents such as DMSO, DMF or CH3CN. This often leads to a necessity of phase 
transfer catalysts (tetraalkylammonium salts, phosphonium salts or cryptands).33 One of 
the underexplored fluorinating reagents is benzoyl fluoride. Doyle first demonstrated the 
use of benzoyl fluoride as a fluorinating reagent for asymmetric epoxide opening 
reactions (Scheme 1.14).34 (–)-Tetraamisole and DBN were utilized as Lewis bases that 
could attack the carbonyl to expel a nucleophilic fluoride. This well-solvated nucleophilic 
fluoride was then reacted with external electrophiles.  
Scheme 1.14 Doyle’s Asymmetric Epoxide Opening Fluorination 
 
One can envision that electron-rich transition metals could insert into the Cacyl–F bond at 
the oxidative addition step, followed by decarbonylation and reductive elimination of aryl 
fluorides to complete the catalytic cycle (Figure 1.4). As an added advantage, acyl 
fluorides are known to be stable to column chromatography and easily accesible from 
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demonstrated by Manabe and his colleagues.35 They recently have shown that Pd-
catalyzed carbonylative fluorination to produce acid fluoride products is possible using 
N-formyl saccharin as a CO source (Scheme 1.15).  
Scheme 1.15 Manabe’s Pd-Catalyzed Fluorocarbonylation 
 
Though there is no mechanistic proposal in the article, this protocol suggests the 
accessibility of a putative PdII(Acyl)F complex. Furthermore, Grushin and coworkers 
previously observed the formation of (PPh3)2Pd(COPh)F by 1H NMR below 10 oC.36 
Given that Ar–F reductive elimination at PdII has been demonstrated under specific 
reaction conditions,20g we reasoned that the proposed Pd-decarbonylative fluorination 
should also feasible based on microscope reversibility. In addition, a number of 
decarbonylation reactions have been reported at a Pd0 center, thereby supporting the 
feasibility of our proposed method.37  Such a protocol would be efficient and atom 
economical, as the benzoyl fluoride would serve as both the fluoride and aryl source, 
and CO would be the byproduct in the overall transformation (Figure 1.5).  






































In summary, this dissertation describes our work in the development of Cu-
catalyzed fluorination of diaryliodonium salts and its mechanistic elucidation (Chapter 2), 
translation of the Cu method to [18F] fluorination (Chapter 3), and development of Ag18F 
elution and translation of known 19F-methods with Ag18F (Chapter 4). These chapters 
are followed by preliminary studies of the development of decarbonylative 
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CHAPTER 2. CU-CATALYZED FLUORINATION OF 
DIARYLIODONIUM SALTS WITH KF: REACTION DEVELOPMENT 
AND MECHANISTIC INVESTIGATIONS 
2.1 INTRODUCTION 
Over the past decade, tremendous effort has been expended to develop transition 
metal-catalyzed fluorination reactions to address limitations in classical methods. 1 
Nevertheless, carbon–fluorine bond formation remains a challenging chemical 
transformation, especially in the context of general, functional group-tolerant, late-stage 
fluorination of arenes. Ultimately, the direct fluorination of highly functionalized and 
complex small molecules is a critical goal for fluorine chemistry. In addition to the Balz-
Schiemann reaction and halex fluorination (Chapter 1 Scheme 1.1 eq 2), the fluorination 
of diaryliodonium salts is a known method of forming C(aryl)-F bonds and it has been 
known since the first report by Van Der Puy in 1982 (Scheme 2.1).2 This protocol 
typically affords high yield with symmetrical iodonium salts (Ar2I+). In contrast, with 
unsymmetrical iodonium salts (Aryl(auxillary)I+), both the yield and selectivity are often 
significantly diminished.  
However, unsymmetrical aryl(auxiliary)iodonium salts are especially attractive 
precursors because they are inherently less wasteful than their symmetrical 
counterparts, especially in the context of the late-stage fluorination of complex organic 
molecules (Figure 2.1). For example, Emend (Arepitant) is a fluorine-containing anti-
nausea drug for patients undergoing chemotherapy, and the current state-of-art of 
synthesis involves 10 steps. If symmetrical iodonium salts are used for fluorination, 
Emend is accessible regardless of which Ar-I(III) bond is cleaved (Scheme 2.1, eq 1). 
However, the synthesis of the corresponding aryl counterpart (Emend-I) can be time-
consuming and not economical. In addition, the oxidation of Iodine center with highly 
functionalized molecules can be cumbersome. As such, it would be highly 
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advantageous to have a method in which a simple sacrificial aryl counterpart could be 
incorporated in iodine(III) that could direct the incoming fluoride nucleophile to 
functionalize the desired aryl group (Figure 2.1, eq 2).   
Figure 2.1 Symmetrical vs. Unsymmetrical Ar2I+ 
 
Scheme 2.1 Fluorination of Diaryliodonium Salts with KF2 
 
 A key challenge associated with fluorination of unsymmetrical diaryliodonium 
salts is controlling selectivity. It is generally accepted that diaryliodonium salts react with 
nucleophiles under metal-free conditions via a T-shaped Ar2I–Nu intermediate, with the 
nucleophile and one of the aryl groups in the hypervalent bond. The reaction proceeds 
by thermally-induced reductive elimination: ligand coupling between the nucleophile and 
the equatorial aryl group. When the two aryl ligands at the I(III) center are different, the 
two T-shaped intermediates undergo rapid equilibrium through Berry pseudorotation.3 
Previous studies have revealed that at the I(III) center,  nucleophiles preferentially react 












































































(i.e. the so-called “ortho effect”)4 (Figure 2.2). Thus, the selectivity of Ar2I+ fluorinations 
can be increased by appropriate selection of auxiliary ligands on IIII center.  
Figure 2.2 Selectivity in Metal-free Arylation Reactions with Diaryliodonium Salts 
 
Electronic Effects. The selectivity of the reaction is influenced by electronic effects, 
resulting in the functionalization of the less electron rich aryl group via reductive 
elimination. However, it is generally challenging to achieve high selectivity with 
diaryliodonium salts of two electronically similar aryl groups as ligands. In 2008, Coenen 
demonstrated the radiofluorination of electron-rich arenes using the highly electron rich 
2-thienyl group as a directing ligand.5 A positive Hammett value was measured for the 
reaction, which suggests that electron-withdrawing substituents accelerate the reaction 
rate, and, in principle, this should translate to the non-radiofluorination chemistry as well. 
However, using cold fluoride 19F–, low yields were observed with either CsF or KF 
(Scheme 2.2).6 Furthermore, the 2-thienyl iodonium salts are generally challenging to 
synthesize and unstable to long term storage. Hence, this electronic effect is not 
commonly used for achieving the control of regioselectivity and development of a more 
robust approach is still required.  
Scheme 2.2 Electronically-Controlled Selectivity 
 
 Steric effects. Steric influences are another means to control the chemoselectivity 
of nucleophilic functionalizations of diaryliodonium salts.7 An intriguing feature of the 
reaction of diaryliodonium salts with nucleophiles is the influence of substituents, which 
have been reported to direct an incoming nucleophile to attack the ortho-substituted aryl 

















CsF, 80°C: 4 %





originate from two factors: (1) bulkier aryl rings prefer a more spacious equatorial site 
syn to the nucleophile and (2) ortho-substituted aryl rings prefer conformations in which 
the pi-system is aligned with the incoming nucleophile.7,9 However, only a small number 
of electronically similar aryl rings have been investigated and highly electron-rich 
derivatives (for example, 2-Me-4-OMePh) have not been successfully employed.10 
Scheme 2.3 Sterically-Controlled Selectivity 
 
In addition to ortho effects, in 2010 DiMagno and co-workers introduced a 
concept called Stereoelectronic Control of Unidirectional Reductive Elimination 
(SECURE)11 where they demonstrated that sterically bulky cyclophane-derived directing 
groups can forcibly lock the geometry of diaryliodonium salts. Severe out-of-plane, but 
little in-plane steric congestion from the cyclophane group leads to a highly strained 
transition state for reductive elimination (Scheme 2.3). However, this process still 
involves high reaction temperatures and often leads to the formation of regioisomeric 
products (minor product in Scheme 2.3) via aryne intermediates. Furthermore, the 
cyclophane starting material requires a multi-step synthesis.  
Scheme 2.4 DiMagno’s Stereoelectronically-Controlled Selectivity 
 
One possible solution to this challenge is the introduction of catalysis into the 
transformation. Hypervalent iodine(III) oxidants are widely known in transition metal 
catalysis as powerful oxidants, providing access to high-valent Pd(IV), 12  Pt(IV), 13 
Ni(IV)14 and Cu(III)15 intermediates  Not only can I(III) reagents serve as 2e– oxidants, 
but they can also can serve as an aryl source for coupling with a nucleophilic ligand 

























Scheme 2.5 Reactivity of Mesityl Aryl Iodonium Salts with Transition Metals 
 
In particular, seminal reports were disclosed by MacMillan, Gaunt, and Suna in 
which Cu-catalyzed C–H arylation was achieved using diaryliodoinum salts as an aryl 
source.16 With a mesityl group as a sacrificial aryl ligand on I(III), exclusive transfer of 
the smaller aryl group was observed. We hypothesized that the addition of nucleophilic 
fluoride to such reactions would enable C–F bond formation via reductive elimination 
from a high-valent Cu(III) complex (Scheme 2.6). 
Scheme 2.6 Cu-Catalyzed Fluorination of Diaryliodonium Salts with F– 
 
 To develop the proposed transformation, we sought to identify a suitable system 
that enables the selective fluorination of diaryliodonium salts using nucleophilic fluoride 
(F–), with the goal of accessing electron-rich fluoroarenes. The nucleophilic fluorination 
of electron-rich arenes is a long-standing challenge in the field of C–F bond formation, 
since such compounds can not be accessed using traditional SNAr fluorination 
reactions.  
This chapter describes our work towards the development of the Cu-catalyzed 
fluorination of diaryliodonium salts with potassium fluoride. This work represents the first 
example of a general method for nucleophilic fluorination using catalytic Cu.17 Included 
in this chapter are: (1) methodology development and (2) experimental and 


























2.2 RESULTS AND DISCUSSION 
Development of Cu-catalyzed fluorination of diaryliodonium salts with KF. 
Our initial studies focused on developing a Cu-catalyzed method for arene fluorination 
that proceeds under mild conditions. In 2012, Fier and Hartwig reported the first CuI/III-
mediated nucleophilic fluorination of aryl iodides (ArI) using silver fluoride (Scheme 
2.7).19  However, the use of a superstoichiometric non-commercial copper catalyst, a 
high reaction temperature (140 ºC) and long reaction times (22 h) were required. These 
conditions are necessary because of the high energy barrier for oxidative addition of 
iodoarenes to the CuI center, which is the proposed rate-limiting step of the reaction 
(Scheme 2.8a). Furthermore, this methodology does not provide access to electron rich 
fluoroarenes such as 4-fluoroanisole. We envisioned that the use of highly electrophilic 
diaryliodonium salts (Ar2I+), which undergo fast oxidative addition, would enable much 
milder nucleophilic fluorination and potentially address these limitations (Scheme 2.8b). 
Scheme 2.7 Copper-Mediated Fluorination of Iodoarenes (Hartwig)  
 
Scheme 2.8. Proposed Mechanisms 
 
 













































assessing the feasibility of Cu-catalysis through evaluation of a series of different 
copper salts. In the absence of copper salts, only fluoromesitylene 2 was detected by 
19F NMR spectroscopy under our reaction conditions. This selectivity was expected 
based on the previous literature (for example, see Scheme 2.3, above).16 A series of 
Cu(I) and Cu(II) salts were tested in conjunction with KF and 18-crown-6 to solubilize 
the KF. Copper (II) trifluromethanesulfonate [Cu(OTf)2] gave the best yield of 85% with 
an excellent selectivity of 98:2 (Table 2.1, entry 9). Subsequent studies showed that the 
18-crown-6 is unnecessary, but it speeds up the reaction. Overall, this transformation 
reached completion in 3 h, giving 81% yield of 1 and a 97:3 product ratio compared to 
44% yield without 18-crown-6 under otherwise analogous conditions (Table 2.1, entry 
10).  
Table 2.1 Evaluation of Copper Salts 
 
Entry [Cu] Yield Selectivity (1:2) 
1 none 28 1:>99 
2 (tBuCN)2CuOTf 44 >99:1 
3 CuBr 51 92:8 
4 (CH3CN)4CuOTf 73 96:4 
5 Cu(OAc)2 41 >99:1 
6 CuBr2 26 >99:1 
7 CuF2 29 24:76 
8 Cu(TFA)2H2O 22 82:18 
9 Cu(OTf)2 85 98:2 
10a Cu(OTf)2 81 97:3 
11b Cu(OTf)2 44 97:3 
a 0.4 equiv 18-crown-6; reaction time = 3 h. b0 equiv 18-crown-6; reaction time = 3 h 
Substrate Scope: Having confirmed that the mesityl group is a good directing 
group, we next investigated the scope of this transformation with substrates of the 
general structure [Mes-I-Ar]BF4, where Ar = electron rich (hetero)aromatic ring. These 
substrates were the focus of our study because they are typically the most challenging 
substrates for traditional nucleophilic fluorination reactions.20,21 As summarized in Figure 
2.3, fluorinated products 3-26 were all obtained in good yield and high selectivity from 
this reaction. All products with boiling points over 180 ºC were isolated, and the purity of 
20 mol % [Cu]  
1.1 equiv KF
40 mol % 18-crown-6









the isolated products was >98% unless otherwise noted. Gratifyingly, electron-rich 
arenes underwent fluorination smoothly under mild conditions with the use of 
nucleophilic fluoride. As discussed above, many of these products were previously 
difficult to access unless electrophilic fluoride (F+) was used.22 Remarkably, even 2-
fluorothiophene 16 could be formed, albeit under more forcing conditions (130 ºC for 2 
h). This highly electron-rich heterocycle was previously used as a sacrificial directing 
group in uncatalyzed diaryliododium fluorination reactions (Scheme 2.3). With these 
electron rich substrates, the analogous Cu-free reactions proceeded in modest yields 
and provided Mes-F 2 as the major product.  
Substrates bearing electron-withdrawing substituents on the Ar ring were also 
investigated. When the substituents were moderately electron-withdrawing, Cu catalysis 
resulted in significant enhancements in yield and selectivity (e.g., 18-22) relative to the 
uncatalyzed nucleophilic fluorination reaction. Aryl halides (19-21) and aldehyde (22) 
substituents were tolerated under the reaction conditions. Substrates bearing strongly 
electron withdrawing groups (e.g., 24-26) reacted in good yield and selectivity in both 
the presence and absence of Cu. This trend is consistent with prior reports of 
uncatalyzed fluorination of diaryliodonium reagents. One particularly noteworthy 
substrate in this series is chloropyridine 23. Cu-catalyzed fluorination generated 23 in a 
modest 33% yield but with high selectivity for fluorination at the 5-position. This 
substitution pattern is often challenging to access in nucleophilic fluorination reactions 














Figure 2.3 Substrate Scope of Cu-catalyzed Fluorinationa 
 
aConditions: [Mes–I–aryl]BF4 (1 equiv), Cu(OTf)2 (0 or 0.2 equiv), KF (1.1 equiv), 18-crown-6 (0.4 equiv), DMF (0.1 
























































































































































product). dWith 0.5 equiv Cu(OTf)2. e5 equiv of CsF, 130 ºC, 2 h. fWith 1 equiv of Cu(OTf)2. g95% purity. hWith 1.1 
equiv CsF at 25 ºC. 
As expected, a large erosion in selectivity was observed with electron rich 
substrates bearing ortho-substituents (eq 1). For instance, 27 underwent unselective 
fluorination to provide a 62% yield of a 50 : 50 mixture of 28 and 2. In contrast, the 
electronically similar, but less sterically hindered substrate 29 afforded 91% yield of 30 
with high selectivity (30 : 2 = 99 : 1). The chemoselectivity and yield of 1-
fluoronaphthalene could be enhanced with an even more sterically congested directing 
group 2,6-diisopropylphenyl (31b) to afford 70% yield with high selectivity (32:2 = 94:6) 
(eq 3).  
 
In summary, a Cu-catalyzed fluorination of diaryliodonium salts with KF was 
developed. This is the first general fluorination process that uses catalytic Cu to achieve 
high yields and selectivities with electron-rich arenes. The iodonium substrates are 
readily available in a single step from commercial MesI(OAc)2 and diverse boronic acid 
derivatives, and the less-sterically hindered aryl ligand on iodine is fluorinated with high 
selectivity. 
 Mechanistic investigations into CuI/III-Catalyzed Fluorination of 
Diaryliodonium Salts. We next sought to elucidate the mechanism of this highly 
I
BF4– 20 mol % Cu(OTf)21.1 equiv KF
DMF, 60 ºC, 18 h
F F
+
 50:50, 62% yield
(1)
I
BF4– 20 mol % Cu(OTf)2
1.1 equiv KF
DMF, 60 ºC, 18 h
F F
+
 99:1, 91% yield
(2)
20 mol % Cu(OTf)2






(31a) DG1 = mesityl
(31b) DG2 = 2,6-diisopropylphenyl
(3)
DG1 = 91:9, 45% yield









practical fluorination reaction. Over the past several years, there have been numerous 
studies on the development of Cu-catalyzed cross-couplings of diaryliodonium salts with 
diverse coupling partners.23,24,25,26 Although a number of literature reports have probed 
the mechanisms of metal-free reactions of diaryliodonium salts with nucleophiles,27 
there is still little known about the detailed mechanism of aryl transfer from 
diaryliodonium salts to transition metals like Cu.28 For example, the nature of the active 
Cu catalyst that reacts with the diaryliodonium salt has not been elucidated in most 
systems. Furthermore, the mechanistic origin of the selectivity of aryl transfer from 
unsymmetrical I(III) reagents to transition metal centers is poorly understood.27 We 
propose that the Cu-catalyzed fluorination of diaryliodonium salts proceeds via a CuI/III-
catalytic cycle (Figure 2.4). In this part of chapter, our computational and experimental 
mechanistic investigation of the Cu-catalyzed fluorination protocol is detailed. To gain 
further mechanistic insights, Prof. Allan Canty conducted density functional theory 
(DFT) calculations on the Cu(OTf)2-catalyzed fluorination of [Ph-I-Mes]BF4 with KF. 




 Time studies: Our initial mechanistic proposal involves Cu(I) as the active 
catalyst (Scheme 2.7a). As such, we were intrigued that a copper(II) precatalyst gives a 
better overall yield.  When an analogous Cu(I) salt [(CH3CN)4CuIOTf] was used, it led to 
a lower yield of 73% (Table 2.1, entry 4). In order to probe the reactivity of these Cu 
salts in more detail, we selected (CH3CN)4CuOTf and Cu(OTf)2 as pre-catalysts and 



























120 minutes of the reaction, suggesting that the CuI salt may form an active catalyst 
more rapidly under the reaction conditions (Figure 2.5). However, the Cu(OTf)2 catalyst 
provided a higher yield of 85% yield at 18 hours (Scheme 2.8, eq 1). GC-MS analysis 
and isolation of the side product confirmed the formation of biphenyl as a by-product in 
10% yield (along with traces of benzene, mesitylene and diphenyl ether) (Scheme 2.9, 
eq 2); thus, we concluded that for promoting the desired fluorination reaction, Cu(II) is a 
more ideal pre-catalyst since there are less of side products formed under the 
conditions.  
Scheme 2.9 Effect of Catalyst Source (CuI vs. CuII) 
 
Figure 2.5 PhF Formation as a Function of Time in the Reaction of [Mes(Ph)I]+ with KF 
Catalyzed by Cu(OTf)2 (u, red)and Cu(OTf)(CH3CN)4 (, orange) in DMF at 60 ºC 
 
Oxidation state of the Copper catalyst: Literature reports of Cu-catalyzed 
transformations often propose Cu(I)/Cu(III) catalytic cycles; however, few mechanistic 
studies have been conducted to probe the oxidation state of the active catalyst that 
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CuII(OTf)2 were subjected to the standard reaction conditions with various solvents. A 
strong solvent dependence was observed for reactions catalyzed by both copper 
complexes. Dipolar aprotic solvents such as DMF and NMP showed high selectivity and 
good yields whereas ethyl acetate and toluene afforded low yields. Interestingly, in 
EtOAc and toluene, the Cu catalyzed reactions switched the selectivity and favored 
fluoromesitylene 2 as a major product. Moreover, reactions catalyzed by CuI salts 
resulted in lower yields than those catalyzed by CuII salts (all but NMP solvent, Table 
2.2).  
Table 2.2. Cu-catalyzed Fluorination of [Mes(Ph)I]+ as a Function of Cu Precatalyst and 
Solvent 
 
Solvent [Cu] Yield (PhF:MesF) 
DMF Cu(OTf)2 85% (98:2) 
DMF Cu(OTf)(CH3CN)4 73% (99:1) 
NMP Cu(OTf)2 38% (95:5) 
NMP Cu(OTf)(CH3CN)4 55% (>99:1) 
EtOAc Cu(OTf)2 39% (13:87) 
EtOAc Cu(OTf)(CH3CN)4 39% (13:87) 
toluene Cu(OTf)2 35% (14:86) 
toluene Cu(OTf)(CH3CN)4 34% (13:87) 
It is worth noting that the fluorination process was also tested using a 4 : 1 
mixture of EtOAc/DMF as solvent (0.1 M in PhIMes). Gratifyingly, this solvent system 
afforded 86% overall yield (98 : 2 selectivity) while using only EtOAc as solvent could 
not result in the desired selectivity (Scheme 2.10). 
Scheme 2.10 Co-Solvent (DMF/EtOAc) for the Cu-catalyzed Fluorination 
  
This set of results led us to hypothesize that the two precatalysts might be 
operating via an analogous CuI active species. In the case of Cu(OTf)2, the copper 
20 mol % [Cu]
solvent





20 mol % Cu(OTf)2
EtOAc/DMF (4:1)









catalyst is presumably reduced to CuI in situ, accounting for the slower initial rate with 
this precatalyst (Figure 2.1). Notably, DMF is known to reduce transition metals.29 To 
test for this possibility, we aimed for colorimetric detection of CuI by means of CuI 
trapping experiments. Lockhart has demonstrated that 2,2’-biquinoline (biq) has a 
strong binding affinity for CuI, and the resulting complexes exhibit a characteristic 
intense purple color (λmax = 540 nm).30 Thus, we used this ligand to interrogate the 
oxidation state of Cu formed when Cu(OTf)2 is dissolved in a variety of solvents (Table 
2.3).  An intense purple color was observed in DMF and NMP within 5 min at room 
temperature in both the presence and absence of 1.1 equiv of KF, indicating the 
formation of CuI in these solvents. UV-vis spectroscopic analysis of these purple 
solutions showed a λmax between 540 and 550 nm, further consistent with the formation 
of CuI under these conditions. In sharp contrast, when Cu(OTf)2 and biq were stirred in 
EtOAc or toluene, an orange precipitate formed, which is indicative of the formation of 
[CuII(biq)2].31 This orange precipitate was then treated with DMF, and it immediately 
turned to intense purple solution at room temperature. Overall, this experiment 
supported the hypothesis that DMF is necessary for reduction of CuII to CuI to occur at 
60 oC. Different selectivity was observed depending on solvents, and DMF is proven 
necessary for an active CuI  species based on observation of the selectivity analogous 
to metal-free reactions in EtOAc and toluene. Thus, we concluded that CuI species are 
available with both the Cu(OTf)2 and Cu(OTf)(CH3CN)4 precatalysts, and that CuI is 













Table 2.3.  CuI/II Trapping Experiment 
 
 
[Cu] Solvent λmax Color 
Cu(OTf)2 DMF 540 dark purple solution 
Cu(OTf)(MeCN)4 DMF 540 dark purple solution 
Cu(OTf)2 NMP 550 light purple solution 
Cu(OTf)2 EtOAc n/a orange precipitate 
Cu(OTf)2 toluene n/a orange precipitate 
 
Evaluation of Fluoride Salts: We next sought to evaluate a series of fluoride salts 
to test if we can further enhance both yield and selectivity in these systems. In sharp 
contrast to KF, which is not readily soluble in DMF at room temperature, reactions 
conducted with more soluble salts such as CsF or Me4NF led to a switch in the ratio of 
1:2 (Table 2.4 entry 2, 4 respectively). This result was intriguing as it suggests that a 
high initial concentration of fluoride in the reaction mixture readily generates the 
undesired product 2, and that was counterintuitive, as low solubility of KF and CsF is 
always discussed as a challenge associated with nucleophilic fluorination reactions.  










with or without 1.1 equiv KF
(results were identical)
0 or 20 mol % Cu(OTf)2
1.1 equiv F– salt
40 mol % 18-crown-6

















1 KF 39 18:82 85 98:2 
2 CsF 93 22:78 72 21:79 
3 AgF 9 22:78 13 85:15 
4 Me4NF 78 28:72 40 25:75 
5 Bu4NF 57 28:72 69 26:74 
32 
	
 Computational Studies on Ligand Exchange at I(III) center and Cu:  The results in 
Table 2.4 suggest that a low initial concentration of fluoride is key for a selective 
transformation. In order to better understand this observation, we turned to DFT 
calculations in collaboration with Prof. Allan Canty from University of Tasmania, 
Australia. 32  His DFT calculations show that both Cu and [(Mes)(Ph)I]+ are 
thermodynamically favored to bind to F– (entries 3, 6-9). In DMF, the cationic form of the 
iodonium salt ([Mes(Ph)I]+ 3) undergoes facile oxidative addition to the CuI catalyst 
However, when there is a high concentration of fluoride in solution, 3 is readily 
concerted to Mes(Ph)IF (4). Compound 4 is not reactive with CuI, and instead 
undergoes uncatalyzed reductive elimination to selectively form the undesired product 
MesF (2) (Scheme 2.10). Hence, we hypothesized that the dramatic change in 
selectivity with more soluble fluoride sources is due to a change in the resting state of 
the diaryliodonium salt from the cation [Mes(Ph)I]+ to the neutral species 
Mes(Ph)IF(Scheme 2.10). 
Table 2.5 Computation for Reactions of CuI and [Mes(Ph)I]+ with Donor Ligands 
Present During Cu-Catalyzed Reactions 
Entry  Ligand Exchange at IIII and CuI centers  ΔG  
(kcal/mol) 
1 [Mes(Ph)I]+ + DMF→[Mes(Ph)I(DMF)]+     2.7 
2 [Mes(Ph)I]+ + OTf–→Mes(Ph)I(OTf) 1.6 
3 [Mes(Ph)I]+  +  F–→Mes(Ph)IF –15.7 
4 [Cu(DMF)2]+ + OTf– →Cu(OTf)(DMF) + DMF 0.7 
5 Cu(OTf)(DMF) + OTf–→[Cu(OTf)2]– + DMF 2.0 
6 [Cu(DMF)2]+ + F– →CuF(DMF) + DMF –20.7 
7 CuF(DMF) + F–→ [CuF2]– + DMF –16.4 
8 [Cu(OTf)2]+ +  F– →[CuF(OTf)]– + OTf– –20.8 
9 [CuF(OTf)]–  +  F–→[CuF2]– + OTf– –19.1 
 














Impact of KF Stoichiometry: To test this proposal experimentally, we examined 
the impact of the ratio of KF to (Cu(OTf)2 + 3) on catalysis. These studies were 
conducted using 20 mol % of Cu(OTf)2 and 1 equiv of [Mes(Ph)I]+, and the amount of 
KF was varied from 0.5 equiv to 3.0 equiv relative to the iodonium reagent. At 1.4 equiv 
of KF, the iodonium reagent should be saturated with F–, assuming that all of the KF is 
soluble. The extent of Cu-catalysis versus the uncatalyzed, background reaction can be 
estimated based on the ratio of products PhF: MesF. Under Cu-catalyzed conditions, 
PhF is favored by ≥97: 3, while the uncatalyzed reaction affords an approximately 20 : 
80 ratio of PhF : MesF. As shown in Table 2.6, an outcome consistent with Cu catalysis 
was observed up to 1.25 equiv of KF. However, significant erosion of selectivity was 
observed at 1.5 equiv suggesting that presence of excess fluoride is detrimental. 
Furthermore, with 2.0 or more equiv of KF, the observed selectivity was identical to that 
of the uncatalyzed reaction, suggesting that the iodine(III) reagent has been completely 
converted to 4 and no Cu catalysis is occurring under these conditions 




Yield PhFa Yield MesFa Ratio (PhF:MesF) 
1 0.5 37% <1% >99 : 1 
2 1.1 83% 1% 99 : 1 
3 1.25 74% 2% 98 : 2 
4 1.5 25% 22% 53 : 47 
5 2.0 10% 40% 20 : 80 
6 3.0 9% 34% 21 : 79 
      To further probe the hypothesis, slow addition of Bu4NF•3H2O was performed. By 
adding 2.0 equiv of Bu4NF•3H2O in DMF dropwise over 7 hours, the exclusive formation 
of 1 was observed, which is complementary to the result of the addition of 2 equiv of 
Bu4NF•3H2O in one portion (Scheme 2.12). This further indicates that Cu catalysis is 
slower with high KF concentration in the reaction.  
 
20 mol % Cu(OTf)2







Scheme 2.12 Slow addition of Bu4NF•3H2O 
 
Potential Fluorocopper(I) Reactants: The computations in Table 2.5 also illustrate 
the competitive nature of DMF and triflate as ligands for CuI (entries 4 and 5). We 
therefore computationally examined the possibility of three different active CuI 
complexes as reactants in the oxidative addition step: [Cu(OTf)F]–, Cu(DMF)F and 
[CuF2]– Their thermodynamic profile was successfully computed and found to be very 
similar to each other, differing by less than 3.3 kcal mol-1 (Figure 2.6). Under the 
standard fluorination conditions, the formation of all three CuI species is possible; 
consequently, we next computed reasonable energy pathways for the formation of 
fluorinated product 1. DFT calculations show four low energy pathways for oxidative 
transfer of Ph+ from [Mes(Ph)I]+ to CuI. These pathways proceed from [CuF(OTf)]– (2 
pathways), [CuF(DMF)] (1 pathway) and [CuF2] (1 pathway). These are all likely feasible 
under the standard reaction conditions (Figure 2.6).  
Figure 2.6 Three Possible Active CuI Complexes Generated in Situ 
 
 The concentration of DMF relative to Cu(OTf)2 under the standard reaction 
conditions is 12.9 M; thus, the formation of CuF(DMF) seems very likely. For CuF(DMF), 
the energy profile of the pathway to product formation is shown in Figure 2.6, and all 
barriers are reasonable. However, the activation energies for all transfer reactions are 
higher than the lowest energy pathways for [Cu(OTf)F]– and [CuF2]–, noting the 
uncertainties in comparing energy barriers between the three systems. Furthermore, the 
20 mol % Cu(OTf)2
DMF, 60 ºC, 18 h
F FI
BF4
29% yield of ArF; PhF : Mes F = 18 : 78Bu4NF added in one portion:
2.0 equiv Bu4NF•H2O
(1) (2)
Bu4NF added slowly over 7 h: 29% yield of ArF; PhF : MesF = >99 : 1
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energy pathway from CuF(DMF) does not lead to a viable transition structure for mesityl 
group transfer. Notably, reductive elimination of PhF from (DMF)CuIIIFPh is a very facile 
process (from B to C via TS-B), only requiring a ΔG‡ of 3.6 kcal/mol, which is 
substantially lower than for the oxidation processes. Ribas and co-workers previously 
computed C–F bond-forming reductive elimination at a five-coordinated CuIII center 
containing a tetradentate macrocyclic ligand, [CuIIIF(L-C,N,N’,N’)]+ (see Scheme 1.12 in 
Chapter 1).33 For this macrocycle, a ΔG‡ of 16.2 kcal/mol was calculated, which is 
notably higher than in the current system. This may be due to either (1) the extra 
stability provided by their polydentate ligand and/or (2) the differences between 
reductive elimination from four- versus five-coordinate CuIII centers. Further studies will 
be required to delineate this difference.  
Figure 2.7 Energy profile for the Energy profile for the reaction of [Mes(Ph)I]+ with 
CuF(DMF) at 60°C. Energies ΔG(ΔH) in kcal/mol. 
 
 
Two other possible active CuI species ([CuF(OTf)]– and [CuF2]–) were computed 














































data do not definitely rule out one species over the other as the active species for the 
catalytic fluorination reaction. We attempted to experimentally probe the [CuF2]– 
pathway by using CuF2 as a precatalyst; however, this Cu salt only works when an 
equimolar amount is present relative to [ArMesI]+. When substoichiometric amounts of 
CuF2 are present, the selectivity is switched to fluoromesitylene 2. This might be due to 
the low concentration of fluoride in the reaction.  




In summary, this chapter has described a mild Cu-catalyzed nucleophilic 
fluorination of unsymmetrical diaryliodonium salts with KF. Using the mesityl group as 
auxiliary directing ligand at the I(III) center, this protocol preferentially fluorinates the 
less sterically hindered aromatic group. The reaction exhibits a broad substrate scope 
(particularly with electron rich arene substrates) and proceeds with high 
chemoselectivity and functional group tolerance. A combination of experimental and 
density functional theory (DFT) investigations provide evidence for a CuI/CuIII catalytic 
cycle. The key to selective Cu-catalyzed fluorination is to keep the fluoride 
concentration low relative to the iodonium reagent. This allows the cationic [Mes(Ar)I+] 
to be available for oxidative “Ar+” transfer to the CuI center with one or two fluoride 
ligands: Cu(DMF)F, [CuF(OTf)]– and [CuF2]–. Energy profiles of these possible Cu 
catalysts were computationally evaluated, and it was found that all show low-energy 
pathways to fluorinated products. In all cases, oxidative addition is computed as the 
rate-limiting step. Reductive elimination to form the Ar–F bond is computed to be very 




2.4 PERSPECTIVE AND OUTLOOK 
Although Cu-catalyzed fluorination of (Mesityl)(Aryl)iodonium salts with KF 
demonstrates superior reactivity to other precursors such as aryl halides/pseudohalides, 
direct access from readily available reagents would be very desirable. Along these lines, 
forming diarylidonium salts in situ would offer an even more practical method. This in 
situ generation would avoid the cumbersome step of isolation of the iodonium species. 
As a preliminary result, 19% of 1,4-difluorobenzene was obtained when potassium 4-
fluorophenyl trifluoroborate and bis(trifluoroacetoxy)iodobenzene were heated with 1 
equivalent of Cu(OTf)2 at 90 ºC, followed by addition of 1.4 equivalents of KF at 60 ºC 
(Scheme 2.13). Further optimization is required, but this result suggests that the 
possibility of a one-pot approach to fluoroarenes from aryl trifluoroborate salts and 
commercially available I(III) reagents. It would be a highly practical method toward 
making a wide variety of clinically relevant molecules, especially in drug discovery as 
well as PET radiotracers.  


















Synthesis of Diaryliodonium Salts:  
 
General Procedure A: Tetrafluoroborate Salts. [Ar–I–Mes]BF4 substrates were 
prepared by the following procedure adapted from the literature: 35  the indicated 
arylboronic acid (1.0 equiv) and CH2Cl2 (0.075 M) were combined in an oven-dried 
round-bottom flask equipped with a stir bar. The mixture was cooled to 0 ºC, BF3•OEt2 
(1.10 equiv) was added, and the mixture was stirred for 10 min. 2-
(Diacetoxyiodo)mesitylene (1.05 equiv) was then added as a solution in CH2Cl2 (0.33 M), 
and the mixture was warmed to room temperature and stirred for 2 h. The reaction was 
quenched by the addition of sat. aqueous NaBF4. After 30 minutes of vigorous stirring, 
the aqueous layer was extracted with CH2Cl2 (2x). The combined organic layers were 
dried over MgSO4, filtered, and concentrated under vacuum. Et2O was added to the 
residual solid and the diaryliodonium tetrafluoroborate was collected via filtration, 
washed with Et2O, dried under vacuum overnight, and stored in a drybox under N2 until 
use.  
 
General Procedure B: Triflate Salts. [Ar–I–Mes]OTf substrates were prepared by the 
following procedure adapted from the literature:36 to an oven-dried round-bottom flask 
equipped with a stir bar was added m-CPBA (1.10 equiv), CH2Cl2 (0.20 M), the 
indicated iodoarene (1.00 equiv), and mesitylene (1.10 equiv). The mixture was cooled 
to 0 ºC and TfOH (2-3 equiv) was added dropwise while stirring. The reaction was then 
warmed to room temperature and stirred for 2 h. The solvent was removed under 
vacuum and Et2O was added to provide a heterogeneous mixture, which was cooled to 




    CH2Cl2, 0 °C, 10 min
2. MesI(OAc)2, rt, 2h








TfOH (2-3 equiv) 






funnel, washed with Et2O, dried under vacuum overnight, and stored in a glovebbox 
under N2 until use. 
 
General Procedure for the Fluorination of Diaryliodonium Salts with KF. 
General Procedure a Cu-Catalyzed Reaction on Small Scale. In a glovebox, 
substrate (0.05 mmol, 1 equiv), Cu(OTf)2 (3.6 mg, 0.01 mmol, 0.2 equiv unless 
otherwise noted), KF (3.2 mg, 0.055 mmol, 1.1 equiv unless otherwise noted), and 18-
crown-6 (5.3 mg, 0.02 mmol, 0.4 equiv) were combined with DMF (0.5 mL) in a 4 ml vial. 
The vial was sealed with a Teflon-lined cap, and the reaction mixture was stirred at 60 
ºC for 18 h unless otherwise noted. After cooling to room temperature, the reaction was 
quenched with sat. aqueous NaHCO3 (0.5 mL), and 1-fluoro-3-nitrobenzene (5.3 μl, 
0.05 mmol, 1 equiv) was added as an internal standard. The reaction mixture was 
diluted with CH2Cl2 (2 mL), and was analyzed by 19F NMR spectroscopy and GC-MS.  
General Procedure b: Non-Catalyzed (Cu-Free) Reaction on Small Scale. Reactions 
were conducted analogously to General Procedure A, but in the absence of Cu. 
General Procedure c: Cu-Catalyzed Reaction on Larger Scale for Isolation. 
Reactions were conducted analogously to General Procedure A, but on a 0.1–0.5 mmol 
scale as indicated. After quenching with NaHCO3, the mixture was extracted with 
pentane (3 x 10 mL) and the combined organic layers were dried over MgSO4, filtered, 
and concentrated by rotovap at 0 ºC. The resulting crude residue was purified by flash 
column chromatography. 
20 mol % Cu(OTf)2








a. Mesityl(Aryl)iodonium Salts: 
Diaryliodonium Salt 1. General procedure A was followed 
using phenylboronic acid (1.22 g, 10 mmol), providing 1 as an 
off-white solid (2.79 g, 68% yield). The 1H, 13C, and 19F NMR 
spectroscopic data were identical to that reported previously in 
the literature.37 HRMS [M-BF4]+ Calcd for C15H16I+: 323.0291; 
Found: 323.0301.  
Diaryliodonium Salt 2. General procedure A was followed 
using 4-(tert-butyl)phenylboronic acid (267 mg, 1.5 mmol), 
providing 2 as a white solid (510 mg, 73% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 7.86 (d, J = 8.4 Hz, 2H), 7.50 (d, J 
= 8.4 Hz, 2H), 7.21 (s, 2H), 2.60 (s, 6H), 2.29 (s, 3H), 1.24 
(s, 9H). 13C NMR (176 MHz, DMSO-d6): δ 154.7, 142.9, 141.4, 134.1, 129.7, 128.9, 
123.2, 111.8, 34.8, 30.7, 26.3, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. 
HRMS [M-BF4]+ Calcd for C19H24I+: 379.0917; Found: 379.0924. 
Diaryliodonium Salt 3. General procedure A was followed 
using 4-methoxyphenylboronic acid (454 mg, 3.0 mmol), 
providing 3 as an off-white solid (1.01 g, 76% yield). The 
1H, 13C, and 19F NMR spectroscopic data were identical to 
that reported previously in the literature.38 HRMS [M-BF4]+ 
Calcd for C16H18IO+: 353.0397; Found: 353.0404. 
Diaryliodonium Salt 4. General procedure A was followed using 3-
methoxyphenylboronic acid (454 mg, 3.0 mmol), providing 
4 as a mustard-yellow solid (240 mg, 30% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 7.56 (s, 1H), 7.43-7.40 (multiple 
peaks, 2H), 7.23 (s, 2H), 7.20 (d, J = 7.7 Hz, 1H), 3.78 (s, 
3H), 2.60 (s, 6H), 2.30 (s, 3H). 13C NMR (176 MHz, 
DMSO-d6): δ 160.5, 143.2, 141.7, 132.6, 129.8, 126.0, 123.5, 120.0, 117.2, 114.4, 54.8, 














C16H18IO+: 353.0397; Found: 353.0405. 
Diaryliodonium Salt 5. General procedure A was followed 
using 2-methoxyphenylboronic acid (456 mg, 3.0 mmol), 
providing 5 as a white solid (1.05 g, 100% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 8.15 (d, J = 7.0 Hz, 1H), 7.64 (t, J = 
7.0 Hz, 1H), 7.29 (d, J = 7.0 Hz, 1H), 7.17 (s, 2H), 7.08 (t, J = 7.0 Hz, 1H), 3.87 (s, 3H), 
2.60 (s, 6H), 2.27 (s, 3H). 13C NMR (176 MHz, DMSO-d6): δ 156.6, 142.7, 141.8, 137.6, 
134.6, 129.6, 123.3, 121.5, 113.3, 103.9, 56.8, 25.9, 20.5. 19F NMR (376 MHz, DMSO-
d6): δ –14                                                                                                                                                                   
8.2, –148.3. HRMS [M-BF4]+ Calcd for C16H18IO+: 353.0397; Found: 353.0406. 
Diaryliodonium Salt 6. General procedure A was followed using naphthalene-2-
boronic acid (516 mg, 3.0 mmol), providing 6 as an off-white 
solid (805 mg, 73% yield). The 1H, 13C, and 19F NMR 
spectroscopic data were identical to that reported previously 
in the literature.38 HRMS [M-BF4]+ Calcd for C19H18I+: 
373.0448; Found: 373.0456. 
Diaryliodonium Salt 7 General procedure A was followed using 3,4-
dimethoxyphenylboronic acid (546 mg, 3.0 mmol), providing 
7 as a light brown solid after 3x recrystallization from 
DCM/hexane (1.02 g, 72% yield). 1H NMR (700 MHz, 
DMSO-d6): δ 7.58 (s, 1H), 7.48 (d, J = 7.0 Hz). 7.20 (s, 2H), 
7.02 (d, J = 7.0 Hz, 1H), 3.78 (s, 3H), 3.77 (s, 3H), 2.62 (s, 
6H), 2.29 (s, 3H). 13C NMR (176 MHz, DMSO-d6): δ 151.7, 150.1, 142.9, 141.5, 129.7, 
128.2, 123.0, 117.7, 114.2, 102.8, 56.2, 55.8, 26.3, 20.5. 19F NMR (376 MHz, DMSO-
d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C17H20IO2+: 383.0502; Found: 
383.0508. 
 Diaryliodonium Salt 8. General procedure A was 
followed using 3,4,5-trimethoxyphenylboronic acid (318 
mg, 1.5 mmol), providing 8 as a brown solid (266 mg, 
35% yield). The material was recrystallized 3x from 
















d6): δ 7.28 (s, 2H), 7.22 (s, 2H), 3.77 (s, 6H), 3.67 (s, 3H), 2.65 (s, 6H), 2.30 (s, 3H). 13C 
NMR (176 MHz, DMSO-d6): δ 154.4, 143.1, 141.7, 140.5, 129.7, 122.8, 112.6, 106.8, 
60.4, 56.7, 26.5, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-
BF4]+ Calcd for C18H22IO3+: 413.0608; Found: 413.0613. 
Diaryliodonium Salt 9. General procedure A was followed using 4-
(phenoxy)phenylboronic acid (642 mg, 3.0 mmol), 
providing 9 as a white solid (1.14 g, 76% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 7.97 (d, J = 8.4 Hz, 2H), 7.45 (t, J 
= 8.4 Hz, 2H), 7.25 (t, J = 8.4 Hz, 1H), 7.21 (s, 2H), 7.09 
(d, J = 8.4 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 2.61 (s, 6H), 
2.29 (s, 3H). 13C NMR (176 MHz, DMSO-d6): δ 160.1, 
154.6, 143.0, 141.5, 136.9, 130.5, 129.7, 125.1, 123.0, 120.5, 120.1, 106.0, 26.3, 20.5. 
19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M- BF4]+ Calcd for 
C21H20IO+: 415.0553; Found: 415.0549.  
Diaryliodonium Salt 10. General procedure A was followed using 4-
(benzyloxy)phenylboronic acid (684 mg, 3.0 mmol), 
providing 10 as a white solid (867 mg, 56% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 7.92 (d, J = 9.1 Hz, 2H), 7.42 (d, J 
= 8.4 Hz, 2H), 7.38 (t, J = 8.4 Hz, 2H), 7.33 (t, J = 8.4 Hz, 
1H), 7.19 (s, 2H), 7.11 (d, J = 9.1 Hz, 2H), 5.14 (s, 2H), 
2.60 (s, 6H), 2.28 (s, 3H). 13C NMR (176 MHz, DMSO-d6): δ 160.8, 142.9, 141.3, 136.6, 
136.1, 129.7, 128.5, 128.2, 127.9, 123.1, 118.3, 103.6, 69.7, 26.2, 20.5. 19F NMR (376 
MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C22H22IO+: 429.0710; 
Found: 429.0706. 
Diaryliodonium Salt 11. General procedure A was 
followed using 4-biphenylboronic acid (594 mg, 3 .0 mmol), 
providing 11 as a white solid (1.05 g, 72% yield). The 1H, 
13C, and 19F NMR spectroscopic data were identical to that 
reported previously in the literature. 39  HRMS [M-BF4]+ 












Diaryliodonium Salt 12. General procedure A was 
followed using the corresponding estrone-derived 
boronic acid (prepared by a literature procedure40,41 
(253 mg, 0.8 mmol), providing 12 as an off-white solid 
(342 mg, 73% yield). 1H NMR (700 MHz, DMSO-d6): δ 
7.74 (s, 1H), 7.70 (d, J = 8.4 Hz, 1H), 7.39 (d, J = 8.4 
Hz, 1H), 7.21 (s, 2H), 2.86 (m, 2H), 2.61 (s, 6H), 2.42 (dd, J  = 10.5, 8.4 Hz, 1H), 2.30-
2.29 (multiple peaks, 5H), 2.07 (m, 1H), 1.94 (m, 2H), 1.74 (d, J = 9.1 Hz, 1H), 1.56-
1.46 (multiple peaks, 3H), 1.38-1.37 (multiple peaks, 3H), 0.80 (s, 3H). 13C NMR (176 
MHz, DMSO-d6): δ 219.4, 144.1, 142.9, 141.5, 140.9, 134.4, 131.7, 129.7, 128.9, 2.5, 
111.2, 49.5, 47.2, 43.7, 36.8, 35.3, 31.2, 28.7, 26.4, 25.4, 24.9, 21.1, 20.5, 13.4. 19F 
NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C27H32IO+: 
499.1492; Found: 499.1500. 
Diaryliodonium Salt 13 General procedure A was 
followed using dibenzo[b,d]thien-2-ylboronic acid (315 mg, 
1.4 mmol), providing 13 as a brown solid (464 mg, 77% 
yield). 1H NMR (700 MHz, DMSO-d6): δ 9.15 (s, 1H), 8.52 
(d, J = 7.7 Hz, 1H), 8.19 (d, J = 7.0 Hz, 1H), 8.12 (d, J = 
8.4 Hz, 1H), 8.05 (dd, J = 7.0, 1.4 Hz, 1H), 7.61-7.55 
(multiple peaks, 2H), 7.20 (s, 2H), 2.69 (s, 6H), 2.27 (s, 3H). 13C NMR (176 MHz, 
DMSO-d6): δ 142.9, 142.1, 141.6, 139.1, 137.3, 133.6, 132.0, 129.7, 128.9, 128.4, 
126.5, 125.4, 123.3, 123.2, 122.8, 110.4, 26.4, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –












Diaryliodonium Salt 14. General procedure A was followed using dibenzofuran-4-
boronic acid (636 mg, 3.0 mmol), providing 14 as a white solid 
(1.02 g, 68% yield). 1H NMR (700 MHz, DMSO-d6): δ 8.46 (d, J 
= 7.0 Hz, 1H), 8.32 (d, J = 7.0 Hz, 1H), 8.22 (d, J = 7.0 Hz, 1H), 
7.85 (d, J = 7.0 Hz, 1H), 7.65 (t, J = 7.0 Hz, 1H), 7.53-7.49 
(multiple peaks, 2H) , 7.17 (s, 2H), 2.75 (s, 6H), 2.22 (s, 3H). 
13C NMR (176 MHz, DMSO-d6): δ 155.4, 153.8, 143.5, 142.1, 
134.6, 130.1, 129.6, 126.2, 126.1, 125.9, 124.9, 123.6, 123.4, 122.7, 112.4, 95.4, 26.3, 
20.4. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for 
C21H18IO+: 413.0397; Found: 413.0398.  
Diaryliodonium Salt 15. Substrate 15 was prepared 
according to a literature procedure. 42 The 1H, 13C, and 19F 
NMR were identical to that reported previously. HRMS [M-
BF4]+ Calcd for C13H14IS+: 328.9855; Found: 328.9858.  
 
Diaryliodonium Salt 16. General procedure A was followed 
using 3-(methoxycarbonyl)phenylboronic acid (360 mg, 2.0 
mmol), providing 16 as a white powder (325 mg, 35% yield). 
1H NMR (700 MHz, DMSO-d6): δ 8.49 (s, 1H), 8.13 (d, J = 
7.0 Hz, 1H), 8.07 (d, J = 7.0 Hz, 1H), 7.63 (t, J = 7.0 Hz, 1H), 
7.25 (s, 2H), 3.89 (s, 3H), 2.59 (s, 6H), 2.29 (s, 3H). 13C NMR (176 MHz, DMSO-d6): δ 
164.5, 143.4, 141.7, 138.3, 134.5, 132.3, 132.2, 132.0, 129.9, 122.5, 114.5, 52.9, 26.3, 
20.6. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for 
C17H18IO2+, 381.0346; Found: 381.0353. 
Diaryliodonium Salt 17. General procedure A was 
followed using 4-fluorophenylboronic acid (419 mg, 1.1 
mmol), providing 17 as a white powder (363 mg, 85% yield). 
The 1H and 13C NMR spectroscopic data were identical to 
that reported previously in the literature.37 19F NMR (376 
MHz, DMSO-d6): δ  –107.3 (app tt, J = 9.8, 7.7 Hz), –148.2, 















Diaryliodonium Salt 18. General procedure A was followed 
using 4-chlorophenylboronic acid (235 mg, 1.5 mmol), 
providing 18 as a white powder (310 mg, 45% yield). The 1H 
and 13C NMR spectroscopic data were identical to that 
reported previously in the literature.37 19F NMR (376 MHz, 
DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C15H15ClI+: 356.9901; Found: 
356.9903. 
Diaryliodonium Salt 19. General procedure A was 
followed using 4-iodophenylboronic acid (372 mg, 1.5 
mmol), providing 19 as a white powder (500 mg, 63% 
yield). The 1H and 13C NMR spectroscopic data were 
identical to that reported previously in the literature.34 19F 
NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C15H15I2+: 
448.9258; Found: 448.9256. 
Diaryliodonium Salt 20. General procedure A was followed using 3-formyl-4-
methoxyboronic acid (540 mg, 3.0 mmol), providing 20 as a white solid (323 mg, 23% 
yield). 1H NMR (700 MHz, DMSO-d6): δ 10.3 (s, 1H), 8.18 (s, 
1H), 8.13 (d, J = 9.1 Hz, 1H), 7.34 (d, J = 9.1 Hz, 1H), 7.21 
(s, 2H), 3.95 (s, 3H), 2.59 (s, 6H), 2.30 (s, 3H). 13C NMR 
(176 MHz, DMSO-d6): δ 177.8, 153.2, 133.2, 131.6, 131.5, 
124.0, 119.8, 116.2, 112.9, 106.8, 94.1, 46.7, 16.3, 10.5. 19F 
NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C17H18IO2+: 
381.0346; Found 381.0349. 
Diaryliodonium Salt 21. General procedure B was followed using 2-chloro-5-
iodopyridine (700 mg, 3.0 mmol), providing 21 as a brown 
solid (300 mg, 22% yield). 1H NMR (700 MHz, DMSO-d6): δ 
8.93 (s, 1H), 8.42 (d, J = 8.4 Hz, 1H), 7.69 (d, J = 8.4 Hz, 1H), 
7.23 (s, 2H), 2.61 (s, 6H), 2.30 (s, 3H). 13C NMR (176 MHz, 
DMSO-d6): δ 153.7, 153.1, 145.1, 143.4, 141.7, 129.9, 127.7, 
122.8, 112.2, 26.3, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –


















Diaryliodonium Salt 22. General procedure A was 
followed using 4-benzoylphenylboronic acid (678 mg, 3.0 
mmol). The product mixture was further purified by flash 
column chromatography using 0-20% MeOH/DCM as 
the eluent to afford a white solid (532 mg, 34% yield). 1H 
NMR (700 MHz, DMSO-d6): δ 8.10 (d, J = 7.0 Hz, 2H), 7.78 (d, J = 8.4 Hz, 2H), 7.68 
(multiple peaks, 3H), 7.54 (t, J = 7.0 Hz, 2H), 7.26 (s, 2H), 2.63 (s, 6H), 2.32 (s, 3H). 13C 
NMR (176 MHz, DMSO-d6): δ195.0, 143.1, 141.6 139.5, 135.9, 134.2, 133.4, 132.1, 
129.8, 129.7, 128.7, 123.3, 119.4, 26.8, 21.0. 19F NMR (376 MHz, DMSO-d6): δ –148.2, 
–148.3. HRMS [M- BF4]+ Calcd for C22H20IO
+: 427.0553; Found: 427.0553.  
 
Diaryliodonium Salt 23. General procedure A was 
followed using 4-(methylsulfonyl)phenylboronic acid (600 
mg, 3.0 mmol), providing 23 as a white solid (169 mg, 
35% yield). 1H NMR (700 MHz, DMSO-d6): δ 8.20 (d, J = 
7.0 Hz, 2H), 8.00 (d, J = 7.0 Hz, 2H), 7.26 (s, 2H), 3.28 (s, 
3H), 2.61 (s, 6H), 2.31 (s, 3H). 13C NMR (176 MHz, DMSO- d6): δ 143.6, 143.5, 141.8, 
135.2, 129.9, 129.8, 122.7, 119.7, 43.0, 26.3, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –
148.2, –148.3. HRMS [M-BF4]+ Calcd for C16H18IO2S+: 401.0067; Found: 401.0068.  
Diaryliodonium Salt 24. General procedure A was followed 
using 4-cyanophenylboronic acid (438 mg, 1.0 mmol), 
providing 24 as an off-white solid (209 mg, 16% yield). 1H 
NMR (700 MHz, DMSO-d6): δ 8.11 (d, J = 8.4 Hz, 2H), 7.95 
(d, J = 8.4 Hz, 2H), 7.25 (s, 2H), 2.58 (s, 6H), 2.31 (s, 3H). 
13C NMR (176 MHz, DMSO-d6): δ 143.5, 141.8, 135.0, 134.9, 129.9, 122.8, 119.6, 
117.5, 114.4, 26.3, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-
BF4]+ Calcd for C16H15IN+: 348.0244; Found: 328.0240.  
Diaryliodonium Salt 25 (Compound 27). General procedure A 
was followed using 2,6-dimethylphenylboronic acid (157 mg, 
1.05 mmol), providing 25 as a white solid (331 mg, 72% yield). 














(d, J = 7.0 Hz, 2H), 7.24 (s, 2H), 2.54 (s, 6H) 2.51 (s, 6H), 2.32 (s, 3H). 13C NMR (176 
MHz, DMSO-d6): δ 142.8, 142.2, 142.0, 132.5, 130.3, 129.6, 122.6, 118.8, 25.5, 25.3, 
20.4. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for 
C17H20I+: 351.0604; Found: 351.0613. 
 
Diaryliodonium Salt 26 (Compound 29). General procedure A 
was followed using 3,5-dimethylphenylboronic acid (224 mg, 
1.5 mmol), providing 26 as a white solid (479 mg, 73% yield). 
1H NMR (700 MHz, DMSO-d6): δ 7.64 (s, 2H), 7.27 (s, 1H), 
7.21 (s, 2H), 2.60 (s, 6H), 2.30 (s, 3H), 2.28 (s, 6H). 13C NMR 
(176 MHz, DMSO-d6): δ 142.9, 141.6, 141.5, 133.4, 131.9, 
129.7, 122.2, 114.1, 26.3, 20.6, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. 
HRMS [M-BF4]+ Calcd for C17H20I+: 351.0604; Found: 351.0603. 
Diaryliodonium Salt 27 (Compound 31b). General procedure A was followed using 
naphthalene-1-boronic acid (258 mg, 1.5 mmol) and 2,6-
(diisopropyl)iodobenzene diacetate,43 providing 27 as a beige 
solid (364 mg, 72% yield). 1H NMR (700 MHz, DMSO-d6): δ 
8.23-8.20 (multiple peaks, 3H), 8.09 (d, J = 8.4 Hz, 1H), 7.88 
(t, J = 7.0 Hz, 1H), 7.75 (t, J = 7.0 Hz, 1H), 7.57 (m,  2H), 7.42 
(d, J = 7.0 Hz, 2H), 3.49 (septet, J = 7.0 Hz, 2H), 1.12 (d, J = 
7.0 Hz, 12H). 13C NMR (176 MHz, DMSO-d6): δ 151.2, 136.2, 134.3, 133.3, 133.1, 
131.0, 129.5, 129.4, 128.5, 128.0, 127.8, 127.7, 126.9, 118.0, 24.1. 19F NMR (376 MHz, 
DMSO-d6): δ –148.2, –148.3. HRMS [M-BF4]+ Calcd for C22H24I+: 415.0917; Found: 
415.0920. 
b. Fluorinated Product:  
 
Fluorinated Product 1, Small Scale. General procedure A was followed using 









formed in 85% yield as a 98:2 mixture of 1:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 1 matched that of 
an authentic sample (Matrix Scientific, m, –113.02 ppm in DMF). The identity of the 
product was further confirmed by GCMS analysis, where the product peak was 
observed at 3.56 min.  
 
Fluorinated Product 3, Small Scale. General procedure A was followed using 
diaryliodonium salts 2 (23.3 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 3 was 
formed in 73% yield as a 99:1 mixture of 3:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, CDCl3): δ –119.61 ppm (lit. –
119.0 ppm).44 The identity of the product was further confirmed by GCMS analysis, 
where the product peak was observed at 10.6 min. 
 
Fluorinated Product 4, Small Scale. General procedure A was followed using 
diaryliodonium salts 3 (22.0 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 4 was 
formed in 85% yield as a 99:1 mixture of 4:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 4 matched that of 
an authentic sample (Oakwood Products, –124.27 ppm in DMF). The identity of the 
product was further confirmed by GCMS analysis, where the product peak was 









Fluorinated Product 5, Small Scale. General procedure A was followed using 
diaryliodonium salts 4 (22.0 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 5 was 
formed in 54% yield as a 96:4 mixture of 5:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 5 matched that of 
an authentic sample (Aldrich, m, –111.07 ppm in DMF). The identity of the product was 
further confirmed by GCMS analysis, where the product peak was observed at 9.37 min.  
 
Fluorinated Product 6, Small Scale. General procedure A was followed using 
diaryliodonium salts 5 (22.0 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 6 was 
formed in 48% yield as a 96:4 mixture of 6:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F spectral data for 6 matched that of 
authentic sample (Matrix Scientific, m, –135.47 ppm in DMF). The identity of the product 
was further confirmed by GCMS analysis, where the product peak was observed at 9.74 
min. 
 
Fluorinated Product 7, Small Scale. General procedure A was followed using 
diaryliodonium salts 6 (23.0 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 7 was 
formed in 86% yield as a 98:2 mixture of 6:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –123.40 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 12.7 min.  
Fluorinated Product 7, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 6 (230 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (36.0 mg, 0.1 
mmol, 0.2 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (53.0 mg, 0.2 mmol, 






chromatography using 100% pentane as the eluent, affording product 7 as a white solid 
(56.9 mg, 78% yield, Rf = 0.48 in 100% pentane, mp = 54-55 ºC). The 1H, 13C, and 19F 
NMR spectroscopic data were identical to that reported previously in the literature.45 
HRMS EI [M]+ Calcd for C10H7F: 146.0532; Found 146.0532. 
 
Fluorinated Product 8, Small Scale. General procedure A was followed using 
diaryliodonium salts 7  (23.5 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 8 was 
formed in 99% yield as a 96:4 mixture of 8:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –123.11 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 12.3 min. 
Fluorinated Product 8, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 7 (235 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (36.0 mg, 0.1 
mmol, 0.2 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (53.0 mg, 0.2 mmol, 
0.4 equiv), and DMF (5.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 0–50% Et2O in pentane as the eluent, affording product 8 as a 
colorless oil (12.3 mg, 74% yield, Rf = 0.57 in 90% pentane/10% Et2O). The 1H, 13C, and 
19F NMR spectroscopic data were identical to that reported previously in the literature.46 
HRMS EI [M]+ Calcd for C8H9FO2: 156.0587; Found 156.0586. 
 
 
Fluorinated Product 9, Small Scale. General procedure A was followed using 
diaryliodonium salts 8 (25.0 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 9 was 










analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –125.32 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 13.9 min.  
Fluorinated Product 9, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 8 (75.0 mg, 0.15 mmol, 1.0 equiv), Cu(OTf)2 (27.1 mg, 0.075 
mmol, 0.5 equiv), KF (9.6 mg, 0.165 mmol, 1.1 equiv), 18-crown-6 (15.9 mg, 0.06 mmol, 
0.4 equiv), and DMF (1.5 mL). The crude reaction mixture was purified by flash column 
chromatography using 0–10% Et2O in pentane as the eluent, affording product 9 as a 
colorless crystalline solid (14.3 mg, 51% yield, Rf = 0.71 in 90% pentane/10% Et2O, mp 
= 54-55 ºC) containing 2% 3,4,5-trimethoxyiodobenzene as an impurity. 1H NMR (700 
MHz, CDCl3): δ 6.31 (d, J = 9.8 Hz, 2H), 3.83 (s, 6H), 3.79 (s, 3H). 13C NMR (176 MHz, 
CDCl3): δ 159.4 (d, J = 240 Hz), 153.9 (d, J = 12.3 Hz), 134.4 (d, J = 4.6 Hz), 93.0 (d, J 
=  26.6 Hz), 61.1, 56.3. 19F NMR (376 MHz, CDCl3): δ –113.63 (t, J = 10.1 Hz). HRMS 





Fluorinated Product 10, Small Scale. General procedure A was followed using 
diaryliodonium salts 9 (25.1 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 9 was formed in 95% yield as a 98:2 mixture 
of 10:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
19F NMR (376 MHz, DMF): δ –120.22 ppm. The identity of the product was further 
confirmed by GCMS analysis, where the product peak was observed at 14.8 min. 
Fluorinated Product 10, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 9 (251 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (90.0 mg, 0.25 
mmol, 0.5 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (53.0 mg, 0.2 mmol, 
0.4 equiv), and DMF (5.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 100% pentane as the eluent, affording product 10 as a colorless 
oil (76.1 mg, 81% yield, Rf = 0.53 in 100% pentane) containing 2% phenoxybenzene as 
an impurity. The 1H, 13C, and 19F NMR spectroscopic data were identical to that 
reported previously in the literature.47 HRMS EI [M]+ Calcd for C12H9FO: 188.0637; 
Found 188.0640. 
 
Fluorinated Product 11, Small Scale. General procedure A was followed using 
diaryliodonium salts 10 (25.8 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 11 was formed in 83% yield as a 96:4 mixture 
of 11:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
19F NMR (376 MHz, DMF): δ –124.00 ppm. The identity of the product was further 








Fluorinated Product 11, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 10 (258 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (90.0 mg, 0.25 
mmol, 0.5 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (53.0 mg, 0.2 mmol, 
0.4 equiv), and DMF (5.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 0–5% Et2O in pentane as the eluent, affording product 11 as a 
white solid (81.8 mg, 81% yield, Rf = 0.63 in 90% pentane/10% Et2O, mp = 49-50 ºC) 
containing 2% 4-benzyloxyiodobenzene as an impurity. The 1H, 13C, and 19F NMR 
spectroscopic data were identical to that reported previously in the literature.48 HRMS EI 
[M]+ Calcd for C13H11FO: 202.0794; Found 202.0794.  
 
Fluorinated Product 12, Small Scale. General procedure A was followed using 
diaryliodonium salts 11 (24.3 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 12 was 
formed in 86% yield as a 95:5 mixture of 12:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –115.92 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 14.6 min. 
Fluorinated Product 12, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 11 (243 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (90.0 mg, 0.25 
mmol, 0.5 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (53.0 mg, 0.2 mmol, 
0.4 equiv), and DMF (5.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 100% pentane as the eluent, affording product 12 as a white 
solid (69.7 mg, 81% yield, Rf = 0.48 in 100% pentane, mp = 69-70 ºC). The 1H, 13C, and 
19F NMR spectroscopic data were identical to that reported previously in the literature.45 





Fluorinated Product 13, Small Scale. General procedure A was followed using 
diaryliodonium salts 12 (29.3 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 13 was formed in 86% yield as a 96:4 mixture 
of 13:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
19F NMR (376 MHz, DMF): δ –118.18 ppm. The identity of the product was further 
confirmed by GCMS analysis, where the product peak was observed at 9.10 min using 
the following GC oven temperature program: start at 100 ºC, ramp 15 ºC/min to 240 ºC, 
and hold for 1 min. 
Fluorinated Product 13, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 12 (58.6 mg, 0.1 mmol, 1.0 equiv), Cu(OTf)2 (18.1 mg, 0.05 
mmol, 0.5 equiv), KF (6.4 mg, 0.11 mmol, 1.1 equiv), 18-crown-6 (10.6 mg, 0.04 mmol, 
0.4 equiv), and DMF (1.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 90% hexanes/10% EtOAc as the eluent, affording product 13 as 
a colorless crystalline solid (19.6 mg, 72% yield, Rf = 0.20 in 90% hexanes/10% EtOAc, 
mp = 175-176 ºC). The 1H, 13C, and 19F NMR spectroscopic data were identical to that 
reported previously in the literature.41 HRMS EI [M]+ Calcd for C18H21FO: 272.1576; 
Found 272.1581. 
 
Fluorinated Product 14, Small Scale. General procedure A was followed using 
diaryliodonium salts 13 (25.8 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 14 was formed in 58% yield as a 98:2 mixture 










19F NMR (376 MHz, DMF): δ –117.3 ppm. The identity of the product was further 
confirmed by GCMS analysis, where the product peak was observed at 7.84 min. 
Fluorinated Product 14, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 13 (51.6 mg, 0.1 mmol, 1.0 equiv), Cu(OTf)2 (18.1 mg, 0.05 
mmol, 0.5 equiv), KF (6.4 mg, 0.11 mmol, 1.1 equiv), 18-crown-6 (10.6 mg, 0.04 mmol, 
0.4 equiv), and DMF (1.0 mL). The solvent was evaporated at room temperature, and 
the crude reaction mixture was purified by flash column chromatography using 100% 
pentane as the eluent, affording product 14 as a white solid (11.3 mg, 56% yield, Rf = 
0.67 in 100% pentane, mp = 83-84  ºC). The 1H, 13C, and 19F NMR spectroscopic data 
were identical to that reported previously in the literature.49 HRMS EI [M]+ Calcd for 
C12H7FS: 202.0252; Found 202.0253. 
 
Fluorinated Product 15, Small Scale. General procedure A was followed using 
diaryliodonium salts 14 (25.0 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 15 was formed in 73% yield as a 83:17 
mixture of 15:2 as determined by 19F NMR spectroscopic analysis of the crude reaction 
mixture. 19F NMR (376 MHz, DMF): δ –134.90 ppm. The identity of the product was 
further confirmed by GCMS analysis, where the product peak was observed at 6.20 min. 
Fluorinated Product 15, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 14 (250 mg, 0.5 mmol, 1.0 equiv), Cu(OTf)2 (90.4 mg, 0.25 
mmol, 0.5 equiv), KF (32.0 mg, 0.55 mmol, 1.1 equiv), 18-crown-6 (52.8 mg, 0.20 mmol, 
0.4 equiv), and DMF (5.0 mL). Product 15 proved difficult to separate from the impurity 
2-iododibenzofuran. Thus, the crude reaction mixture was subjected to the following 
conditions adapted from the literature50  in order to convert 2-iododibenzofuran into 
dibenzofuranol, thereby facilitating purification of 15: CuI (47.6 mg, 0.25 mmol, 0.5 
equiv), 8-hydroxyquinoline (50.8 mg, 0.35 mmol, 0.7 equiv), and DMSO (2.0 mL) were 





reaction mixture (containing 15 + the aryliodide impurity), aqueous tetrabutylammonium 
hydroxide [1.0 mL of a ~1.5 M solution (Fluka),1.5 mmol, 3.0 equiv], and H2O (2.9 mL) 
were combined. To the resultant cloudy suspension, the CuI/8-hydroxyquinoline solution 
was added via syringe and the reaction was stirred at 100 ºC for 16 h. After cooling to 
room temperature, the reaction mixture was diluted with sat. aqueous NaHCO3 (1 mL) 
and H2O (10 mL). The mixture was extracted with pentane (3 x 10 mL) and the 
combined organic layers were washed with 1 M NaOH, dried over MgSO4, filtered, and 
concentrated by rotovap at 0 ºC. The resulting crude residue was purified by flash 
column chromatography using 100% pentane as the eluent, affording product S29 as a 
white solid (46.4 mg, 50% yield, Rf = 0.56 in 100% pentane, mp = 50-51 ºC). 1H NMR 
(400 MHz, CDCl3): δ 7.95 (d, J = 7.0 Hz, 1H), 7.72 (dd, J = 6.4, 1.2 Hz, 1H), 7.63 (d, J= 
8.4 Hz, 1H), 7.51 (td, J = 8.4, 1.2 Hz, 1H), 7.38 (td, J = 8.4, 1.2 Hz, 1H), 7.30-7.21 
(multiple peaks, 2H). 13C NMR (156 MHz, CDCl3): δ 156.8, 149.3, 147.9, 143.1, 128.2, 
124.2, 123.6, 123.5, 121.3, 116.5, 113.9 (d, J = 17.5 Hz),112.4. 19F NMR (376 MHz, 
CDCl3): δ –136.7 (q, J = 5.6 Hz). HRMS EI [M]+ Calcd for C12H7FO: 186.0481; Found 
186.0483. 
 
Fluorinated Product 16, Small Scale. General procedure A was followed using 
diaryliodonium salts 15 (20.8 mg, 0.05 mmol, 1.0 equiv), Cu(OTf)2 (18.1 mg, 0.05 mmol, 
1.0 equiv), and CsF (30.4 mg, 0.2 mmol, 4.0 equiv) at 130 ºC for 2 h. The fluorinated 
product 16 was formed in 42% yield as a >99:1 mixture of 16:2 as determined by 19F 
NMR spectroscopic analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ 
–134.10 ppm (lit. –134.44 ppm in CDCl3).51 The identity of the product was further 





Fluorinated Product 17, Small Scale. General procedure A was followed using 
diaryliodonium salts 16 (23.4 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 17 was 
formed in 73% yield as a 96:4 mixture of 17:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –112.61 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 11.5 min. 
Fluorinated Product 17, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 16 (187 mg, 0.4 mmol, 1.0 equiv), Cu(OTf)2 (28.9 mg, 0.08 
mmol, 0.2 equiv), KF (25.6 mg, 0.44 mmol, 1.1 equiv), 18-crown-6 (42.3 mg, 0.16 mmol, 
0.4 equiv), and DMF (4.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 0–5% Et2O  in pentane as the eluent, affording product 17 as a 
colorless oil (43.1 mg, 70% yield, Rf = 0.44 in 100% pentane) containing 5% 3-
(methoxycarbonyl)iodobenzene as an impurity. The 1H, 13C, and 19F NMR spectroscopic 
data were identical to that reported previously in the literature.52  HRMS EI [M]+ Calcd 
for C8H7FO2: 154.0430; Found 154.0432. 
 
Fluorinated Product 18, Small Scale. General procedure A was followed using 
diaryliodonium salts 17 (21.4 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 18 was formed in 92% yield as a 86:14 
mixture of 18:2 as determined by 19F NMR spectroscopic analysis of the crude reaction 







m, –120.01 ppm in DMF). The identity of the product was further confirmed by GCMS 
analysis, where the product peak was observed at 3.71 min. 
 
Fluorinated Product 19, Small Scale. General procedure A was followed using 
diaryliodonium salts 18 (22.2 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 19 was formed in 74% yield as a 94:6 mixture 
of 19:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
The 19F spectral data for 19 matched that of an authentic sample (Oakwood Products, 
m, –117.38 ppm in DMF). The identity of the product was further confirmed by GCMS 
analysis, where the product peak was observed at 7.97 min. 
 
Fluorinated Product 20, Small Scale. General procedure A was followed using 
diaryliodonium salts 19 (26.8 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 20 was formed in 77% yield as a 95:5 mixture 
of 20:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
The 19F spectral data for 20 matched that of an authentic sample (Aldrich, m, –114.40 
ppm in DMF). The identity of the product was further confirmed by GCMS analysis, 










Fluorinated Product 21, Small Scale. General procedure A was followed using 
diaryliodonium salts 20 (23.4 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 21 was 
formed in 66% yield as a 97:3 mixture of 21:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. 19F NMR (376 MHz, DMF): δ –120.75 ppm. The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 13.2 min. 
Fluorinated Product 21, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 20 (140 mg, 0.3 mmol, 1.0 equiv), Cu(OTf)2 (21.6 mg, 0.06 
mmol, 0.2 equiv), KF (19.2 mg, 0.33 mmol, 1.1 equiv), 18-crown-6 (31.8 mg, 0.12 mmol, 
0.4 equiv), and DMF (3.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 10–60% Et2O  in pentane as the eluent, affording product 2 as a 
colorless crystalline solid (mg, 67% yield, Rf = 0.37 in 90% pentane/10% Et2O, mp = 40-
41 ºC), containing 2% 2-methoxybenzaldehyde as an impurity. The 1H, 13C, and 19F 
NMR spectroscopic data were identical to that reported previously in the literature.53 
HRMS EI [M]+ Calcd for C8H7FO2: 154.0424; Found 154.0430. 
 
Fluorinated Product 22, Small Scale. General procedure A was followed using 
diaryliodonium salts 21 (25.4 mg, 0.05 mmol, 1.0 equiv), Cu(OTf)2 (18.1 mg, 0.05 mmol, 
1.0 equiv), and CsF (8.35 mg, 0.055 mmol, 1.1 equiv) at room temperature. The 
fluorinated product 22 was formed in 33% yield as a 97:3 mixture of 22:2 as determined 
by 19F NMR spectroscopic analysis of the crude reaction mixture. The 19F spectral data 










identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 8.88 min. 
 
Fluorinated Product 23, Small Scale. General procedure A was followed using 
diaryliodonium salts 22 (23.4 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 23 was formed in 76% yield as a 95:5 mixture 
of 23:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
19F NMR (376 MHz, DMF): δ –105.72 ppm. The identity of the product was further 
confirmed by GCMS analysis, where the product peak was observed at 6.75 min. 
Fluorinated Product 23, Scale-Up for Isolation. General procedure C was followed 
using  diaryliodonium salts 22 (128 mg, 0.3 mmol, 1.0 equiv), Cu(OTf)2 (54.2 mg, 0.15 
mmol, 0.5 equiv), KF (19.2 mg, 0.33 mmol, 1.1 equiv), 18-crown-6 (31.8 mg, 0.12 mmol, 
0.4 equiv), and DMF (3.0 mL). The crude reaction mixture was purified by flash column 
chromatography using 10–60% Et2O  in pentane as the eluent, affording product 23 as 
a white solid (37.8 mg, 63% yield, Rf = 0.60 in 95% pentane/5% Et2O, mp = 42-43 ºC). 
The 1H, 13C, and 19F NMR spectroscopic data were identical to that reported previously 
in the literature.54 HRMS EI [M]+ Calcd for C13H9FO: 200.0637; Found 200.0637. 
 
Fluorinated Product 24, Small Scale. General procedure A was followed using 
diaryliodonium salts 23 (24.4 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 24 was 
formed in 62% yield as a 94:6 mixture of 24:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 24 matched that 









was further confirmed by GCMS analysis, where the product peak was observed at 14.4 
min. 
 
Fluorinated Product 25, Small Scale. General procedure A was followed using 
diaryliodonium salts 24 (26.1 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 25 was 
formed in 52% yield as a 93:7 mixture of 25:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 25 matched that 
of an authentic sample (Oakwood, m, –102.54 ppm in DMF). The identity of the product 
was further confirmed by GCMS analysis, where the product peak was observed at 10.2 
min.  
 
Fluorinated Product 26, Small Scale. General procedure A was followed using 
diaryliodonium salts 25 (21.9 mg, 0.05 mmol, 1.0 equiv). The fluorinated product 26 was 
formed in 31% yield as a 50:50 mixture of 26:2 as determined by 19F NMR 
spectroscopic analysis of the crude reaction mixture. The 19F NMR spectral data for 26 
matched that of an authentic sample (Apollo Scientific, m, –121.53 ppm in DMF). The 
identity of the product was further confirmed by GCMS analysis, where the product peak 
was observed at 8.78 min. 
 
Fluorinated Product 27, Small Scale. General procedure A was followed using 







formed in 91% yield as a 99:1 mixture of 27:2 as determined by 19F NMR spectroscopic 
analysis of the crude reaction mixture. The 19F NMR spectral data for 27 matched that 
of an authentic sample (Oakwood, m,  –114.66 ppm). The identity of the product was 
further confirmed by GCMS analysis, where the product peak was observed at 8.74 min.  
Fluorinated Product 32, Small Scale. General procedure A was followed using 
diaryliodonium salts 27 (23.0 mg, 0.05 mmol, 1.0 equiv) and Cu(OTf)2 (9.0 mg, 0.025 
mmol, 0.5 equiv). The fluorinated product 32 was formed in 70% yield as a 94:6 mixture 
of 32:2 as determined by 19F NMR spectroscopic analysis of the crude reaction mixture. 
19F NMR (376 MHz, DMF): δ –123.39 ppm. The identity of the product was further 
confirmed by GCMS analysis, where the product peak was observed at 12.8 min. 
Fluorinated Product 27, Scale-Up for Isolation. General procedure C was followed 
using diaryliodonium salts 27 (138 mg, 0.3 mmol, 1.0 equiv), Cu(OTf)2 (54.2 mg, 0.15 
mmol, 0.5 equiv), KF (19.2 mg, 0.33 mmol, 1.1 equiv), 18-crown-6 (31.8 mg, 0.12 mmol, 
0.4 equiv), and DMF (3.0 mL). The crude reaction mixture was 
purified by flash column chromatography using 100% pentane 
as the eluent, affording product 32 as a colorless oil (23.6 mg, 
54% yield, Rf = 0.66 in 100% pentane) containing 3% 2-iodo-
1,3-diisopropylbenzene as an impurity. The 1H, 13C, and 19F 
NMR spectroscopic data were identical to that reported previously in the literature.45 
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CHAPTER 3. CU-CATALYZED [18F]FLUORINATION OF  
(MESITYL)(ARYL)IODONIUM SALTS AND SYNTHETIC 
APPLICATIONS 
3.1 INTRODUCTION 
     Positron emission tomography (PET) is a powerful and minimally invasive medical 
imaging technique that provides kinetic physiochemical information. 1  The most 
commonly used radioisotope for PET is fluorine-18, which offers the advantages of high 
resolution imaging (ca.  2.5 mm in tissue), a relatively long half-life (t1/2 = 109.7 min), 
compared to that of 11C (t1/2 = 20.3 minutes) and minimal perturbation of radioligand 
binding. Furthermore, 18F– can be easily prepared from [18O]water via the 18O(p,n)18F 
nuclear reaction, making 18F radiotracers ideal for monitoring in vivo metabolic 
processes.2  
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     In the clinical setting, PET imaging is used to assist in the early diagnosis and 
treatment of brain diseases, including nascent Alzheimer’s disease (AD) and Chronic 
Traumatic Encephalophathy (CTE).3  Currently, definitive clinical diagnosis of AD3a or 
CTE3b relies on the detection of plaques and neurofibrillary tangles by post-mortem 
analysis. In contrast, by using PET, CTE and AD can be diagnosed in vivo by 
measuring the concentration and damage of tau protein (CTE) and β-amyloid (AD) 
respectively. The early development of 18F-radiotracers for CTE diagnosis was limited to 
mainly Csp3-labeled 18F-tracers such as [18F]FDDNP4 to image the desired pathologies 
in living humans. However, these molecules were prone to undesired metabolic 
processes leading to loss of [18F]fluoride as a leaving group. These shortcomings 
spurred efforts to develop other radiopharmaceuticals such as [18F]T807 5   and 
[18F]THK5117,6  which can identify tau-protein deposits in living human brains years 
before symptoms appear (Figure 3.2).7,8  
Figure 3.2 Chemical Structures of [18F]FDDNP, [18F]T807 and [18F]THK5117 
 
     The discovery and development of novel therapeutics in the pharmaceutical industry 
demands enormous time and expenditure. The entire process from target identification, 
to clinical evaluation and ultimately to approval can take nearly a decade. As such, drug 
development costs for a typical pharmaceutical can be higher than $10 billion. 9 
Therefore, the pharmaceutical industry strongly desires to utilize any technique that has 
the ability to ensure that the experimental agent is interacting with the sought-after 
target and producing a consistent biological response. In this context, PET imaging 
techniques can make a significant contribution to the pharmaceutical discovery process 
by aiding in the selection of the most encouraging lead agents in early clinical 
development and reducing the aforementioned risks.  PET imaging is also a valuable 





















 PET can also be used for diagnostic imaging, which monitors the metabolic 
processes of administered medicines/drug candidates in a patient. This can enable 
selection of suitable medical treatment for individuals (“personalized therapies”). Such 
advancements will be highly useful and practical for human healthcare in the future 
(Figure 3.3). 11 More specifically, PET imaging technique is used for predicting response 
to therapy12 and monitoring response to therapy.13 Furthermore, it can provide clinical 
trial enrichment. Currently, there are problems with diagnostic accuracy in dementia of 
only 60 – 85% when using clinical symptoms. It is attributed to problems with expensive 
clinical trials and also figuring out if a patient is improving is very subjective in dementia 
patients. Therefore, PET and a pharmacological biomarker of disease is used to get the 
right patients in clinical trials and monitor response to therapy.14 
Figure 3.3 Personalized Medicine 
 
     Despite the advantages of PET imaging techniques, the development of novel 18F 
radiotracers is currently impeded by a scarcity of general and effective radiofluorination 
methods. At present, the most successful radiopharmaceutical is [18F]fludeoxyglucose 
(FDG), which contains a Csp3-18F bond. As the result of its FDA-approved status and 
simple, well-established synthetic protocol, [18F]FDG is used in greater than 90% of PET 
scans conducted in the United States annually (Scheme 3.1).15  


























The major shortcoming of [18F]FDG as a radiotracer is its lack of in vivo site-specificity. 
Jacob and colleagues have compared different radiotracer probes (18F-FDG, 18F-L-
DOPA and 13N-Ammonia) for patients with low-grade brain tumors16 and demonstrated 
that although 18F-FDG is known as an excellent tracer for oncological studies,17 the high 
background use of glucose (and therefore background uptake of [18F]FDG) in the 
healthy brain complicates identification and staging of brain tumors with this tracer. An 
alternative radiotracer with no (or minimal) normal background activity, such as 18F- L-
DOPA, would offer advantages, as it is selectively taken up into tumor cells with large 
amino acid pools, thus allowing invaluable imaging brain tumor imaging (Figure 3.4). 
Despite the attractive attributes of this tracer, [18F]-L-DOPA is still a mostly 
investigational radiopharmaceutical that has not advanced to routine clinical use 
because the current-state-of-the-art synthetic methodologies are not capable of 
sufficiently producing [18F]- L-DOPA for routine clinical use.18  
Figure 3.4 Brain Image of Patient with Brain Tumor with Low Grade Astrocytoma16 
 
There are currently few robust synthetic procedures for the incorporation of 18F 
into organic molecules with sufficient speed, selectivity, yield, radiochemical purity, and 
reproducibility to provide imaging materials for clinical application. Methodologies for the 
late stage nucleophilic [18F]fluorination of electron-rich aromatic substrates remain an 
especially long-standing challenge in the PET community. 19  The majority of 















reagents derived from [18F]F2.1 However, [18F]F2 production typically requires 19F2 as a 
carrier gas, which leads to low specific activity (SA; a ratio of 18F-tracer/19F-tracer) 
radiotracers (typically <1.0 Ci/mmol) and requires specialized facilities for handling this 
highly toxic gas. 
 The development of [18F]KF production from [18O]water has provided the means 
to synthesize high SA radiotracers (>1,000 Ci/mmol) through nucleophilic substitution 
(typically SN2 or SNAr).1 However, the use of [18F]KF is generally limited to the formation 
of primary sp3-C-F bonds or sp2-C-F bonds contained in activated electron-deficient 
aromatic groups (Scheme 3.2). 
Scheme 3.2 Nucleophilic Aromatic Radiofluorinatoin 
 
Two major strategies have been used to address these limitations. The first involves 
radiofluorination of powerful electrophiles, such as diaryliodonium salts. 20 
Diaryliodonium salts bearing 2-thienyl functional groups have been shown to react with 
[18F]KF at elevated temperatures (≥150 ºC) to afford [18F]fluoroarenes (Scheme 3.3).21 
In these systems, the 2-thienyl group is used as a directing group that enables selective 
radiofluorination of the less electron-rich aromatic ligand on iodine, with moderate to 
good selectivity.21 However, the [(thienyl)(aryl)I+] starting materials are often challenging 
to prepare, suffer from low stability, and have a limited shelf-life. 22   Furthermore, 
substrates bearing electron neutral or donating aromatic substituents often require high 
temperatures, react with modest regioselectivity, demonstrate limited functional group 
tolerance, and provide low radiochemical yields.21 As such, this strategy has proven 
inadequate to access important radiotracers, most notably 6-[18F]fluoro-L-DOPA 
derivatives.23It was noted after our publication, DiMagno demonstrated a successful 













Scheme 3.3 Radiofluorination of (2-thienyl)(aryl)iodonium Salts 
 
A second strategy applies transition metal catalysts and/or reagents to achieve 
nucleophilic radiofluorination. 25 , 26  Transition metal catalysis offers opportunities for 
accelerating radiofluorination reaction rates as well as enhancing selectivity and 
reactivity. For instance, Hooker and Ritter pioneered nucleophilic radiofluorination 
methods utilizing Pd25a-b and Ni25c complexes (Scheme 3.4). These systems were 
successfully applied to synthesize various radiotracers, including paroxetine, 25b a 5-
HT2c agonist, 25b MDL 100907, 25d and 5-fluorouracil. 25e However, the requirement for 
the multistep synthesis of organometallic reagents under inert atmospheres has thus far 
limited adoption of these chemistries by non-experts.27 


























































































In Chapter 2, the development of Cu-catalyzed fluorination of  
(mesityl)(aryl)iodonium salts with KF was detailed. We sought to translate this 
methodology to radiofluorination for the synthesis of diverse 18F-labeled aromatic 
substrates that previously were difficult to access using conventional methods. We 
hypothesized that, through the merging of transition metal catalysis with fluorination of 
diaryliodoinum reagents, our goal to develop a practical and selective procedure for 
routine PET tracer syntheses would be achieved (Scheme 3.5).28 
Scheme 3.5 Proposed Cu-mediated Radiofluorination of Diaryliodonium Reagents 
 
This chapter describes our investigation into translating the Cu-catalyzed 
fluorination of (mesityl)(aryl)iodonium salts with KF into a radiofluorination method. This 
work was conducted in collaboration with Professor Peter Scott, and his colleagues in 
the UM Department of Radiology.29,30 As detailed below, we successfully developed a 
practical, rapid and highly selective Cu-catalyzed radiofluorination of 
(mesityl)(aryl)iodonium salts using [18F]KF to access 18F-labeled electron-rich, neutral, 
and deficient aryl fluorides under a single set of reaction conditions. This methodology 
was applied to the synthesis of analogues of radiotracer molecules with potential clinical 
applications, including a protected versin of [18F]F-DOPA. 
3.2 RESULTS AND DISCUSSION 
The translation of our previously reported Cu-catalyzed fluorination method,31 first 
required us to consider key challenges for [18F]fluorination: (1) reaction stoichiometry 
has to be compatible with nanomolar concentrations of the radionuclide; (2) 
radiochemical reaction times must be short (typically 3 to 30 min) due to the limited half-
lives of PET radionuclides (11C t1⁄2 = 20.38 min, 18F t1⁄2 = 109.7 min); (3) radiochemical 
yields (RCY) of the radiopharmaceutical must be high enough, such that after 
completion of quality control testing (20 min to 1 h) and transport of the dose(s) to the 
PET imaging center (minutes to hours) there is a sufficient dose remaining to administer 
to the patient(s); (4) methods should generate radiopharmaceuticals in high specific 
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activity (>1 Ci mmol–1). Specific activity is the activity of a given radioisotope per unit 
mass. Synthesis of 18F-radiopharmaceuticals with high specific activity provides 
quantitative information that is important for assessing radioactivity in certain 
environments. This is readily achievable using high specific activity nucleophilic fluoride, 
but cannot be achieved using electrophilic 18F-19F gas as the fluoride source. (5) For a 
novel PET radiochemistry methodology to find the greatest applicability it must be 
operationally simple and readily translatable to PET Centers all over the world for use 
by non-experts. Many imaging centers do not have the luxury of trained organic 
chemists on staff.  
As a demonstration of the potential for Cu-catalyzed 18F-fluorination of 
(mesityl)aryl iodonium salts, we first optimized reaction conditions to increase the rate of 
the transformation. We found that the use of a stoichiometric amount of Cu(OTf)2 and of 
18-crown-6 enabled the formation of 3,4-dimethoxyfluorobenzene (Ar, Scheme 3.6) and 
fluoroestrone (Ar’) in good yield and excellent selectivity within 10 minutes. We also 
found during the course of mechanistic investigation studies (details are discussed in 
chapter 2) that fluoride can be the limiting reagent and still afford product in 74% yield 
with 99:1 selectivity (Scheme 3.7).  
Scheme 3.6 Rapid Cu-Catalyzed Fluorination of (Mesityl)Aryl iodonium Salts
 
Scheme 3.7 Cu-Catalyzed Fluorination of (Mesityl)phenyl Iodonium Salts with KF as the 
Limiting Reagenta 
 
aYield calculated based on the amount of KF. 
Ar I
BF4 Cu(OTf)2 (1 equiv) 
KF (1.5 equiv)
DMF (0.1 M)
18-crown-6 (2 equiv) 
85 °C, 10 min
MeO
MeO







Ar': 69 %, >99:1Ar = 3,4-OMe
Ar' = estrone
20 mol % Cu(OTf)2








     Preliminary Results and Key Considerations. Having identified conditions to achieve 
the rapid fluorination of highly electron-rich substrates, we next tested  our Cu-catalyzed 
protocol under 18F-fluorination conditions. The iodonium salt [Mes-I-pOMePh]+ was 
selected as a model compound, as previous literature reports have demonstrated that 
4-methoxylphenyl groups are difficult to 18F-label, typically affording low yields (0-4% 
radiochemical yield (RCY)).32 To isolate  [18F]fluoride, we utilized Kryptofix (K2,2,2) as a 
phase transfer catalyst to form KF-Kryptofix complex (shown in Scheme 3.8). Our first 
trial using [18F]KF-Kryptofix afforded product 1 in 8% yield in 20 min (as determined by 
radio-HPLC). High selectivity was observed for 4-[18F]fluoroanisole, and <1% of 
[18F]fluoromesitylene was detected by radio-TLC or radio-HPLC.  To put this initial result 
into context, if 10% RCC of a desired 18F-labeled product is obtained, the yield is good 
enough to be considered for automated synthesis. We quickly identified that radio-
HPLC had some discrepancy in quantifying product yields, and was therefore not 
suitable for quantitative reaction analysis. A radioactivity detecting TLC scanner allowed 
for more accurate quantification of the radioactivity on TLC-plates, because the mass 
was 100% conserved, whereas loss of [18F]fluoride can occur on the HPLC, likely due to 
the hydrogen bonding to free silanol during inefficient reverse phase column capping 
process.33 As such, RCCs computed from HPLC traces tend to be higher than the 
actual value. 34  Using this TLC method, 15% RCC was obtained for the model 
compound. Furthermore, HPLC was primarily used for qualitative analysis to determine 
the radiochemical purity of the reaction mixture and identify the radioactive compounds 
observed by TLC. This was done by co-injecting authentic samples of unlabeled 19F 














          Evaluation of Cu-precatalyst: Kryptofix contains two nitrogen atoms (highlighted in 
blue, Scheme 3.8) that could potentially coordinate to Cu in situ.35 Hence, 18-crown-6 
was next explored as the phase transfer catalyst, resulting in an improved 36 ± 19% 
RCC (entry 1, Table 3.1). To further address the irreproducibility issue, we sought an 
alternate Cu precursor to catalyze the radiofluorination. A variety of CuI and CuII 
complexes were examined (see entries 2-4). Commercially available and bench stable 
(CH3CN)4CuOTf proved optimal, providing high radiochemical conversion and improved 
reproducibility (70 ± 11% RCC over n = 11, entry 4). A control experiment in the 
absence of Cu provided no detectable 4-[18F]fluoroanisole and only 6% RCC of 
[18F]fluoromesitylene (entry 5). The highest yields and reproducibility were achieved 




















































20 min, in a total volume of 750 μL DMF.  Using these conditions, 2 was obtained in 79 
± 8% (n = 38). 
Table 3.1 Evaluation of Cu Salts with Iodonium Salt 1 to yield 4-[18F]-anisole 
 
Entry [Cu] [Cu]:(1) RCC 2  
1 Cu(OTf)2 1:2 36±19% (n = 15) 
2 CuCO3•Cu(OH)2 1:2 10±6% (n = 3) 
3 CuOTf•toluene 1:2 43±15% (n = 3) 
4 (CH3CN)4CuOTf 1:2 70±11% (n = 11) 
5 none n/a <1% 
6 (CH3CN)4CuOTf 1:1 79±8% (n = 38) 
As described above, we obtained better results with Cu(I) precatalysts versus Cu(II) 
precatalysts for PET chemistry. Previously, in the course of mechanistic studies using 
KF, (CH3CN)4CuOTf was shown to have faster initial reaction rates relative to Cu(OTf)2 
(Chapter 2, Figure 2.3). We hypothesize that this is why (CH3CN)4CuOTf is a better 
choice of precatalyst for these 20 min radiofluorination reactions. This catalyst is stable 
in DMF and the stock solution can stand on benchtop after approximately 3 hours and 
still show the same reactivity. In PET chemistry, poor reproducibility is frequently 
observed, and an initial concern was that merging Cu-catalysis to radiofluorination 
under ambient conditions would lead to challenges. However, despite the ambient 
atmosphere, this chemistry proved highly tolerant of air and moisture and was highly 
reproducible. This Cu protocol obviates the need for extensive drying of reagents.36 As 
a demonstration of the high practicality of this methodology, multiple scientists have 
performed radiofluorinations using these conditions and the outcomes were quite 



















Table 3.2 Scope of Cu-Mediated [18F]fluorination of (Mesityl)(aryl)iodonium Salts  
 
 
     Substrate Scope. We next examined the substrate scope of this radiofluorination. As 
shown in Table 3.2, this protocol affords modest to good RCCs with a series of highly 
electron-rich substrates within 20 minutes (2–5, 7 and 8). This chemistry is also tolerant 
of a wide variety of important functional groups, including amides 6, esters 10, iodo 9 
substituents, and aldehydes.  
Three (mesityl)(aryl)iodonium salts derived from aromatic amino acids (12, 14, 
and 16) were prepared and subjected to the radiofluorination protocol in collaboration 
with Dr. Joseph Topczewski. Without any additional optimization, the radiolabeled 
products 13, 15, and 17 were obtained in 17-23% RCC (eq 1-3). Importantly, 13 
represents the protected analog of 4-[18F]fluoro-L-phenylalanine (F-PHE), a radiotracer 
originally developed in the 1970s as a probe of pancreatic cancer and cerebral protein 
synthesis.37 However, clinical applications of F-PHE to tumor imaging have not been 
realized partially due to a deficiency of acceptable radiosynthesis procedures. The 
original doses of F-PHE were prepared in low specific activity (<0.01 Ci/mmol) and 
required a dose “approaching toxic levels in order to obtain adequate sample count 
rates.”21b,38  The current protocol affords protected F-PHE (13) in 23% RCC (eq 1) as 

























































    Finally, protected 6-[18F]fluoro-L-DOPA 17 was prepared in 17±6% RCC (eq 3). As 
discussed above, this molecule has been of great interest to the PET community since 
the 1970’s due to its numerous clinical applications.39,40 Traditionally, 6-[18F]fluoro-L-
DOPA was employed in studies of the dopaminergic system and post-treatment 
monitoring of Parkinson’s disease.9a More recently, applications of 6-[18F]fluoro-L-DOPA 
have expanded into oncology, such as the study of neuroendocrine tumors, as well as 
congenital hyperinsulinism.9b The most significant limitation to the use of 6-[18F]fluoro-L-
DOPA is the most common method to prepare this radiotracer uses toxic and low 
specific activity [18F]F2 gas. However, despite decades of research, there is no routine 
automated synthesis of 18F-DOPA in clinical use. To further demonstrate the utility of 
this method, we have performed an automated synthesis of 17 from the shelf stable salt 
16. This afforded a 17±6% RCC of 17 (ca. 60 mCi) with a SA of 4000±2000 Ci/mmol (n 
= 2), thus offering a practical F-DOPA synthesis for further clinical development. 
 
 
 Isotopic Exchange. One concern in the radiofluorination of tetrafluoroborate salts 
such as 1 is the possibility for isotopic dilution, via 18F/19F exchange between the 
[19F]BF4– counter ion and [18F] KF.41  Although it is often expressed as a concern, 




















































diaryliodonium salts has not been thoroughly investigated to date (Scheme 3.9). 
Previously, Berridge observed isotopic exchange of 18F/19F from tetrafluoroborate anion 
in the context of the Balz-Schiemann reaction. 42  In addition, Knochel replaced 
tetrafluoroborate derivatives with tetrachloroborate anions and [18F]Bu4NF to 
radiofluorinate p-toluidine diazonium tetrachlorate in good radiochemical yield. A side 
product, [18F]BFCl3–, was also formed in the transformation.43  
Scheme 3.9 Does Isotopic Dilution Occur Under the Optimized Condition? 
 
In principle, this issue could be addressed by changing the counter ion; 44 
however, an evaluation of different [4-OMePh-I-Mes]X salts showed that the highest 
radiochemical yields were obtained with BF4 (entry 1, Table 3.3), potentially due to to 
the enhanced solubility of the tetrafluoroborate salt towards undesired side reactions. 
On the contrary, fluoride-free counter ions, such as tosylate (entry 2) or bromide (entry 
5), led to a steep erosion in yield.  
Table 3.3. Studies on Counteranion Effects 
 
Entry X RCC 
1 BF4 79±8% (n = 38) 
2 TsO 45±26% (n = 3) 
3 PF6 53±7% (n = 3) 
4 TfO <1% 
5 Br <1% 
 
Furthermore, we examined the influence of temperature, identifying 85 ºC as the optimal. 
Interestingly, as we evaluated elevated temperatures not only did the RCC of 2 


























This suggests that side reactions occur at high temperatures with faster relative rates 
(Table 3.4). These observations led us to consider whether isotopic exchange may 
occur at higher temperature.  
Table 3.4 Influence of Temperaturea 
 





39 ± 8 
76 ± 3 
3 100 43 ± 16 
4 115 52 ± 12 
 
Specific Activity Study. Specific activity is the ratio of 18F/19F (Ci/mmol), which 
measures isotopic dilution under the reaction conditions. In our studies, automated 
syntheses were conducted in a standard automated synthesis module with 1500 mCi 
initial activity of 18F. To test whether isotopic dilution from the BF4 counter ion occurs 
under our optimized conditions, we compared the specific activity (SA) of the 4-
[18F]fluoroanisole product obtained from [4-OMePh-I-Mes]BF4 to that from [4-OMePh-I-
Mes]OTs. Under automated conditions, [4-OMePh-I-Mes]BF4 afforded a RCY of 
40±10% and a SA of 1800±800 Ci/mmol (n=3), while [4-OMePh-I-Mes]OTs afforded 
10±2% RCY with a comparable SA of 3000±1000 Ci/mmol (n=3). Within the error of the 
measurement, these values are approximately the same. These results indicate that, 
while there might be a slight decrease in SA between the BF4 and OTs analogs, isotopic 
dilution is not a significant problem under these reaction conditions as it was predicted 
that the specific activity would be below 1000 Ci/mmol if significant isotopic exchange 
occurs under the reaction condition.45 For a proof-of-concept, this reaction was repeated 
with [4-OMePh-I-Mes]BF4 at 150°C and found that not only the RCC decreased to 6±1%, 
but specific activity of the reaction mixture was significantly reduced to 300±170 
Ci/mmol (entry 3). This suggested that isotopic exchange is very rapid under the 












to the reaction temperature and the use of readily soluble iodonium salts which overall 
accelerate the desired radiofluorination.  
Table 3.5 Specific Activity Calculation 
 
Entry X Temp (°C) RCC Specific Activity 
(SA) (Ci/mmol) 
1 BF4 85 40±10% (n = 3) 1800±800  
2 OTs 85 10±2% (n = 3) 3000±1000 
3 BF4 150 6±1% (n = 3) 300±170 
Synthesis of 18F-MHPG. We next sought to apply our Cu-mediated nucleophilic 
radiofluorination of (mesityl)(aryl)iodonium salts to the development of a high yielding, 
automated, and clinically useful synthesis of the radiotracer 4-[18F]fluoro-m-
hydroxyphenethylguanidine (4-[18F]MHPG). Developed by Professor David Raffel and 
his colleagues at University of Michigan, [18F]MHPG is a promising radiotracer for 
quantifying regional cardiac sympathetic nerve density in the human heart.46 There are 
only a few radiotracers reported that are selective for the cardiac nerve system in vivo. 
[131I]meta-Iodobenzylguanidine ([131I]MIBG)47 is one of the first radiopharmaceuticals 
developed for scintigraphic imaging of presynaptic sympathetic nerve fibers. These 
radiotracers can visualize changes in the regional distribution of cardiac sympathetic 
nerves in many heart diseases, such as congestive heart failure, diabetic autonomic 
neuropathy, myocardial infarction, cardiac arrhythimia and Parkinson’s disease. 48 
Preliminary results from the Raffel group suggest that 16 could out-perform MIBG, 
which is the current standard of care (Figure 3.5).  





















Despite great promise for [18F]MHPG as a radiotracer, there is not a viable synthesis 
in place to meet clinical demand. The current state-of-art method for the synthesis of 4-
[18F]MHPG involves three linear steps that take place following the 18F-labeling of (2-
thienyl)(m-benzoylphenethyl(N-Boc)amine)iodonium bromide. A severe 18F-decay 
occurred during the following steps. In total this route affords a 7±3% radiochemical 
yield of 4-[18F]MHPG, which is equal to less than 100 mCi of activity (~10-20 mCi) at the 
end of the synthesis (Scheme 3.10). Overall the time from the end of bombardment (i.e. 
the complete production of nucleophilic [18F]fluoride from the cyclotron) for this method 
exceeds 1 hour, and therefore results in a significant loss of radioactivity. The authors 
hypothesized that late-stage radiofluorination of an intermediate such as 17, could 
circumvent the aforementioned problems, but their attempts to achieve late-stage 
radiofluorination was unfortunately unsuccessful (Scheme 3.11). This part of chapter 3 
describes our efforts toward applying our Cu-mediated [18F]fluorination protocol to the 
synthesis of 4-[18F]F-MHPG.  












































7±3% decay corrected yield 




Scheme 3.11 Attempted Radiofluorination of 17 
 
Our preliminary investigation began by first synthesizing an iodonium tosylate salt 
19-OTs and subjecting it to our optimized Cu-mediated [18F]fluorination reaction 
conditions. Protecting groups were required to obviate hydrogen bonding with 
[18F]fluoride, and we aimed to deprotect after the radiofluorination step. Unfortunately, 
under our standard conditions the desired product 20 was not observed (Table 3.6, 
entry 1-3). We noted that 19-OTs is only sparingly soluble in DMF at room temperature; 
therefore we also evaluated the PF6 derivative as a means to enhance solubility and 
potentially improve RCC. Indeed, the hexafluorophosphate salt is fully soluble under the 
reaction conditions, and it afforded a 7% RCC (entry 5). With (CH3CN)4CuOTf, the yield 
remained unchanged when using 1 or 5 equiv of Cu relative to 19-PF6 (entry 4 and 5). 
However, the use of 1 equiv of Cu(OTf)2 afforded a significant enhancement in yield 
(entry 6); furthermore, using 5 equiv Cu(OTf)2 provided a 44% RCC, our best result to 
date (entry 8). The results in Table 3.10 demonstrate that the Cu-mediated 18F-
fluorination of the late-stage intermediate 19 is feasible and that this substrate is highly 
sensitive to reaction conditions (e.g., counterion, Cu source, and Cu loading). Given 
these observations, we anticipate that the RCC for radiofluorination of the MHPG 































Table 3.6 Cu-Mediated Radiofluorination of 19 
 
Entry X [Cu] [Cu]:Ar2I+ RCC (n = 2)b 
1 OTs (CH3CN)4CuOTf 1:2 <1% 
2 OTs (CH3CN)4CuOTf 1:1 <1% 
3 OTs (CH3CN)4CuOTf 5:1 <1% 
4 PF6 (CH3CN)4CuOTf 1:1 8% 
5 PF6 (CH3CN)4CuOTf 5:1 7%  
6 PF6 Cu(OTf)2 1:1 20% 
7 PF6 Cu(OTf)2 2:1 28% 
8 PF6 Cu(OTf)2 5:1 44% 
9 PF6 Cu(OTf)2 10:1 22% 
 With the reaction conditions for 19-PF6 (Table 3.6, entry 8) in hand, the 
automated synthesis of 20 was performed. Unfortunately, the automated synthesis 
afforded 20 in only 13% RCC. Furthermore, a full automated synthesis of 4-[18F]MHPG 
was attempted, but only 1.5 mCi of activity (RCY = 0.1%) was isolated in the preliminary 
investigation (Scheme 3.12). The low overall yield of [18F]MHPG may be due to the 
presence of a super-stoichiometric amount of Cu in the subsequent deprotection steps. 
Unfortunately, the automated module does not allow the HPLC purification of 
intermediates, but removal of Cu was possible by running through a plug of Chelex®, 
wherein 95% of Cu was successfully removed. This filtration step can be accomplished 
between radiofluorination and deprotection steps. We anticipate that this should 
improve the overall yield of product 16, and pursuing this strategy is a key future goal 




























Scheme 3.12 Automated Synthesis of [18F]MHPG 16 
 
 Application to Syntheses of Heterocycles. A number of pharmaceuticals that 
contain fluoropyridine scaffolds have been used for increasing applications in PET 
(Figure 3.6).  
Figure 3.6 Representative Radiotracers Containing 2-[18F]fluoropyridine 
 
 
Although 2-fluoropyridine can be prepared from SNAr methodologies,49 the 2-position of 
pyridine is activated and prone to further SNAr by other nucleophiles, which can result in 
the loss of 18F-fluoride.50 The synthesis of [18F]CABS13 exemplified such concern.49a 
Treatment of 21 with aqueous trifluoroacetic acid led to acid-catalyzed nucleophilic 
displacement  (Nuc = undefined in the publication) to form 22 and free 18F-fluoride 
(Scheme 3.13). Installation of [18F]fluoride at 3-position may circumvent the undesired 




















































Scheme 3.13 Acid-Promoted SNAr Reaction and Loss of 18F-label from the CABS13 
  
Efficient methods for synthesizing 3-fluoropyridines are currently rare. 51  The 3-
fluoropyridine can be found as a component of LBM-415, a peptide deformylase 
inhibitor that is used for the treatment of community-acquired respiratory tract disease 
and serious infections caused by microbial gram-positive bacteria.52  Therefore, we 
attempted to radiofluorinate pyridine substrate 23 under the same reaction conditions as 
described above. As shown in Scheme 3.13, [18F]2-chloro-5-fluoropyridine was formed 
in 17% RCC. Further optimization is required specifically for radiolabeling of 
heterocycles (Scheme 3.14) 
Scheme 3.14 Radiofluorination of (Mesityl)(2-chloro-3-iodopyridine)Iodonium Salt 2353  
 
3.3 CONCLUSIONS 
This chapter describes the development of a general, mild, high-yielding, and 
user-friendly procedure for the radiofluorination of diverse aromatic substrates through 
the merger of transition metal catalysis with the fluorination of diaryliodonium salts. 
Electronically varied diaryl iodonium salts show high reactivity with nucleophilic 
[18F]fluoride under our optimal conditions; in particular, high yields with electron-rich 
arenes are observed, which is complementary to traditional radiofluorination methods. 
Simply switching from CuII to a CuI catalyst, (CH3CN)4CuOTf, allowed us to develop a 
highly reproducible and robust method that was tolerant of ambient reaction conditions. 



































molecules such as amino acids (phenylalanine, tyrosine, and DOPA) and 4-[18F]F-
MHPG. Furthermore, initial investigations suggest that this transformation may be 
further expanded upon for the radiofluorination of medicinally relevant heterocycles.  
3.4 PERSPECTIVE AND OUTLOOK 
Merging transition metal catalysis and radiotracer syntheses has enabled the 
radiofluorination of challenging substrates. The biggest remaining challenge is the 
validation of the clinical synthesis of radiotracers through automation and establishing 
adequate product purification. Preliminary results for the automated synthesis of 
[18F]MHPG suggest that the removal of excess Cu is necessary for subsequent Boc-
group deprotection steps and to ensure acceptable purity of the radiolabeled product.   
In addition, new developments are needed such that the scope of the Cu-
mediated radiofluorination of (mesityl)(aryl)iodonium salts can be expanded for the 
synthesis of fluorinated heterocycles. The presence of Lewis basic heterocycles in a 
substrate may lead to undesired Lewis base/acid interaction with Cu catalysts, and thus 
result in decreased product yields. For optimization, one approach could be to 
synthesize N-oxide iodonium salts for two benefits: (a) the N-oxide could potentially 
prevent  undesired oxidation reactions from excess I(III) reagents and (b) the N-oxide 
would block the N-atom, and limit binding to the Cu catalyst.54 Thus, such iodonium 
salts may enable a good RCY for desired the heterocycles (Scheme 3.15). 
Scheme 3.15 Possible Future Direction for the radiofluorination of pyridyl-containing 
Heterocycles 
 
Another expansion of this Cu-mediated radiofluorination of I(III) reagents would be 
to develop Cu-mediated methods for the radiofluorination of aryl boronic acids, aryl 
stannanes, and aryl iodides. From a practical perspective, these are ideal 
radiofluorination precursors, as they are easily synthesized and/or commercially 















work, there were no nucleophilic radiofluorination methods available for electron-rich 
aryl boronic acids, stannanes, or iodides. Thus, it is of interest to develop processes to 
fluorinate Ar–X using the combination of a Cu mediator and either K18F (X = B or Sn)55 
or Ag18F (X = I). 56  Progress towards these goals is discussed in chapter 4. 
Subsequently, applying any new methodologies to the synthesis of radiotracers of 
interest for clinical applications, such as 18F-MHPG, L-DOPA, MPPF, and L-
phenylalanine, will be ideal (Scheme 3.16).  
Scheme 3.16 Direct Fluorination of Iodonium Salt Precursors by a Cu-Mediated 
pathway 
 
Furthermore, a significant difference in stoichiometry, air/moisture sensitivity of 
reaction systems exists between fluorination and radiofluorination, but there is still little 
mechanistic understanding between these closely related fields. This lack of 
understanding tends to lead to failure in attempts to translate 19F-fluorination methods to 
radiofluorination.57 Therefore, conducting mechanistically driven experiments for new 
radiofluorination reactions could help to facilitate the translation of current state-of-art 
fluorination methods to the analogous 18F-transformations. Utilizing fluorine-18 in 
mechanistic studies of fluorination reactions could provide a way to not only provide 
new methods for radiofluorination but give greater insight into the reaction mechanism 
being studied due to the ease with which fluorine-18 containing molecules can be 






















I. General Procedures and Materials and Methods 
Instrumental Information. NMR spectra were obtained on a Varian MR400 (400.52 
MHz for 1H; 100.71 MHz for 13C; 376.87 MHz for 19F), a Varian vnmrs 500 (500.10 MHz 
for 1H), or a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 MHz for 13C) spectrometer. 
1H and 13C NMR chemical shifts are reported in parts per million (ppm) relative to TMS, 
with the residual solvent peak used as an internal reference. 19F NMR spectra are 
referenced based on an internal standard, 1,3,5-trifluorobenzene (–110.00 ppm). 1H and 
19F multiplicities are reported as follows: singlet (s), doublet (d), triplet (t), quartet (q), 
and multiplet (m). High performance liquid chromatography (HPLC) was performed 
using a Shimadzu LC-2010A HT system equipped with a Bioscan B-FC-1000 radiation 
detector. Radio-TLC analysis was performed using a Bioscan AR 2000 Radio-TLC 
scanner with EMD Millipore TLC silica gel 60 plates (3.0 cm wide x 6.5 cm long).  
Materials and Methods. Diaryliodonium tetrafluoroborate 1, and the substrates for 
fluorides 3-5, 7, 8, and 11 were prepared according to a literature procedure.28 The salts 
[p-OMePh-I-Mes]X (X = Br, OTf, OTs, PF6) were prepared according to a literature 
procedure.58 MesI(OAc)2 was obtained from TCI America. BF3OEt2 was obtained from 
Alfa Aesar or Aldrich. m-CPBA was obtained from Sigma Aldrich. Arylboronic acids 
were obtained from Aldrich, Frontier Scientific, Oakwood Products and Combi Blocks. 
Anhydrous DMF, (CH3CN)4CuOTf, and 18-crown-6 were obtained from Aldrich. 1,3,5-
Trifluorobenzene was obtained from Oakwood Products. Authentic 19F samples of 
compounds 2, 5, 7, 9, 10, 11 were purchased from the following vendors: 4-
fluoroanisole 2 (Oakwood), 2-fluoroanisole 5 (Aldrich), 4-fluorobiphenyl 7 (Oakwood), 4-
fluoroiodobenzene 9 (Oakwood), 3-methyl-fluoroacetate 10 (Acros), and 3-
fluorobenzaldehyde 11 (Acros). Standards of 19F-fluorinated compounds 3, 4, 6, 8, and 
13 were prepared according to literature procedure, and all spectroscopic data were in 
accordance with the literature. All reactions were conducted under a nitrogen 
atmosphere or using standard Schlenk techniques unless otherwise stated. All reactions 
conducted at elevated temperatures were heated on a hot plate using an aluminum 
block. Temperatures were regulated using a thermocouple. 
II.  Radiochemistry 
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A. General Methods 
Material and Methods. Unless otherwise stated, reagents and solvents were 
commercially available and used without further purification. Ethanol was purchased 
from American Regent. HPLC grade acetonitrile was purchased from Fisher Scientific. 
18-Crown-6 and anhydrous N,N-dimethylformamide were purchased from Sigma-
Aldrich. Sterile product vials were purchased from Hollister-Stier. QMA-light Sep-Paks 
were purchased from Waters Corporation. QMA-light Sep-Paks were flushed with 10 
mL of ethanol followed by 10 mL of 0.5 M sodium bicarbonate solution, and finally 10 
mL of sterile water prior to use.   
B. Radiosynthesis of 18F Labeled Molecules 
Synthesis of [18F]KF18-crown-6 Complex. All loading operations were conducted 
under ambient atmosphere. Argon was used as a pressurizing gas during automated 
sample transfers. Potassium [18F]fluoride was prepared using a TRACERLab FXFN 
automated radiochemistry synthesis module (General Electric, GE). [18F]Fluoride was 
produced via the 18O(p,n)18F nuclear reaction using a GE PETTrace cyclotron (40 μA 
beam for 2 min generated ca. 150 mCi of [18F]fluoride). The [18F]fluoride was delivered 
to the synthesis module in a 1.5 mL bolus of [18O]water and trapped on a QMA-light 
Sep-Pak to remove [18O]water. [18F]Fluoride was eluted into the reaction vessel using 
aqueous potassium carbonate (3.5 mg in 0.5 mL of water). A solution of 18-crown-6 (15 
mg in 1 mL of acetonitrile) was added to the reaction vessel, and the resulting solution 
was dried by azeotropic distillation to give dry [18F]KF-18-crown-6.  Evaporation was 
achieved by heating the reaction vessel to 100 °C and drawing vacuum for 4 min. After 
this time, the reaction vessel was subjected to an argon stream and simultaneous 
vacuum draw for an additional 4 min. Finally, N,N-dimethylformamide (8 mL) was added 
to the dried reagent, and the resulting solution was transferred to a sterile vial for 





General Procedures for Manual Synthesis of 18F-labeled Compounds (activity of 
300-700 μCi per reaction).  
On the bench top, solid [Mes-I-Ar]X (6 μmol) was weighed into a 4 mL amber glass vial 
containing a stir bar and was then dissolved in DMF (350 μL). A stock solution of 
tetrakis(acetonitrile)copper(I) triflate (CH3CN)4CuOTf was prepared (14.3 mg in 1 mL of 
anhydrous DMF, 0.04 M), and aliquots of this solution were used for several reactions. 
A 150 μL aliquot of CuOTf solution (6 μmol) was added to the vial containing [Mes-I-
Ar]X. The reaction vial was sealed under an atmosphere of ambient air with a 
PTFE/Silicone septum cap, and then the solution was thoroughly mixed (vortex shaker, 
Barnstead® Thermolyne Type 16700). Via a syringe, a 250 μL aliquot of [18F]KF•18-
crown-6 complex (typically 300-700 μCi, prepared as described above) was added to 
the reaction vial.* The vial was then heated in an aluminum block with stirring at 85 ºC 
for 20 min. After 20 min, the reaction was allowed to cool to room temperature. A 100 
μL aliquot was withdrawn from the vial and added to 400 or 900 μL of CH2Cl2 in a 4 mL 
vial (choice of volume of CH2Cl2 was dependent on activity). The CH2Cl2 mixture was 
shaken by hand and then used for radio-TLC analysis to obtain radiochemical yields 
(RCY).† In addition, an 100 μL aliquot of the reaction solution was used for radio-HPLC 




                                                
* On a typical day, several reactions (4-20) were set up together. Due to this, the time of mixing and time of incubation 
at room temperature prior to heating varied slightly from day to day.However, the results of the radiofluorination 
appear to be insensitive to this variation. 
 
† The reaction mixture was diluted to obtain more reproducible TLC results. Undiluted samples of the reaction 
showed the same RCY; however, broadening was observed as a result of the DMF, and this made accurate 
integration more difficult. Radio-TLCs where counted immediately after being developed. This was particularly critical 
when the fluoroarene was volatile (e.g., 4-fluoroanisole), because the apparent RCY was found to decrease as a 
function of time due to the product evaporating off of the TLC plate. The RCY was determined by dividing the 
integrated area under the fluoroarene spot by the total integrated area of the TLC plate. 
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General Procedures for Automated Synthesis of 18F-labeled Compounds (initial 
activity of 1.5 Ci).   
The production-scale synthesis of radiolabeled arenes was conducted using a 
TRACERLab FXFN automated radiochemistry synthesis module (General Electric, GE). 
The synthesis module was pre-charged with a solution of the [Mes-I-Ar]X precursor (18 
μmol) and tetrakisacetonitrile copper(I) triflate (8.0 mg, 20 μmol) in DMF (0.75 mL) to be 
added from an automated port prior to 18F delivery. [18F]Fluoride was produced via the 
18O(p,n)18F nuclear reaction using a GE PETTrace cyclotron (40 μA beam for 30 min 
generated 1,500 mCi of [18F]fluoride). The [18F]fluoride was delivered to the synthesis 
module (in a 1.5 mL bolus of [18O]water) and trapped on a QMA-light Sep-Pak to 
remove [18O]water.  [18F]Fluoride was eluted into the reaction vessel using aqueous 
potassium carbonate (3.0 mg in 0.5 mL of water). A solution of 18-crown-6 (5 mg in 1 
mL of acetonitrile) was added to the reaction vessel, and the resulting solution was 
dried by azeotropic distillation to give dry [18F]KF•18-crown-6.  Evaporation was 
achieved by heating the reaction vessel to 100 °C and drawing vacuum for 4 min. After 
this time, the reaction vessel was subjected to an argon stream and simultaneous 
vacuum draw for an additional 4 min. The reaction vessel was cooled to 50 °C, DMF 
(0.75 mL) was added, and the resulting mixture was stirred for 1 min. A preloaded 
solution of iodonium salt and copper was added to the reaction vessel, and the vessel 
was sealed, heated to 85 ºC, and held at that temperature for 20 min.  The reaction 
vessel was then cooled to 50 °C, and DMF (8.5 mL) was added. The additional DMF 
was not necessary, but was used to reduce hand exposure during sample 
manipulations and analysis. The resulting solution (10 mL) was transferred to a sterile 









a. Iodonium Salts 
 
(Mesityl)(para-acetamidophenyl)iodonium tetrafluoroborate was prepared by the 
following procedure adapted from the literature. 59  A brown powder (395 mg, 40% yield). 
1H NMR (700 MHz, DMSO-d6): δ 10.3 (s, 1H), 7.91 (d, J = 9.1 Hz, 2H), 7.67 (d, J = 9.1 
Hz, 2H), 7.20 (s, 2H), 2.60 (s, 6H), 2.29 (3H), 2.05 (s, 3H). 13C NMR (176 MHz, DMSO-
d6): δ 169.0, 142.9, 142.4, 141.4, 135.8, 129.7, 122.9, 121.5, 105.8, 26.2, 24.1, 20.5. 
19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS (ESI+) [M-BF4]+ Calcd for 
C17H19INO+: 380.0506; Found: 380.0518. 
 
(Mesityl)(3-formylphenyl)iodonium tetrafluoroborate was prepared by the following 
procedure adapted from the literature.59 A white powder (276 mg, 63% yield). 1H NMR 
(700 MHz, DMSO-d6): δ 9.99 (s, 1H), 8.45 (s, 1H), 8.19 (d, J = 7.0 Hz, 1H), 8.14 (d, J = 
7.0 Hz, 1H), 7.72 (t, J = 7.0 Hz, 1H), 7.24 (s, 2H), 2.61 (s, 6H), 2.31 (s, 3H). 13C NMR 
(176 MHz, DMSO-d6): δ 191.6, 143.3, 141.7, 139.4, 138.4, 134.3, 132.7, 132.6, 129.9, 
122.6, 115.1, 26.3, 20.5. 19F NMR (376 MHz, DMSO-d6): δ –148.2, –148.3. HRMS 

















(Mesityl)(N-acetyl-4-phenylalanine)iodonium tetrafluoroborate was prepared by the 4 
step syntheses whose details are reported in the manuscript.29 A white solid (201 mg, 
1.5 mmol, 46% yield). 1H NMR (500 MHz, CDCl3) δ 7.64 (d, J = 8.4 Hz, 2H), 7.23 (d, J = 
8.4 Hz, 2H), 7.11 (s, 2H), 6.42 (d, J = 7.8 Hz, 1H), 4.77 (m, 1H), 3.67 (s, 3H), 3.16 (dd, J 
= 14.0, 5.5 Hz, 1H), 3.05 (dd, J = 14.0, 7.1 Hz, 1H), 2.60 (s, 6H), 2.34 (s, 3H), 1.92 (s, 
3H). 13C NMR (126 MHz, CDCl3) δ 171.5, 170.3, 144.7, 142.6, 141.6, 133.4, 133.2, 
130.6, 119.7, 110.0, 52.9, 52.6, 37.2, 27.1, 22.8, 21.1. HRMS (ESI+) [M–BF4]+ Calcd for 
C21H25INO3+: 466.0879; Found: 466.0874. 
 
(Mesityl)((S)-methyl 2-acetamido-5-(2-methoxyphenyl)iodonium tosylate was prepared 
by the following 6 step synthesis whose details are reported in the manuscript.29 A white 
solid (56 mg, 0.084 mmol, 42% yield) 1H NMR (700 MHz, CD3OD) δ 7.74 (d, J = 2.0 Hz, 
1H), 7.65 (d, J = 7.9 Hz, 2H), 7.45 (dd, J = 8.5, 2.0 Hz, 1H), 7.18 (d, J = 7.9 Hz, 2H), 
7.15-7.12 (m, 3H), 4.61 (dd, J = 9.1, 5.6 Hz, 1H), 3.86 (s, 3H), 3.64 (s, 3H), 3.12 (dd, J = 
14.1, 5.6 Hz, 1H), 2.90 (dd, J = 14.1, 9.1 Hz, 1H), 2.62 (s, 6H), 2.35 (s, 3H), 2.32 (s, 
3H), 1.85 (s, 3H). 13C NMR (176 MHz, CD3OD) δ 171.7, 171.5, 156.0, 143.9, 142.4, 
142.0, 140.3, 136.3, 135.4, 132.9, 129.7, 128.4, 125.5, 119.6, 112.6, 101.7, 56.7, 53.5, 
51.4, 35.6, 25.5, 20.9, 19.9, 19.6. HRMS (ESI+) [M–OTs]+ Calcd for C22H27INO4+: 










iodonium tosylate  was prepared by the following 6 step synthesis whose details are 
reported in the manuscript. 29  A white solid. 1H NMR (700 MHz, CD3OD) δ 8.04 (d, J = 
7.8 Hz, 1H, exchanges), 7.69 (d, J = 7.0 Hz, 2H), 7.21 (d, J = 7.0 Hz, 2H), 7.19 (s, 2H), 
7.13 (s, 1H), 7.06 (s, 1H), 4.58 (apparent q, J = 7.5 Hz, 1H), 3.83 (s, 3H), 3.71 (s, 3H), 
3.66 (s, 3H), 3.40 (dd, J = 14.5, 7.2 Hz, 1H), 3.22 (dd, J = 14.5, 8.1 Hz, 1H), 2.60 (s, 
6H), 2.36 (s, 3H), 2.34 (s, 3H), 1.08 (s, 9H). 
13C NMR (176 MHz, CD3OD) δ 180.1, 171.7, 152.5, 149.9, 144.3, 142.0, 140.2, 133.8, 
130.0, 128.4 (2C), 125.7, 120.7, 117.6, 113.9, 105.0, 55.4, 55.3, 52.6, 51.7, 38.6, 38.1, 
26.2, 25.4, 19.8, 19.5. HRMS (ESI+) [M–OTs]+ Calcd for C26H35INO5+: 568.1554; Found: 
568.1554. 
 
(Mesityl)(MHPG)iodonium hexafluorophosphate  was prepared by the following 
procedure. The corresponding tetraBoc protected (MHPG)-SnMe3 was prepared 
according the procedure adapted from literature. 60  In an oven-dried flask, 
iodomesitylene diacetate (2.0 equiv) was added with CH3CN (0.2M) and cooled to 5°C 
using an ice bath. To the color solution, was p-TsOHH2O (1.1 equiv) added in one 
portion, and the solution immediately turned color to yellow and let it stir for 10 minutes. 

















reaction was warmed up to room temperature and stir for 2 days. To the reaction, 
saturated LiPF6 (aq) was added and vigorously stirred for 30 minutes. The organic layer 
was separated, and the aqueous layer was extracted with methylene chloride twice and 
concentrated. The colorless oil was triturated with hexane to afford a white powder 
(52% yield). 1H NMR (700 MHz, CD3OD) δ 7.43-7.34 (m, 5H), 7.04 (s, 2H), 7.01 (s, 1H), 
6.87 (d, J = 7 Hz, 1H), 6.78 (d, J = 7 Hz, 1H), 3.90 (t, J = 7 Hz, 2H), 2.90 (t, J = 7.0 Hz, 
2H), 2.51 (s, 6H), 2.34 (s, 3H), 1.50-1.44 (m, 36H). 
13C NMR (176 MHz, CD3OD) δ 157.9, 151.4, 147.8, 144.7, 144.0, 143.4, 141.9, 135.1, 
131.8, 130.3, 129.3, 129.2, 128.4, 124.9, 124.4, 114.8, 84.2, 82.5, 71.9, 48.6, 33.5, 































b. Radio-HPLC/Radio-TLC analysis for 18F-labeled Compounds 2-11, 13, 15, and 17 
 
4-[18F]fluoroanisole 2 RAD trace overlaid with UV trace (280 nm) 
 
4-[18F]fluoroanisole 2 RAD trace overlaid with UV trace (280 nm) spiked with 4-
fluoroanisole 
 

















































 [18F]3,4-(dimethoxyl)fluorobenzene 3 RAD trace overlaid with UV trace (280 nm)  
 
[18F]3,4-(dimethoxyl)fluorobenzene 3  RAD trace overlaid with UV trace (280 nm) spiked 
with with 3,4-(dimethoxyl)fluorobenzene 
 
Radio-TLC Conditions: 50% EtOAc/Hexanes 
 
























































020514_3,4-OMe_spiked w 25uL stock
UV Detector Ch2-280nm







[18F](3,4,5-trimethoxy)fluorobenzene 4 RAD trace overlaid with UV trace (280 nm) 
 
[18F](3,4,5-trimethoxy)fluorobenzene 4 RAD trace overlaid with UV trace (280 nm) 
spiked with 3,4,5-trimethoxyfluorobenzene 
 
Radio-TLC Conditions: 50% EtOAc/Hexanes 
 
























































020514_3,4,5-OMe-1 spiked with 25uL stock
UV Detector Ch2-280nm





2-[18F]fluoroanisole 5 RAD trace overlaid with UV trace (280 nm)  
 
2-[18F]fluoroanisole 5 RAD trace overlaid with UV trace (280 nm) spiked with 2-
fluoroanisole  
 
Radio-TLC Conditions: 20% EtOAc/Hexane 
 


















































020514_2-OMe-1 spiked with 25uL stock
UV Detector Ch2-280nm






4-[18F]fluorophenylacetamide 6 RAD trace overlaid with UV trace (280 nm) 
 
4-[18F]fluorophenylacetamide 6  RAD trace overlaid with UV trace (280 nm) spiked with 
4-fluorophenylacetamide 
 
Radio-TLC Conditions: 80% EtOAc/Hexane 
 

























































4-NHAc-1 spiked w25uL stock 2-11
UV Detector Ch2-280nm





4-[18F]fluorobiphenyl 7 RAD trace overlaid with UV trace (254 nm)  
 
4-[18F]fluorobiphenyl 7 RAD trace overlaid with UV trace (254 nm) spiked with 4-
fluorobiphenyl 
 
Radio-TLC Conditions: 100% EtOAc  
 



























































 [18F]fluoro-estrone 8 RAD trace overlaid with UV trace (254 nm)  
 
































































Radio-TLC Conditions: 50% EtOAc/Hexanes 
 
 
4-[18F]fluoro-iodobenzene 9 RAD trace overlaid with UV trace (280 nm) 
 
4-[18F]fluoro-iodobenzene 9  RAD trace overlaid with UV trace (280 nm) spiked with 4-
fluoro-iodobenzene 
 
Radio-TLC Conditions: 50% EtOAc/Hexanes 
 




























































Methyl 3-[18F]fluorobenzoate 10 RAD trace overlaid with UV trace (280 nm) 
 
Methyl 3-[18F]fluorobenzoate 10 RAD trace overlaid with UV trace (280 nm) spiked with 
methyl-3-fluorobenzoate 
 
Radio-TLC Conditions: 100% EtOAc 
 





























































3-[18F]fluorobenzaldehyde 11 RAD trace overlaid with UV trace (254 nm) 
 

































































Radio-TLC Conditions: 100% EtOAc/Hexan
 
 
[18F]fluoro-L-phenylalanine 13 RAD trace overlaid with UV trace (254 nm) 
 
[18F]fluoro-L-phenylalanine 13 RAD traced overlaid with UV trace (254 nm) spiked with 
fluoro-L-phenylalanine 
 
Radio-TLC Conditions: 100% EtOAc 
 




































2-12-14 PHE-NHAc-1 SPIKED with 50 uL stock
UV Detector Ch2-280nm
2-12-14 PHE-NHAc-1 SPIKED with 50 uL stock
Minutes























3-[18F]fluoro-tyrosine 15 RAD trace overlaid with UV trace (280 nm) 
 
3-[18F]fluoro-tyrosine 15 RAD trace overlaid with UV trace (280 nm) spiked with 3-fluoro-
tyrosine 
 
Radio-TLC Conditions: 80% EtOAc/Hexane 
 




































































6-[18F]fluoro-DOPA 17 RAD trace overlaid with UV trace (280 nm)‡ 
 
6-[18F]fluoro-DOPA 17 RAD trace overlaid with UV trace (280 nm) spiked with 6-fluoro-
DOPA 
                                                
‡ The Rad peak at ca. 21.5 min corresponds to [18F]fluoromesitylene.  The ratio between fluoromesitylene and fluoro-
DOPA is 87:13. 
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CHAPTER 4. DEVELOPMENT OF CU-MEDIATED 
[18F]FLUORINATION OF ARYL BORONATES AND SYNTHESIS OF 
AG[18F]F AND ITS APPLICATION 
4.1 INTRODUCTION 
Positron emission tomography (PET) imaging is a powerful diagnostic imaging 
technique, and today over 1.5 million PET scans are performed annually just in the 
U.S.1 Despite the utility and explosive growth of modern PET technology, the synthetic 
techniques used to incorporate radionuclides such as 11C and 18F into 
radiopharmaceuticals have remained relatively unchanged since the inception of the 
field in the 1950’s. Indeed, many of the reactions used towards 18F labeling such as SN2 
and Halex reactions are considered “classical”, having been developed as early as 
1900.2  This trend is attributable to the lack of collaboration between chemists focused 
on method development and those focused on radiotracer synthesis, as both play a role 
in the development of suitable synthetic protocols that can be translated to 
radiofluorination. After almost a decade of renaissance in transition metal-catalyzed 
aromatic fluorination reactions (see Chapter 1 for more details), there has likewise been 
an explosion in the development of metal-catalyzed 18F-radiofluorination methodologies 
over the last 3-4 years. There are multiple active collaborations between radiochemistry 
experts and synthetic/organometallic chemists, which have spurred various inventions 
in methodology development for 18F-incorporation.3  
This chapter details our exploration into Cu-mediated radiofluorination of aryl boronates 
and aryl iodides (Scheme 4.1). From a practical perspective, these are ideal 
radiofluorination precursors, as they are easily synthesized and/or commercially 
available, and are typically bench-stable. However, at the time that we started this work, 
there were no nucleophilic radiofluorination methods available for electron-rich aryl 
boronic acids, stannanes, or iodides. Developing such Cu-catalyzed fluorination 
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methods would allow synthetic chemists to bypass a step to synthesize iodonium salts 
to access desired [18F]fluoroarenes, simply by introducing Cu catalysts. Thus, it is of 
interest to develop processes to fluorinate Ar–X using the combination of a Cu catalyst 
and either K18F (X = B or Sn)4 or Ag18F (X = I).5  
Scheme 4.1 Cu-Mediated Fluorination of Precursors for (Mesityl)(aryl)iodonium salts 
 
In addition to developing a new Cu-mediated method, our PET team was also interested 
in developing new methods to prepare and isolate organic-soluble metal 18F-fluoride 
salts. The most commonly used 18F-fluoride source is K[18F]F (Figure 4.1), which is 
typically prepared and dried in the presence of K2CO3 and a phase transfer reagent, 
typically a cryptand. 6  The procedure for K18Fcryptand synthesis involves passing 
aqueous 18F– through a quaternary methylammonium (QMA) anion exchange cartridge. 
The QMA resin causes 18F– to localize on the cartridge via anion exchange. An aqueous 
solution containing K2CO3/cryptand (typically Kryptofix or 18-crown-6) is then passed 
through the cartridge to desorb (elute) the 18F– as the K18Fcryptand hydrate complex. 
Azeotropic drying with CH3CN affords anhydrous K18Fcryptand complex, which is then 
re-dissolved in a dry polar aprotic solvent for use in radiolabelling reactions. The current 
problem with this method is that the isolation of K18Fcryptand requires several 
azeotropic drying cycles that take approximately 10 min, leading to an 18F– loss of 5-6% 
due to radioactive decay. Furthermore, the presence of K2CO3 and cryptands can be 
detrimental to Cu-catalyzed reactions. For instance, K2CO3 can promote ring cyclization 
of iodonium salts in the presence of amine functionality.7 Also, carbonate salts are 
commonly used in Cu-catalyzed aryl-aryl cross coupling reactions, which may lead to 




















fluorination protocols utilize different nucleophilic fluorides sources, including 
Bu4NF(tBuOH), 9  Me4NF, 10  CsF 11  and AgF5. Therefore, further exploration of new 
fluoride elution methods could provide techniques that complement metal-mediated 18F-
radiotracer synthesis.  




This chapter describes our investigation into (1) translating Cu-mediated fluorination of 
aryl boronates and boronic acids to radiofluorination and (2) establishing synthesis of 
Ag18F salt and its application to radiofluorination of aryl iodides. In both cases, the 
development of new 18F– elution procedures was critical for successful reaction 
development and optimization. 
4.2 RESULTS AND DISCUSSION  
Cu-mediated Fluorination of Aryl Boron Compounds. In  2013, the Sanford lab 
disclosed the Cu-mediated fluorination of aryl trifluoroborates, arylboronate esters, and 
aryl boronic acids with KF (Scheme 4.2).12 We immediately sought to translate this 
discovery to a radiofluorination of aryl boron compounds with K18F for the following 
reasons: (1) aryl boron compounds are readily available, (2) no-carrier-added 
nucleophilic fluorination with K18F is ideal, (3) there are much lower safety concerns with 
residual Cu compared to Pd13 or Ni14 and (4) this is an operationally simple fluorination 
method with commercially available reagents.  
 
























Scheme 4.2 Cu-Mediated Fluorination of Aryl Trifluoroborates with KF12 
 
In order to examine the feasibility of translating this method to radiofluorination, 
this protocol was further examined for air and water tolerance. It was found that the 
reaction can tolerate water and air (entry 1-3) and afford modest to good yields (Table 
4.1). This offers the possibility of this Cu-mediated fluorination could work without 
needing an air-free glovebox set up at the PET facility.  
Table 4.1 Examination on Air and Water Tolerance of the Protocol  
 
Entry Conditions 18F NMR 
Yield 
1 Set up inside of the glovebox 72% 
2 Set up outside the glovebox 81% 
3 5 equiv of H2O 41% 
As a first attempt, an electronically activated 4-cyanophenyl trifluoroboborate 3 was 
selected as a model compound. In the presence of Cu(OTf)2 and K18F18-crown-6 in 
acetonitrile for 30 minutes, we did not observe 4-[18F]fluorobenzonitrile 4 on radio-TLC 
(Scheme 4.3).  
Scheme 4.3   Initial Attempt on Cu-mediated Fluorination 
 
 
Given that 19F-fluorination needs a reaction time of 20 h, we next decided to optimize 
the reaction condition based on the proposed mechanism of the cold reaction (Scheme 
4.4). Kinetic studies determined the reaction is first-order in aryl trifluoroborates. 15 





























transmetalation, disproportionative oxidation, or reductive elimination. In addition, our 
computational studies in iodonium chemistry showed that fluoride has a high affinity 
toward CuI,16 so it was a reasonable starting point to consider how to accelerate the 
transmetalation step of Cu-mediated fluorination with aryl trifluoroborates. 
Scheme 4.4 Proposed Mechanism of the Cu-Mediated Fluorination of Ar–BF3K 
 
Acceleration of Transmetalation. We first sought to find a set of conditions that 
would show some reactivity with aryl trifluoroborates. Rationalized by the high affinity of 
fluoride to Cu catalysts in the iodonium system (detailed in chapter 2), we hypothesized 
that transmelation can be a problematic step in the mechanism (Scheme 4.5). Therefore, 
we surmised that the activation of the Caryl-B bond through Lewis acid-base interaction 
might accelerate fluorination. Miyaura et. al, reported a detailed mechanistic study on 
Pd-catalyzed borylation of aryl halides by B2(pin)2 in the presence of PdCl2(dppf) and 
excess KOAc as an additive. Their study highlighted the crucial role that acetate plays 
in the reaction, as an isolated trans-ArPd(OAc)(PPh3)2  intermediate rapidly undergoes 
transmetallation with B2(pin)2, a process that is mediated by the acetate ligand. An 
acceleration effect via bases was also seen in Suzuki coupling.17 In addition, the high 
oxophilicity of boron has to be considered as a driving force for the transmetalation step, 
which involves an acetato ligand. Thus, we hypothesized that addition of excess acetate 
salt might accelerate the transmetallation at the Cu center via the hypothetical Cu and 

























Scheme 4.5 Acceleration of Transmetalation in Miyaura Borylation and Possible 
Application to Cu-Mediated Fluorination of Aryl Triflurooborates 
 
In spite of the observation of a peak on radio TLC, HPLC analysis confirmed the 
addition of bases did not produce the desired product 4-[18F]fluorobenzonitrile 4 (Table 
4.2). The identity of the unknown compound in the presence of bases was not 
confirmed in this study; however, it was speculated that the formation of a tetrahedral 
activated boron species was generated through isotopic exchange between 19F from 
potassium trifluoroborate substrate and free 18F-fluoride ([18F]OAcBF3–). This (likely) 
outcome inspired us to shift our focus on aryl boron pinacol esters, which cannot 
undergo isotopic exchange in the presence of suitable bases that activate the boron 
center towards transmetalation.  
Table 4.2 Acetate Salt Additives for Cu-mediated Reactions 
 
Entry M-OAc RCC 
1 KOAc 0% 
2 TBAOAc 0% 












































Figure 4.2 TLC Scan Image of the Reaction with TBAOAc (Entry 2, Table 4.2) 
 
Elution Studies: Cu Salts.  Elution studies were commenced in parallel to the 
aformentioned preliminary studies. Given our hypothesis that our active catalyst was a 
CuII fluoride, it was critical to figure out a way to make the material quickly under the 
given conditions, as only traces of 18F-fluoride (< nM concentration) are actually 
available in the solution during radiolabelling. During the course of our investigation, two 
seminal reports by Doyle18 and Groves19 were separately disclosed. They proposed an 
operationally simple method to form a discrete M–18F complex by tweaking K[18F]F 
processing and purification. In 2014, Doyle reported enantioselective ring opening 
reactions of epoxides using (R,R)-(salen)CoOTs as a precursor.  A [18F](salen)CoF 
species suitable for the radiofluorination of epoxides was generated by eluting 
[18F]fluoride from a QMA ion-exchange cartridge with the salen precursor complex (eq 1, 
Scheme 4.6). This ion exchange cartridge approach was also taken by Groves and his 
colleagues to synthesize a [18F](salen)MnF species by eluting with the corresponding 
Mn-salen-tosylate complex (eq 2, Scheme 4.6). This 18F-labeled complex was utilized to 
radiofluorinate benzylic C-H bonds in a wide variety of substrates.  They used the 






























Scheme 4.6 Doyle’s and Grove’s Elution [18F]fluoride with Metal Complexes  
 
We hypothesized that QMA cartridges could also be utilized for the analogous 
production of Cu–18F, in order to enhance the efficiency of our Cu-mediated fluorination 
of boronate esters method. Evaluating the elution of 18F– from QMA cartridges with 
different Cu2+ salts in various solvents then commenced this part of the study. The 
percent 18F– recovery from QMA resin was calculated by dividing the amount of activity 
that passed through the QMA on elution by the total amount of activity (i.e, total trapped 
18F–) originally present on the QMA cartridge. Fluoride recovery was found to be 
strongly dependent on the solvent used to dissolve the Cu salt. For instance, poor 18F– 
recovery was observed with acetone and acetonitrile solutions of (MeCN)4CuOTf (entry 
1-2, Table 4.3). On the other hand, methanol and DMF solutions afforded a substantial 
18F– fluoride recovery from the QMA (entry 3,4). Switching to 100% MillQ water, fluoride 
recovery increased to 97%. The efficiency was identical when CuMeCN4OTf was 
switched to Cu(OTf)2, resulting in 96% of trapping efficiency using H2O as eluent (entry 








































Table 4.3 Elution Studies with Cu Catalysts 
 
Entry Cu Salta Solvent % 18F– Recovery 
1b (CH3CN)4CuOTf Acetone 0.7 
2b (CH3CN)4CuOTf CH3CN 2.1 
3 (CH3CN)4CuOTf MeOH 64 
4 (CH3CN)4CuOTf DMF 21 
5 (CH3CN)4CuOTf DMF:H2O 76 
5 (CH3CN)4CuOTf H2O 97 
6 Cu(OTf)2 DMF 29 
7 Cu(OTf)2 H2O 96 
a 0.1M of Cu solution was used. b 0.01 M of Cu solution was used. 
Based on this elution study, the procedure outlined in Scheme 4.7 was undertaken: (1) 
Cu(OTf)2 was dissolved in Mill-Q water; (2) this Cu solution was passed through a QMA 
cartridge pre-loaded with 18F–; (3) the filtrate was concentrated and redissolved in 
acetonitrile to produce a “dry” Cu(OTf)18F stock solution (along with free Cu(OTf)2, as it 
was added in excess). This stock solution was then treated with potassium 4-
fluorophenyl trifluoroborate at 100 °C for 30 minutes. Unfortunately, no reactivity was 
observed under these reaction conditions (Scheme 4.7). We hypothesized that lack of 
reactivity was due to the presence of copper hydrate complexes, from which water 










Cu 18F– in H2O18
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Carrier-Added Fluorination. The stoichiometry between Cu salt and KF was 
found to be critical in the original Cu-mediated fluorination of aryl trifluoroborates.4 The 
ratio of Cu: KF needs to be 1:1 in order to obtain a maximum yield of the product. One 
of the challenges in radiofluorination (also discussed in Chapter 3) is that 18F– is present 
only in 10-9–10-12 M scale. Therefore, adjustment of the stoichiometry between copper 
and fluoride by adding carrier (a 19F– fluoride source) was considered, though that would 
result in a significant dilution in the amount of 18F– in the product and hence lead to 
lower SA (Table 4.4). Upon the addition of 4 equiv of 19F KF carrier, we were pleased to 
see 17% radiochemical conversion (RCC) to 4-[18F]fluorobenzonitrile, which was 
confirmed by HPLC analysis (entry 4, Table 4.4).  Ichihara and coworkers have found 
that the combination of potassium fluoride and calcium fluoride is effective and practical 
for nucleophilic fluorination of aryl halides, so this solid mixture was also tested in our 
reaction conditions. This carrier-added reaction led to a higher yield of 23% RCC by 
HPLC (entry 5). This carrier-added study suggests the importance of sufficient formation 
of active copper fluoride complex to induce the desired reactivity, according to the 
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Table 4.4 Carrier-Added Cu-Mediated Fluorination 
 
Entry Carrier HPLC RCC  
1 none 0 
2 NaF 0 
3 LiF 0 
4 KF 17 
5 KF–CaF2 23 
 
Notably, as our project was underway, the Gouverneur group reported a related Cu-
mediated radiofluorination of aryl boronate esters using commercially available 
(py)4Cu(OTf)2 as a precatalyst (py = pyridine; Scheme 4.8).20 Their studies revealed that 
they require catalytic amounts of (py)4Cu(OTf)2 and O2 in the reaction atmosphere. 
However, this protocol had several drawbacks including: (1) the requirement for an 
expensive copper salt (py)4Cu(OTf)2; (2) incompatibility with more abundant 
organoboron precursors such as boronic acids and aryl trifluoroborate salts; and (3) 
incompatibility with automation because of the requirement for O2 in the (rendering the 
reaction incompatible with the inert push gases (argon or N2) used in modern 
automated radiochemistry synthesis modules). The third point is particularly important 
given that all modern radiopharmaceuticals in routine clinical use are prepared 
according to current good manufacturing practice (cGMP) via automated syntheses.21  
Scheme 4.8 Gouverneur’s Cu-catalyzed Radiofluorinatoiin of Boron Pinacol Esters 
 
In addition to the aforementioned shortcomings, the irreproducibility of the 



























biphenyl 6, aniline 7, and 4-acetophenone 8 were synthesized and subjected to 
Gouverneur’s reaction conditions to check its reproducibility. In our hands, the RCC of 
these transformations was quite varied depending on the substrate. We were 
particularly interested in radiolabeling 4-acetylphenyl boron pinacol ester as a model 
compound in connection with a program developing radiotracers for glycogen synthase 
kinase-3 (GSK-3). GSK-3 is a therapeutically valuable kinase that is very promising for 
Alzheimer’s disease. GSK-3 inhibitors offer a valuable approach for a future therapy 
against Alzheimer’s disease, and for our purposes, as imaging modalities for prodromal 
identification of early-stage Alzheimer’s with PET.22 When this substrate was exposed to 
Gouverneur’s conditions, we obtained 4-fluoroacetophenone 8 in just 31±1% (n = 7) 
RCC as opposed to their reported RCC (66±6%) (Scheme 4.9). Hence, our team 
decided to further pursue investigations focused on optimizing the radiofluorination of 
arylboronic acid pinacol esters.23 
Scheme 4.9 Radiofluorination of Boron Pinacol Ester  
 
Optimization of Radiofluorination of Boron Pinacol Ester. Dr. Andrew Mossine led this 
part of the project. We first examined whether Cu(OTf)2 can mediate the 
radiofluorination of 4-acetylphenyl boron pinacol ester 9 in the presence of pyridine in 
analogy to Gouverneur’s condition. 4-[18F]Fluoroacetophenone was observed in 5% 
RCC in the presence of 125 equivalents of pyridine using cGMP automated condition 
(Scheme 4.10). We decided to examine if more commercially abundant boronic acids 
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Scheme 4.10 Utilization of Less Expensive Cu(OTf)2 
 
Elution Studies: Salts. After seeing the report by Gouverneur, our next goal was to 
further improve the fluorination protocol to address unresolved limitations, most notably 
to develop an alternative QMA eluent, as we hypothesized that the K2CO3 that was 
used in the Gouverneur method to elute K[18F]F could be negatively affecting our Cu-
mediated reaction, as it can potentially form CuCO3 and/or promote cross coupling 
reactions. We also noted that Gouverneur and coworkers diluted their 18F– stock 
solutions (thereby diluting the amount of K2CO3 and Kryptofix present in each 
reaction).20 In contrast, the 18F– concentration we prepared followed cGMP standard 
methods.20,21 In addition to using Cu salts with QMA eluents, we studied a series of 
weaker ionic acids and bases (Table 4.5), so as to avoid strong bases that could poison 
the copper catalyst. Each salt required a different concentration to achieve an optimal 
18F– recovery, so the table shows the concentration that yielded optimal results. As with 
K2CO3, other salts such as KOTf, NH4OTf, NH4Cl, and TBACl, all resulted in high 18F– 
recoveries (entry 2-5, Table 4.5). Interestingly, the acidic organic salt pyridinium p-
toluenesulfonate (PPTS) also afforded 76% 18F– recovery (entry 6).  
Table 4.5 Evaluation of Weak Ionic bases/acids for 18F-Fluoride Elution 
Entry QMA Eluent Concentration (M)a [18F]Recovery 
1 K2CO3 0.025 97% 
2 KOTf 0.109 97% 
3 NH4OTf 0.170 93% 
4 NH4Cl 7.00 >99% 
5 TBACl 1.75 96% 
6 PPTSb 0.111 76% 
aWater was used for solvent. bPPTS = Pyridinium p-Toluene Sulfonate. 
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Application of New Elution Method.23 Neumaier has shown that the use of large 
quantities of strongly basic K2CO3 to elute 18F– from quaternary methyl ammonium 
(QMA) ion cartridges can be problematic for downstream copper-mediated 
radiofluorination reactions.24 As such, minimization or elimination of K2CO3 from the 
eluent was considered as the optimal method by which to ensure greater yields in this 
reaction. Given the importance of pyridine in these reactions,20 elution with a solution of 
pyridinium p-toluenesulfonate (PPTS), was examined which gave 76% 18F–-recovery 
(Table 4.5). The eluted 18F– was then azeotropically dried and combined with Cu(OTf)2, 
4-acetophenylboronic acid, and pyridine in DMF. The reaction was heated at 110 °C for 
20 minutes, after which time radio-TLC and radio-HPLC confirmed the formation of 4-
[18F]fluoroacetophenone in 48±2% RCC (n = 2), which is a significant improvement 
versus elution with K2CO3 (Scheme 4.10). These key findings led into further 
optimization of the Cu-mediated radiofluorination of aryl boronic acids, which was 
conducted by Dr. Andy Mossine and Dr. Allen Brooks. It was identified that QMA eluent 
of KOTf/K2CO3 gives the optimal condition, affording the 4-[18F]fluoroacetophenone in 
61±8% RCC. The combination of KOTf/K2CO3 (73:1) allowed significant decrease in the 
amount of K2CO3 (which may cause cross coupling reaction to take place) and 
eliminated the loss of radioactivity during the azeotropic drying procedure, as the 
absence of acidic proton sources precluded the formation of HF (Scheme 4.11). It was 
particularly surprising to observe product formation using boronic acids as precursors 
for nucleophilic radiofluorination, affording the comparable yield (70% RCC starting with 
9). It was initially predicted protons from B(OH)2 might hydrogen bond to fluoride and 
shut down the nucleophilic radiofluorination reaction4, 25  although boronic acids are 
successful substrates for distinctly electrophilic fluorinations such Ritter’s Ag-catalyzed 
method.26 This optimized conditions were successfully applied to synthesize a wide 








Scheme 4.11 Cu-mediated Radiofluorination of Aryl Boronic Acids 
 
Application to Other Boron Reagents. With the optimized condition, we next decided to 
revisit pinacol boronate esters and potassium trifluoroborates, in order to include the 
generality of the new Cu method. The corresponding boron pinacol esters of 4, 8, 11-14 
were prepared, and they were subjected to radiofluorination conditions by Dr. Andy 
Mossine and Dr. Allen Brooks. Using boronate esters, fluorinated products were formed 
in comparable yields to the boronic acid reactions (Figure 4.3). For example, the 
radiofluorination of 9 afforded product 8 in 69 ± 1% RCC (n = 3). Radiofluorination of 
aryltrifluoroborates also proceeded, albeit in low yields. For example, the 
radiofluorination of 3 yielded 9 in up to 6% RCC. As identified in the preliminary study, 
aryltrifluoroborates are less desirable as radiofluorination precursors due to the potential 
for isotopic exchange (see Table 4.2 for early studies). Notably, the new QMA elution 
method and addition of stoichiometric pyridine and Cu(OTf)2 enabled the 
radiofluorination of boron pinacol esters while the stoichiometric amount of 














(QMA eluent: K2CO3: KOTf = 73:1)
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Figure 4.3 Cu-mediated Radiofluorination of Other Boron Reagents 
 
Role of Pyridine. Addition of pyridines to the reaction was found to be critical for this 
radiofluorination, as we observe that the reaction does not occur in the absence of 
pyridine. There could be several possible roles of pyridine in the reaction, including as a 
ligand, solvent, or in the activation of the Csp2–B bond by coordinating to the boron 
center to form a tetracoordinate boron species that accelerates the transmetallation step 
(possible route 1, Scheme 4.12). In 1958, Snyder and colleagues reported the synthesis 
of a 1:1 complex between triphenylboroxine and pyridine, (PhBO)3·pyridine, and 
proposed that the coordination of the pyridine occurs at one boron atom within the B3O3 
ring. 27  Dakternieks and coworkers revisited the synthesis of (PhBO)3·pyridine and 
reported full details of its molecular structure with crystallographic data of the 
compound.28 Furthermore, commercial boronic acid samples come as a mixture of 
boronic acid and the corresponding boroxines. 29   Well-defined (ArBO3)·pyridine 
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to examine if the reaction undergoes boroxine intermediates to generate desired 
[18F]fluoroarenes (possible route, Scheme 4.12).  
Scheme 4.12 Possible Roles of Pyridine in the Cu-Mediated Radiofluorination 
 
Both the biphenyl and 4-methoxypheyl boroxines afforded higher yields (55% and 25% 
respectively) than those with the corresponding boronic acids in the presence of 42 
equivalents of pyridine as an additive. However, the exclusion of the pyridine additive 
resulted in a steep decrease in the yields of the products (2.3% and 5.2%, respectively). 
The role of pyridine in this protocol is therefore still inconclusive, as it was originally 
hypothesized that pyridine was only required to form the reactive boroxine complex in 
situ. Further mechanistic studies are required to shed light on the mechanism. For 
instance, analyzing the reaction mixture after the radiofluorination to understand by-
product distributions would provide important information about the roles of each 







































Table 4.6 Radiofluorination of Aryl Boroxines 
 
R pyridine  RCC RCC with B(OH)2 
4-Ph yes 55% 46±6% 
4-Ph no 2.3% n/a 
4-OMe yes 25% 19±3% 
4-OMe no 5.2% n/a 
 
In addition, the radiofluorination of (ArBO)3·pyridine was translated to 19F-fluorination 
using (4-OMePhBO3)·pyridine under an inert atmosphere (Table 4.7). 4-fluoroanisole 
was generated in 2% yield in the presence of pyridine and Cu(OTf)2 in DMF. In contrast, 
the reaction in CH3CN did not proceed, which agrees well with our previous findings, 
where the addition of pyridines in the cold fluorination of aryl trifluorborates in 
acetonitrile solvent decreased the yield significantly  (Scheme 4.13).30 
Table 4.7 Cu-Mediated Fluorination of Aryl Boroxines 
 
Solvent pyridine  19FNMR 
yield 
DMF yes 2% 
DMF no 0% 
CH3CN yes 0% 






















42  equiv pyridine
1.3 equiv KF





Scheme 4.13 Cu-Mediated Fluorination of Aryl Trifluoroborates 
 
In summary, this part of Chapter 4 has detailed a mild and general Cu-mediated 
method for the radiofluorination of organoboron compounds with K18F. Alternate QMA 
eluents (KOTf/K2CO3) enabled highly reproducible Cu-mediated reactions. This method 
represents the first high yielding nucleophilic fluorination of boronic acids (using 18F or 
19F), is compatible with aryl, heteroaryl and vinyl boronic acids, and thus fills an 
important gap in the late-stage fluorination space. The method is also suitable for the 
radiofluorination of boronate esters and potassium trifluoroborates. Finally, this process 
can be automated on a commercial radiochemistry synthesis module and applied to 
clinically relevant radiotracers, such as [18F]FPEB, synthesized by Katarina 
Makaravage. Validation of the method for cGMP clinical production of [18F]FPEB and 
other radiotracers is currently under investigation. 
Exploration of Ag18F Chemistry. This part of Chapter 4 describes investigations into 
the development of an operationally simple preparation of anhydrous Ag18F. Herein, the 
work detailed was performed in collaboration with Dr. Allen Brooks and Katarina 
Makaravage. Over the past few decades, there have been sporadic examples where Ag 
and/or Ag[18F] have been employed to promote the 18F-fluorination of bioactive 
molecules. The synthesis of Ag18F has been known since 1973, but an operationally 
simple method to produce Ag18F has still not been realized.31 Most of the reported 
examples use specialized equipment (e.g. platinum reaction vessels,31a custom 
cyclotron targets) or insoluble silver sources (Ag2O, 31c-e Ag2CO3, 31e silver wool31f) that 
are not readily adaptable to automated radiosynthesis modules. A synthetically useful 
method for preparing Ag[18F] using the ion exchange (QMA) techniques employed in 
modern radiochemistry has not been reported. We have initiated preliminary efforts to 










with 4 equiv pyridine: 9%19FNMR yield
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Figure 4.4 Available Automated Nucleophilic [18F]fluoride 
 
Development of an operationally simple Ag18F synthesis method is expected to allow 
the translation of a number of recently reported fluorination reactions using Ag18F. There 
has been a series of seminal reports on transition metal catalyzed fluorinations using 
Ag18F as a fluorinating reagent (Scheme 4.14). Such robust nucleophilic fluorinating 
reagents opens up possibility for investigating the corresponding radiofluorinations, 
including Pd-catalyzed asymmetric alllylic fluorination (eq 1),32 Pd-catalyzed benzylic C–
H fluorination (eq 2), 33  Cu-catalyzed Caryl–H fluorinaiton (eq 3) 34  and Cu-catalyzed 

















Scheme 4.14 Fluorination Protocols with AgF 
 
Ag18F Elution Method. The standard approach to prepare K18F is to pass a solution of 
18F– in H218O through a quaternary ammonium Sep-Pak cartridge. The 18F–  is trapped 
on the cartridge, and is subsequently eluted with aqueous K2CO3 to generate K18F 
(Table 4.8). Although a similar approach with Ag2CO3 for Ag18F preparation was 
unsuccessful (entry 2), replacing Ag2CO3 with water-soluble AgOAc, AgBF4, AgOTf, 
AgNO3 and (CH3CN)4AgBF4 resulted in the formation of Ag18F in 95-99% of 18F– 
recovery (Table 4.8, entry 4-8). A problem that was quickly identified was that once 
elution is complete, the filtrate is a heterogeneous mixture, which would cause problems 
for automated synthesis. This was tracked to the bicarbonate counterion associated 
with the QMA resin, which was leading to the formation of AgHCO3 particulate during 























































Table 4.8 Synthesis of Ag18F 
 
Entry QMA eluent solvent [18F]Recovery (%) 
1 K2CO3 H2O 97 
2 Ag2CO3 H2O 0 
3 AgOTf CH3CN 0 
4 AgOAc H2O 97 
5 AgBF4 H2O 99 
6 AgOTf H2O 98 
7 AgNO3 H2O 95 
8 (CH3CN)4AgBF4 H2O 88 
As such, we turned our attention to revising the preconditioning method. QMA 
cartridges contain chloride as the counterion to the quarternary ammonium resin.  This 
is a problem, as chloride can often behave analogously to fluoride in reactions, which 
leads to the formation of an impurity that is largely inseparable from the fluorinated 
radiotracer.  As such, chloride needs to be removed/exchanged for another counterion 
prior to trapping 18F–. To do so, the QMA is typically pre-conditioned with NaHCO3 
solution in order to displace chlorides with bicarbonate ions (STEP 1, in Figure 4.5). 
Bicarbonate is weakly basic and also in equilibrium with carbonate, so we sought to 
identify an alternative salt in order to avoid any carbonates/bicarbonates that could 









Figure 4.5 Diagram of QMA and Standard Operating Procedure  
 
Hence, KNO3, KOTf, KOAc and NaBF4 were evaluated for preconditioning of the QMA 
cartridge. All showed similar 18F– recovery 94-98% (entry 1-3, Table 4.9) except for 
NaBF4 (40% 18F– recovery), possibly due to isotopic exchange with the fluoroborate 
counterion. To directly test Ag18F with the existing Cu method, KOTf was chosen for 
preconditioning, as copper triflate salts were utilized for its optimized condition.  
Table 4.9 Preconditions of QMA Cartridge for Ag18F Synthesis 
 
Entry Salt for Precondition [18F]Recovery (%) 
1 KNO3 98 
2 KOTf 94 
3 KOAc 96 
4 NaBF4 40 
To confirm the formation of Ag18F, this fluorinating reagent was subjected to the 
conditions used for Cu-mediated [18F] fluorination of iodonium salts. To our delight, the 
7!
Ag-18F: Unexplored F– Source 
•  Ag18F is known since a radiolabeling conference in 1973 but there’s no 
operationally simple method to produce Ag18F. 
•  Eluting 18F– with transition metal catalysts have been recently introduced. 










Enantioselective Radiosynthesis of Positron Emission Tomography
(PET) Tracers Containing [18F]Fluorohydrins
Thomas J. A. Graham,† R. Frederick Lambert,† Karl Ploessl,‡ Hank F. Kung,‡,§ and Abigail G. Doyle*,†
†Department of Chemistry, Princeton University, Princeton, New Jersey 08544, United States
‡Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
§Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States
*S Supporting Information
ABSTRACT: Herein, we describe an operationally
straightforward radiosynthesis of a chiral transition metal
fluoride catalyst, [18F](salen)CoF, and its use for late-stage
enantioselective aliphatic radiofluorination. We demon-
strate the utility of the method by preparing single
enantiomer experimental and clinically validated PET
tracers that contain base-sensitive functional groups,
epimerizable stereocenters, and nitrogen-rich motifs.
Unlike the conventional radiosyntheses of these targets
with [18F]KF, labeling with (salen)CoF is possible in the
last step and under exceptionally mild conditions. These
results constitute a rare example of a nucleophilic
radiofluorination using a transition metal fluoride and
highlight the potential of such reagents to enhance
traditional methods for labeling aliphatic hydrocarbons.
The use of [18F]-labeled small molecules for positronemission tomography (PET) represents one of the most
promising approaches to detect disease progression and evaluate
therapeutic effectiveness in vivo.1−3 However, the radiochemical
methods available to introduce [18F]fluoride into bioactive
probes severely limit the potential scope of the imaging
modality.4,5 The short half-life (110 min) and low available
concentrations of 18F (ranging from nM to μM), compounded
with the general difficulties posed by C−19F bond formation,
make the identification of broadly applicable radiofluorinations
of complex molecules incredibly challenging.6,7 Nevertheless, the
past five years have witnessed the discovery of new methods that
begin to address the limited scope of radiolabeling with
[18F]fluoride. The majority of these solutions have focused on
the challenge of [18F]aryl fluoride synthesis.8−10 In contrast,
methods for improving the scope of aliphatic radiofluorination
remain significantly underdeveloped.11,12 Although numerous
modern synthetic methods have been reported that achieve mild
and selective aliphatic carbon−fluorine bond formation, these
methods utilize electrophilic 19F sources.13 Nucleophilic fluoride
is currently the only practical and generally available source of 18F
to prepare PET tracers in high specific activity.13 As such, these
electrophilic methods have proven less useful for applications in
PET.
PET tracers containing aliphatic C−18F labels are typically
prepared using a substitution reaction with activated alcohol
derivatives (i.e., tosylate, mesylate) and [18F]KF in the presence
of cryptands such as Kryptofix 2.2.2. (K222). Substrates
possessing protic functional groups (e.g., alcohols) and
functionality prone to elimination are generally not tolerated
under these reaction conditions due to the high temperatures
(>100 °C) necessary for labeling and the basicity of [18F]KF/
K222.
6,7 Furthermore, despite the importance of stereochemistry
with regard to biological activity, the preparation of single
stereoisomer PET probes is often challenging owing to the
propensity of [18F]fluoride reagents to induce epimerization. As
such, PET tracers are often evaluated as racemic mixtures or they
are subjected to time-consuming chiral HPLC separation.14,15
To the best of our knowledge, methods capable of late-stage
enantioselective labeling with [18F]fluoride are completely
unknown. Herein, we report an asymmetric, no-carrier-added
radiosynthesis of [18F]fluorohydrins by ring opening of epoxides
with chiral cobalt catalysts. In addition to offering direct access to
single enantiomer tracers in the last synthetic step, the method
also addresses many of the noted deficiencies associated with
aliphatic labeling using [18F]KF.
[18F]Fluorohydrins represent a useful motif in probe design
and are featured in several experimental and clinically validated
PET tracers.14,16−18 They are typically prepared through
selective displacement of differentially protected diols followed
by deprotection of the remaining protecting group (vide inf ra).
As such, preparation of a single enantiomer PET probe
containing an [18F]fluorohydrin requires that stereochemistry
be set within an organic molecule prior to labeling. Asymmetric
Received: March 13, 2014
Published: March 17, 2014
Figure 1. (A) Asymmetric fluoride ring opening of epoxides catalyzed
by (salen)Co; DBN: 1,5-diazabicyclo(4.3.0)non-5-ene. (B) Proposed
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reaction provided 36% RCC of 4-[18F]fluoroanisole (Scheme 4.15). This result suggests 
that we have successfully established a practical Ag18F synthesis.  
Scheme 4.15 Cu-Mediated [18F]fluorination of (mesityl)(aryl)iodonium 
Tetrafluoroborates with Ag18F 
 
Cu-mediated Fluorination of Aryl Iodides. Aryl iodides are ideal radiofluorination 
precursors, because they are indefinitely shelf-stable and can be synthesized using 
straightforward methods under mild conditions.36 Furthermore, thousands of (hetero)aryl 
iodides are commercially available. However, despite the great potential utility of the 
nucleophilic radiofluorination of aryl iodides, this transformation has not, to our 
knowledge, been reported. The closest known reaction involves nucleophilic aromatic 
substitution (SNAr). However, the SNAr fluorination of aryl halides is fundamentally 
limited to electron deficient precursors. The nucleophilic fluorination of electron rich aryl 
iodides remains an exceedingly challenging transformation even outside of the realm of 
radiochemistry.  
      To date, there is just a single reported example of this transformation. In 2012, 
Hartwig disclosed Cu-mediated fluorination of aryl iodides. This reaction requires an 
excess of AgF as the fluorinating reagent and a reaction time of 22 h (Scheme 4.16).35 
Scheme 4.16 Hartwig’s Cu-mediated Fluorination of Aryl Iodides35 
 
 
Such methods also provide a direct route to 18F fluoroarenes with Cu1+, bypassing 
oxidation of the iodine center required for the previously disclosed iodonium chemistry 









Cu(OTf)2 toluene: 45% RCC
DMF












source for the Cu-mediated radiofluorination of aryl iodides. To translate this 
transformation into a practical radiofluorination, two challenges must be addressed. First, 
conditions must be developed that employ fluoride as the limiting reagent. Hartwig and 
his co-workers demonstrated that 1.0 equiv of AgF can be used for conversion of 4-
iodobenzaldehyde to afford 75% yield, which suggests that Ag18F can be a limiting 
reagent for desired transformation. Second, the original fluorination requires 22 hours of 
reaction time; therefore we need to find a means to accelerate the reaction rate. 
Scheme 4.17 Direct Access by Cu-mediated [18F]Fluroination with Ag18F 
 
With an optimized synthesis of Ag18F in hand, we conducted preliminary 
experiments on the radiofluorination of 4-iodobiphenyl with Ag18F over a reaction time of 
40 minutes.  An initial screen of Cu salts revealed that the radiofluorination conducted at 
14 mM in DMF, using a 3 :1 ratio of Cu(OTf)(tBuCN)2 : 15 gave 5% RCC of 4-
[18F]fluorobiphenyl 6 (Scheme 4.18). Carrier-added-fluorination (2 equiv AgF) did not 















Scheme 4.18 Fluorination of 15 with Ag18F 
 
 
Our efforts moving forward focused on further optimizing the radiofluorination of 15 with 
Ag18F, with the goal of achieving ≥50% RCC. We hypothesize that the main reason for 
the modest RCCs is that the reaction is too slow to proceed to completion within 40 min. 
The original report proposed that oxidative addition of aryl iodides is the rate-limiting 
step (Scheme 4.19). Two strategies were considered in order to accelerate the reaction 
rate. First, we have evaluated different solvents with high boiling points to raise the 
reaction temperature. Second, a series of electron-rich ligands were evaluated for the 
Cu complex, as literature precedent suggests that oxidative addition should be fastest 
with electron rich CuI complexes.38 
Scheme 4.19  Proposed Mechanism of Cu-mediated fluorinaiton of Aryl Iodide 
 
Unknown Stable M-18F Complexes.  Both solvent screens and ligand screens were 
conducted and unknown large peaks were identified on radio-TLC in both cases. For 
instance, 87% of RCC of an unknown product was observed by radio-TLC when triphos 
was utilized with 3 equiv of BOXCuCl2 (Figure 4.6). However, radio-HPLC showed 
multiple product peaks, and spiking with authentic sample confirmed that the 4-
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The identity of the major products is still unknown. Other ligands, including 
bis(oxazoline)s, bipyridines, diimines, NHCs, and phosphines were evaluated, but they 
led to either no yield or unproductive side product formation. Control studies revealed 
that those unknown peaks were formed in the absence of 15. Therefore, it was 
hypothesized that an unknown stable M–18F complex was formed under these 
conditions.  
Figure 4.6 Radiofluorination of 4-iodobiphenyl 
 
 
Solvents were also screened, and several different classes of high-boiling-point solvents 
were evaluated towards fluorination of aryl iodides. When dioxane or tBuCN were 
utilized, unknown products were formed in greater than 50% RCC, according to radio-
TLC. As shown in Figure 4.6, they were again not the desired products, as co-injection 
on HPLC revealed no product formation (Figure 4.7). Unfortunately, a current lack of 
diagnostic spectroscopic analysis for radioactive materials hindered our attempt to 
figure out the identity of the unknowns. However, it seems conclusive that Cu-mediated 
fluorination of aryl iodides is very slow (low yield <10% RCC) and stable M–18F 



























In summary, the second part of this chapter has described our attempts at translating 
Hartwig’s Cu-mediated fluorination of aryl iodides. It is the first example that 
demonstrated that radiofluorination of aryl iodides is possible in the presence of 
superstoichiometric Cu and Ag18F. The formation of the desired product was observed 
in Cu-mediated radiofluorination of iodonium salts, albeit lower yield than that reported 
previously (Scheme 4.16).37 This may suggest that optimization of the azeotropic drying 
procedure is required in order to eliminate adventitious water from the reaction, 
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In summary, Chapter 4 describes efforts toward developing Cu-mediated 
radiofluorinations of aryl boronic acids and aryl iodides. New elution methods were 
developed for each protocol as a means to produce effectively dry metal [18F]fluoride. 
Aryl boronic acids were successfully radiofluorinated in the presence of Cu(OTf)2 and 
pyridine, and this method is highly reproducible and  uses all commercially available 
reagents to conduct the reaction. Importantly, pyridine was not used in the cold 
chemistry but is essential for this radiofluorination protocol. A practical, rapid synthesis 
of Ag18F was established, and it was used in Cu-mediated radiofluorination of aryl 
iodides. However, to date, the yields of this transformation remain low. Application of 
Ag18F into other protocols is worth considering.  
4.4 PERSPECTIVE AND OUTLOOK 
The radiofluorination of boronic acids has already proven highly reproducible at other 
PET facilities, and we will continue to improve the scope of the chemistry as well as 
elucidate the mechanism of the protocol. Our investigations on the radiofluorination of 
aryl boronic acids revealed the necessity of pyridine in the reaction. The preliminary 
results (such as boroxine chemistry) did not give conclusive data to elucidate the role of 
pyridine in the reaction. Hence, a key focus of future research will be to gain a detailed 
mechanistic understanding of the role of this additive in order to further optimize the 
reaction. Boronic acids are widely commercially available and byproducts of the reaction 
were readily separable by HPLC (even protodeborated products of simple precursors). 
For Ag18F chemistry, though, translation to the Cu-mediated [18F]fluorination of aryl 
iodides was shown to be challenging. However, this Ag18F chemistry could potentially 
be applicable to other fluorination methods in the literature, some examples of which are 





Instrumental Information: NMR spectra were obtained on a Varian MR400 (400.52 
MHz for 1H; 100.71 MHz for 13C; 376.87 MHz for 19F), a Varian VNMRS 500 (500.10 
MHz for 1H), or a Varian VNMRS 700 (699.76 MHz for 1H; 175.95 MHz for 13C) 
spectrometer. 1H and 13C NMR chemical shifts are reported in parts per million (ppm) 
relative to trimethylsilane (TMS), with the residual solvent peak used as an internal 
reference. 19F NMR spectra are referenced based on an internal standard, 1,3,5-
trifluorobenzene (–110.00 ppm). 1H and 19F multiplicities are reported as follows: singlet 
(s), doublet (d), triplet (t), quartet (q), and multiplet (m). High performance liquid 
chromatography (HPLC) was performed using a Shimadzu LC-2010A HT system 
equipped with a Bioscan B-FC-1000 radiation detector. Radio-TLC analysis was 
performed using a Bioscan AR 2000 Radio-TLC scanner with EMD Millipore TLC silica 
gel 60 plates (3.0 cm wide x 6.5 cm long). 
Material and Methods Boronic acid precursors were purchased from Frontier Scientific, 
Oakwood Products and Sigma Aldrich and used as received. B(pin)-PEB39 and B(OH)2-
PEB were prepared according to the literature procedure. Unless otherwise stated, 
reagents and solvents were commercially available and used without further purification. 
Ethanol was purchased from American Regent. HPLC grade acetonitrile was purchased 
from Fisher Scientific. Anhydrous acetonitrile were purchased from Acros. 
Trimethylacetonitrile was purchased from Alfa Aesar and dried over mole sieves 4A. 
Sterile product vials were purchased from Hollister-Stier. QMA-light Sep-Paks were 
purchased from Waters Corporation. Boroxines were prepared according to the 
literature procedure.40  
 
Elution Studies. QMA-light Sep-Paks were flushed with 10 mL of ethanol followed by 
10 mL of 0.5 M potassium triflate solution, and finally 10 mL of ultrapure water prior to 
use. [18F]fluoride was trapped on a QMA cartidge and washed with dry CH3CN (2-5 mL). 
The activity of QMA cartridge was recorded. Then [18F]fluoride was eluted with a freshly 
prepared QMA eluent (1 mL total volume).  After the elution, the remaining activity was 
recorded to calculate the 18F-recovery.  
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Synthesis of K18F.  
All loading operations were conducted under an ambient atmosphere. Argon was used 
as a pressurizing gas during automated sample transfers. Potassium [18F]fluoride was 
prepared using a TRACERLab FXFN automated radiochemistry synthesis module 
(General Electric, GE). [18F]Fluoride was produced via the 18O(p,n)18F nuclear reaction 
using a GE PETTrace cyclotron (40 μA beam for 2-5 min generated ca. 150-375 mCi of 
[18F]fluoride). The [18F]fluoride was delivered to the synthesis module in a 1.5 mL bolus 
of [18O]water and trapped on a QMA-light Sep-Pak to remove [18O]water and other 
impurities. [18F]Fluoride was eluted into the reaction vessel using 550 µL of aqueous 
solution containing 5 mg potassium trifluoromethanesulfonate and 50 µg of potassium 
carbonate.  One milliliter of acetonitrile was added to the reaction vessel, and the 
resulting solution was dried by azeotropic distillation to provide anhydrous K18F. 
Azeotropic drying/evaporation was achieved by heating the reaction vessel to 100 °C 
and drawing vacuum for 6 min. The reaction vessel was then subjected to an argon 
stream and simultaneous vacuum draw for an additional 6 min. Overall, 70% of activity 
remained after azeotropic drying (68 ± 9%, n=12; calculated from TRACERLab FXFN 
reactor radiation detector by comparing activity before and after azeotropic drying). N,N-
dimethylformamide (6 mL) was added to the dried reagent, and heated at 120 °C with 
stirring for 5 min.  The resulting solution was cooled to 40 °C and was transferred to a 
sterile vial for subsequent use in reactions (% activity recovery into dose vial: 40 ± 10%, 
n=7; calculated by comparing activity of recovered solution by Capintec with final 
reading from TRACERLab FXFN reactor radiation detector. As an example, approx. 80 
mCi of prepared K18F in 6 mL DMF is isolated with a 5 min beam.   
General Procedures for Manual Synthesis of 18F-labeled Compounds (activity of 
500-1500 μCi per reaction) for Cu-mediated Radiofluorination of Boronic Acids. 
Unless otherwise noted, this procedure was used for the synthesis of the [18F] 
fluorinated substrates described in Figure 1 of the main text. Stock solutions of boronic 
acid precursor (40 mM), copper (II) trifluoromethanesulfonate (200 mM), and pyridine (1 
M) in DMF were prepared immediately prior to the start of the reaction.  Aliquots of 
these solutions were used to carry out subsequent [18F]fluorination reactions.  In a 
typical reaction, a 100 µL (20 µmol, 5 equiv) of copper (II) trifluoromethanesulfonate 
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aliquot was mixed with a 500 µL (500 µmol, 25 equiv) pyridine aliquot in a colorless 
borosilicate 4 mL scintillation vial.  The solution was briefly agitated using a vortex 
shaker (Barnstead® Thermolyne Type 16700), then a 100 µL (4 µmol, 1 equiv) aliquot 
of boronic acid precursor was added. The reaction vial was sealed under an 
atmosphere of ambient air with a PTFE/Silicone septum cap, and a 100-300 µL aliquot 
of K18F (150-3000 µCi, depending on the time required for HPLC analysis) was added 
to the reaction vial through the septum via a syringe.  Additional anhydrous DMF was 
also added (as required) to bring the total solution volume to 1000 µL.  The vial was 
then heated in an aluminum block (Chemglass Part# CG-1991-04) without stirring at 
110 ºC for 20 min. After 20 min, the reaction was allowed to cool to room temperature.  
Radio-TLC analysis was conducted to determine radiochemical conversion (RCC %).  
Crude reaction mixture was spotted onto standard silica coated glass plates and 
developed with 1:1 hexane/ethyl acetate in a glass TLC chamber.  The RCC was 
determined by dividing the integrated area under the fluorinated product spot by the 
total integrated area of the TLC plate. To prepare samples for HPLC analysis, 50 µL of 
the reaction mixture was mixed with 50 µL acetonitrile or spiked with 50 µL of 1 mg/mL 
fluorinated standard solution in acetonitrile.  Eluent systems and columns used for 
HPLC analysis are described below.   
Synthesis of [18F]AgF. All loading operations were conducted under ambient 
atmosphere. Argon was used as a pressurizing gas during automated sample transfers. 
silver [18F]fluoride was prepared using a TRACERLab FXFN automated radiochemistry 
synthesis module (General Electric, GE). [18F]Fluoride was produced via the 18O(p,n)18F 
nuclear reaction using a GE PETTrace cyclotron (40 μA beam for 2 min generated ca. 
150 mCi of [18F]fluoride). The [18F]fluoride was delivered to the synthesis module in a 
1.5 mL bolus of [18O]water and trapped on a QMA-light Sep-Pak to remove [18O]water. 
[18F]Fluoride was eluted into the reaction vessel using aqueous silver triflate (10 mg in 
1.0 mL of water). Acetonitrle (2 mL) was added to the reaction vessel, and the resulting 
solution was dried by azeotropic distillation to give dry [18F]AgFAgOTf.  Evaporation 
was achieved by heating the reaction vessel to 100 °C and drawing vacuum for 6 min. 
After this time, the reaction vessel was subjected to an argon stream and simultaneous 
vacuum draw for an additional 4 min. Finally, DMF (or solvent of reaction) (3 mL) was 
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added to the dried reagent, and the resulting solution was transferred to a sterile vial for 
subsequent use in reactions (approx. 30 mCi of prepared 18F reagent was transferred).  
General Procedures for Manual Synthesis of 18F-labeled Compounds (activity of 
500-1500 μCi per reaction) of Radiofluorination of Aryl Iodides. 
In a dry box, aryl iodide (1 μmol) and Cu salt (1.5 μmol, 1.5 equiv) was weighed into a 4 
mL amber glass vial containing a stir bar and was then dissolved in DMF (300 μL). The 
reaction vial was sealed under an atmosphere of ambient air with a PTFE/Silicone 
septum cap. Via a syringe, a 100 μL aliquot of [18F]AgF (typically 500- 1500 μCi, 
prepared as described above) was added to the reaction vial. On a typical day, several 
reactions (4-20) were set up together. Due to this, the time of mixing and time of 
incubation at room temperature prior to heating varied slightly from day to day. However, 
the results of the radiofluorination appear to be insensitive to this variation. The vial was 
then heated in an aluminum block with stirring at 140 ºC for 40 min. After 40 min, the 
reaction was allowed to cool to room temperature. The raw reaction mixture was used 
for radio-TLC analysis to obtain radiochemical conversions (RCC). In addition, a 100 μL 
aliquot of the reaction solution was used for radio-HPLC analysis by diluting the sample 
into MeCN (300 μL total volume).  The RCC was determined by dividing the integrated 
area under the fluoroarene spot by the total integrated area of the TLC plate (see below 
for representative TLC traces).  The RCC reported here do not reflect losses during the 















4-[18F]fluoroacetophenone 8 RAD trace overlaid with UV trace (256 nm) 
 




2-[18F]fluoromethylbenzoate 11 RAD trace overlaid with UV trace (256 nm)  
 













4-[18F]fluorobenzonitrile 4 RAD trace overlaid with UV trace (256 nm) 
 


















1-[18F]fluoro-3,4,5-trimethoxybenzene 13 RAD trace overlaid with UV trace (256 nm)  
 
1-[18F]fluoro-3,4,5-trimethoxybenzene 13 RAD trace overlaid with UV trace (256 nm) 










5-[18F]fluoroindole 14 RAD trace overlaid with UV trace (256 nm)  
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CHAPTER 5. PD-CATALYZED DECARBONYLATIVE 
CARBON-HETEROATOM BOND FORMATION 
5.1 INTRODUCTION 
    Catalytic reactions involving carbon monoxide (CO) transfer via transition metals 
are important transformations in the field of organometallic chemistry. Migratory CO 
insertion is a key fundamental step that occurs at a number of transition metal centers in 
which CO inserts into a metal-ligand (M–L) bond to form a metal–acyl intermediate 
(Scheme 5.1).1 This is a well-established process and widely utilized in a number of 
industrial-scale transformations such as hydroformylation, 2   the Fisher-Tropsch 
process, 3  and the Monsanto process (Cativa process). 4  In marked contrast, CO-
deinsertion, the microscopic reverse of CO insertion, is much less utilized, in part, 
because the dissociation of CO from the metal center is generally slow5 due to strong π-
backbonding from CO6 (Scheme 5.1). 
Scheme 5.1  CO-insertion vs. CO-deinsertion 
 
Transition metal-catalyzed (mediated) decarbonylation reaction was first discovered 
by Tsuji and Ohno in 1965. The use of catalytic PdCl2 or Pd/C7 and stoichiometric 
(PPh3)3RhCl (Wilkinson’s catalyst) afforded the decarbonylation of aldehydes and acid 
chlorides (Scheme 5.2).8 Further studies found that numerous aliphatic, aromatic, and 
α,β-unsaturated aldehydes can be decarbonylated in good yields at or above room 
temperature in the substoichiometric amount of Wilkinson’s catalyst. 9,10  Further studies 









because carbon monoxide is released from the coordination sphere of the rhodium and 
the catalyst is regenerated.11  
Scheme 5.2 Decarbonylation of Aldehydes (eq. 1) and Acid Chlorides (eq.2)  
 
In recent years, there is a growing interest in the use of aroyl compounds in metal-
catalyzed decarboxylative or decabonylative coupling. For example, Gooβen employed 
a palladium-copper bimetallic catalytic system to achieve decarboxylative cross 
coupling of carboxylic acids and haloarenes (eq 1, Scheme 5.3).12 Carboxylic acids are 
the most abundant functionality present in organic molecules and the use of such 
chemical feedstocks in transition metal catalysis is highly desired. Since then a number 
of decarboxylative and decarbonylative cross coupling reactions with aroyl compounds 
have been disclosed. 13  Gooβen and Paetzoid reported the Rh-catalyzed 
decarboxylative cross coupling of arylcarboxylic anhydrides and aryl boroxines (eq 2).14 
The stoichiometric studies were conducted on the decarbonylative coupling of diphenyl 
zinc and cyclic anhydrides  or phthalimides to provide the corresponding 
decarbonylative arylation product (eq 3).15,16 More recently, Itami and coworkers have 
suceeded in Ni-catalyzed decarbonylative Suzuki-Miyaura coupling of esters and aryl 
boronic acids (eq 4). 17  As such, modern examples of transition metal-catalyzed 
decarbonylation mainly focuses on the intermolecular reaction between aroyl 
compounds and nucleophiles/transmetalating reagents. In contrast, intramolecular 


















Scheme 5.3 Decarboxylative and Decarbonylative Cross Coupling Reactions 
 
Based on the recent development in catalysis, we reasoned that careful tuning of a 
transition metal catalyst might further facilitate this challenging decarbonylation step 
thereby allowing Tsuji-Wilkinson type direct decarbonylative coupling under milder 
conditions. Notably, our lab demonstrated in 2014 that stoichiometric decarbonylation is 
feasible at a PdII(Ruphos) complex at 80 ºC (Scheme 5.4).18  




































































The premise of this project is to develop a transition metal catalyzed decarbonylative 
coupling method. Our preliminary studies targeted the development of a mild 
decarbonylative fluorination as a means to access aryl fluorides (Scheme 5.5). Notably, 
literature examples utilizing benzoyl fluoride as a fluorinating reagent are scarce,19 and 
there are currently no examples in which as aroyl fluoride is converted to fluoroarene via 
CO-deinsertion.20  
Scheme 5.5 Our  Ultimate Aim: Decarbonylative Fluroination 
 
This strategy would utilize a single reagent that serves as both oxidant and coupling 
partner in the presence of a catalyst. This would circumvent several challenges often 
associated with aromatic fluorination including: (1) it would obviate the poor solubility of 
alkali metal fluorides and  (2) it could be more sustainable and atom-economical than 
traditional cross-coupling methods that require multiple components 
(nucleophiles/transmetalating reagents and bases) (Figure 5.1a). Ultimately, the 
fundamental understanding of the CO-insertion process would help further improve the 
design of competent catalysts and reaction conditions for this transformation. We 










Figure 5.1 Comparison of (b) Cross-Coupling Reactions  and (b) Proposed 
Mechanism of Decarbonylative Fluorination  
 
This chapter describes our investigations into Pd-catalyzed decarbonylative 
functionalizations. The initial focus of the project was to first develop transition-metal 
catalyzed decarbonylative chlorination reactions using aroyl chlorides since the 
oxidative addition of aroyl chlorides to Pd0 was previously reported. Next, this initial 
strategy was further broadened to probe decarbonylative C–S, C–N, C–O, and C–C 
coupling. Finally, efforts aimed at the initial target reaction – decarbonylative fluorination 
– were pursued. This project, specifically initial investigations of decarbonylative 
thioetherification reactions, was in collaboration with Łukasz Woźniak, an exchange 
graduate student from ICIQ in Spain.  
5.2 RESULTS AND DISCUSSION 
C-Cl Bond Formation. The first part of this chapter describes our preliminary 
explorations of Pd-catalyzed decarbonylative chlorination reactions so as to apply this 
preliminary study on decarbonylative carbon-heteroatom bond formation. Carbon–
chlorine (C-Cl) bonds are abundant in natural products, 21  pharmaceuticals 22  and 
agrochemicals (Fig. 5.2).23 They are widely utilized in cross coupling reactions (Figure 










































Figure 5.2 Chlorinated Pharmaceuticals and Agrochemicals 
 
     There are a few literature examples of transition metal-catalyzed decarbonylative 
chlorination reactions. In the 1960s, Blum was the first to investigate stoichiometric Rh-
mediated decarbonylative halogenations, demonstrating successful decarbonylation of 
aroyl chlorides, 24  aroyl bromides, 25  and aroyl iodides using Wilkinson’s complex 
(Scheme 5.6).26  
Scheme 5.6 Rh-mediated Decarbonylative Halogenation23-26 
 
In 1982, Verbickey and coworkers reported the most recent decarbonylative 
chlorination.27 In this protocol, aroyl chlorides were decarbonylated at 360 ºC in the gas 
phase in the presence of 1 mol% of Pd/C (Scheme 5.7). The reaction required forcing 
conditions, thus resulting in narrow substrate scope. During the past two decades, there 
has been significant progress in catalyst and ligand developments that may allow more 
general decarbonylative chlorination reactions.28  
Scheme 5.7 Pd-catalyzed Decarbonylative Chlorination27 
 
Two relevant transition metal-catalyzed electrophilic halogenation approaches have 
been disclosed. One approach is Hunsdiecker type decarboxylative halogenations 
(Scheme 5.8, eq 1). 29  In this approach, either stoichiometric copper halides or 
electrophilic halogenating reagents undergo Ag or Pd-catalyzed reaction with benzoate 
derivatives to afford aryl halide products. Alternatively, our lab has developed PdII/IV 






































halide intermediate, followed by relatively facile reductive elimination to generate aryl 
halides (Scheme 5.8, eq 2).30,31 A common drawback in these two approaches is the 
control in regioselectivity and the use of stoichiometric expensive halogenating reagents.  
Scheme 5.8 Hunsdiecker Type Halogenation (eq 1) and Halogenation via a High-Valent 




Ligand Screen. Our initial studies began with a survey of ligands for this 
transformation. A solution of 4-trifluoromethyl benzoyl chloride 1 in toluene was refluxed 
in the presence of 10 mol % of Pd(P(o-tol)3)2 (Table 5.1, entry 1). This Pd0 precatalyst 
was predicted to be a good catalyst for two reasons: (1) oxidative addition of acid 
chlorides is well-known to occur at electron-rich Pd0 centers and (2) reductive 
elimination of aryl halides from PdII have been reported by Hartwig and coworkers with 
Pd(Po-tol3)2 and P(t-Bu)3 (Scheme 5.9).32  
Scheme 5.9 Csp2–Halogen Bond Formation  
Using this precatalyst in the initial studies, we were pleased to see 4-




X = Cl, Br
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end of reaction, we hypothesized that the addition of electron rich phosphine ligands 
might lead to enhancement in catalytic activity by facilitating oxidative addition. Hence, a 
variety of phosphine ligands were evaluated under the reaction conditions. However, 
neither mono-dentate phosphine ligands (entries 2-3) nor bidentate ligands (entries 4-6) 
led to an improvement in the desired reactivity. Presumably, these ligands may block an 
open coordination site at PdII, thus hindering the decarbonylation step as seen that 
starting material left over at the end of reaction time.9   
Table 5.1 Ligand Screen with Different Denticity 
 
Entry Ligand Denticity GC % Yield (2) GC % Recovery (1) 
1 none  1 4 89 
2 P(o-tol)3 1 5 81 
3 P(Ad)2n-Bu 1 4 75 
4 Xantphos 2 9 28 
5 dppb 2 0 74 
6 rac-BINAP 2 0 85 
It is known that CO deinsertion from a coordinatively unsaturated three-coordinate PdII 
species is expected to be significantly more facile than from a square-planar 
tetracoordinate PdII center.33 Maleckis and Sanford have demonstrated that Ruphos, 
Buchwald’s biarylmonophosphine ligand, allows for the stabilization of the three-
coordinated PdII intermediate via a Cipso–PdII interaction that is indicated by the dash 
line in Scheme 5.2.18a  
Therefore, inspired by the previous study with Ruphos 4, a variety of commercially 
available Buchwald biarylmonophosphine ligands were evaluated (Table 5.2). The use 
of Ruphos 4 provided 8% of 2 (entry 2, Table 5.2).  Gratifyingly, an increase in the yield 
of 2 to 23% was observed by GC analysis when the ligand was switched to the bulky 
tBuXPhos ligand 7 (entry 5). The use of the related XPhos ligand 8 afforded a 
comparable yield for 2 (entry 6). The best yield of 2 was obtained with BrettPhos (29%, 














Table 5.2 Buchwald’s Biarylmonophosphine Ligand Screen (in a sealed 4 mL vial)  
 
Entry Ligand (L) (L) GC % Yield (2) 
1 JohnPhos  3 5 
2 RuPhos  4 8 
3 DavePhos  5 8 
4 SPhos  6 9 
5 tBuXPhos 7 23 
6 XPhos 8 22 
7  BrettPhos 9 29 
 
Palladium Screen. As the Pd (P(o-tol3)2 only displayed moderate reactivity under 
catalytic conditions, a series of PdII/0 precatalysts were examined. Previous studies 
have suggested that the Pd center needs to be sufficiently electron-rich for the oxidative 
addition of acid chlorides to occur.34 Both Pd0 and PdII catalysts were screened and the 
results are shown in Table 5.3. As predicted, using the PdII pre-catalysts (entries 1-7, 
Table 5.3), very poor reactivity of acid chloride 1 was observed, producing <10% of the 
desired product 2. In contrast, the Pd0 catalyst, Pd2(dba)3, showed a slightly better 
performance (entry 8), although the initially identified Pd(P(o-tol3)2 gave the best 

































Table 5.3 Palladium Precatalyst Screening (in a sealed 4 mL vial) 
 
Entry Pd Catalyst GC % Yield (2) 
1 [cinnamylPdCl]2 9 
2 (COD)Pd(CH2TMS)2 0 
3 (PPh3)2PdCl2 0 
4 (Cp)Pd(allyl) 5 
5 (Allyl)PdCl2 5 
6 Pd(TFA)2 0 
7 Pd(OAc)2 0 
8 Pd2(dba)3 10 
9 Pd(PPh3)4 6 
10 Pd(P(o-tol3)2 29 
Temperature Studies. Considering that CO deinsertion is a challenging step at a 
PdII center, it is possible that oxidative addition is reversible, leading to recovered 
starting material at the end of reaction. However, quantifying the starting material 1 by 
GC clearly showed consumption of 1 over time, regardless of the examined temperature 
(rt to 130 °C). Furthermore, the consumption of 1 was observed even in the presence of 
the acid chloride. It is also possible PdII acyl complex had formed and might have slowly 
decomposed into dicationic PdI dimer through disproportionation at low temperatures.18a 
Importantly, the reactions significantly slowed down below the boiling point of toluene 
(b.p. = 110 °C), or a decreased yield of product 2 is observed (entry 2) in a sealed 4 mL 
vial. This result led us to hypothesize that modifying the reaction apparatus to promote 
carbon monoxide dissociation from PdII could have a favorable effect on product 
formation. Another way to shift the equilibrium in a reversible oxidative addition is by 
having an open system that can remove CO from the solution.  
  
10 mol% Pd catalyst
10 mol% Brettphos
Toluene













°C GC % Yield (2) GC % Recovery (1) 
1 130 29 44 
2 100 10 52 
3 80 8 58 
4 60 9 74 
5 22 9 59 
 
Tuning Reaction Set-Up. We next sought to develop a system that could shift the 
equilibrium that favors toward the decarbonylative coupling reaction. We hypothesized 
that having a larger headspace in the reaction vessel could facilitate carbon monoxide 
to vaporize out of the solution. Indeed, instead of using a sealed 4 mL vial (set-up A), 
running the reaction in a sealed 10 mL tall vial greatly improved the yield, generating 
88% of 2 under the reaction conditions in Figure 5.3 (set up B). Other apparatuses were 
tested to further improve the system. Simply increasing the reaction volume using setup 
C, Figure 5.3 did not lead to a better yield, as this resulted in evaporation of the solvent 
from the reaction mixture. Finally, increasing the headspace further to a 40 mL vials 
(Set-up D) led to evaporation of toluene at 130 °C. Based on these results, we decided 
to equip the 4 mL vial with a reflux condenser and an argon balloon (Set-up E) with the 
prediction that carbon monoxide should be displaced by the dense argon (dAr =1.661 
kg/m3; dCO = dN2 =1.165 kg/m3). Set-up E showed an improved the yield compared to 
set-ups A, C and D, but still resulted in lower yield (67%) than set-up B. Since the 
system does not seem to build a lot of CO pressure when we vented a system, for the 
remained chlorination study, set-up B was utilized. Imperfect mass balance (0% SM 
was observed) seems to suggest that some Pd may remain as a Pd-acyl complex or 
that the desired product oxidatively adds to the Pd center under the reaction conditions.  
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Figure 5.3 Tuning Reaction Apparatus for CO Extrusion 
 
 
Set-Up A Set-Up B Set-Up C Set-Up D Set-Up E 
Control Studies. Control studies were performed and confirmed that both Pd and ligand 
are necessary to facilitate this transformation (Table 5.5). 
Table 5.5 Control Studies (Set-Up B)  
 
Entry Pd(P(o-tol)3)2 Brettphos GC % Yield 
1 ✖ ✖ trace 
2 ✖ ¢ trace 
3 ¢ ✖ 4 
4 ¢ ¢ 88  
     Substrate Scope. With the optimal conditions in hand, preliminary evaluation of the 
substrate scope was conducted. The reaction worked well with substrates bearing 
electron-withdrawing (2, 10, 12) and electron-neutral (13) substituents on the aromatic 
ring. However, substrates bearing electron-donating substituents, such as 4-
methoxybenzoyl chloride 11 did not show good reactivity under the conditions, which 
10 mol % Pd(P(o-tol)3)2
10 mol % Brettphos
Toluene
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may be due to slow oxidative addition. Further investigation of substrate scope is 
currently underway. 




 In summary, a mild Pd-catalyzed decarbonylative chlorination was demonstrated 
utilizing a Pd0 catalyst, a commercially available monophosphine ligand, and a 
strategically designed reaction set-up. Our next aim is to translate our preliminary 
chlorination studies to Pd-catalyzed decarbonylative fluorination (Scheme 5.10). 
Scheme 5.10 Translating Pd-Catalyzed Decarbonylative Chlorination to Fluorination 
 
C–F Bond Formation. Aromatic fluorination is a very challenging 
transformation, 35  leading us to initially target the corresponding decarbonylative 
chlorination reaction. These preliminary investigations showed that decarbonylative 
chlorination is feasible. Moreover, the Buchwald lab demonstrated fluorination of aryl 
bromides utilizing [(COD)Pd(CH2TMS)2] and BrettPhos, the same optimal ligand for our 
decarbonylative conditions, which indicates that our decarbonyative pathway may 























X = CF3 (12), 89% yield*














Scheme 5.11 Buchwald’s Pd-catalyzed Fluorination of Aryl Bromide  
 
Decarbonylative C–F Coupling. The optimal chlorination conditions were applied 
to the model substrate 4-trifluoromethyl benzoyl fluoride 14. This electronically activated 
substrate was predicted to exhibit a good reactivity in the optimized reaction condition. 
Upon heating in refluxing toluene, an immediate color change from yellow to dark 
orange was observed, suggesting that a possible change in the oxidation state of Pd as 
such color change did not occur in the absence of the Pd catalyst. However, 100% 
starting material was recovered along with detection of Pd black, and none of the 
desired fluorinated product 15 was observed (Scheme 5.12).  
Scheme 5.12 Attempts at Pd-catalyzed Decarbonylative Fluorination 
 
 
It is possible that oxidative addition of benzoyl fluoride may have occurred but the 
reversibility of this process led back to the starting benzoyl fluoride back under the 
reaction conditions (Scheme 5.12) 36,37 Notably, when 3-fluorophenylboronic acid was 
reacted with aroyl fluoride 16 in the presence of the Pd, Brettphos and K3PO4, 
benzophenone 17 was observed as a cross-coupled product (16% of 16 remained at 
the end of reaction) (Scheme 5.13). The identity of 17 was confirmed by GC-MS.38 This 
seemed to suggest oxidative addition of benzoyl fluoride is occurring in the condition. 
Stoichiometric reaction of 18 was also conducted but no oxidative addition product 19 
was detected but free P(t-Bu)3 and Pd(P(t-Bu)3) (Scheme 5.14). Hence, there was no 
direct evidence of Pd-acyl(F) complex through oxidative addition. After initial attempts, a 
series of Pd precatalysts, ligands, and solvents were evaluated but no decarbonylative 
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Scheme 5.13 Formation of Cross-Coupled Product 
 
Scheme 5.14 Stoichiometric Reaction of Benzoyl Fluoride 18 to Pd(P(t-Bu)3)2 
 
The hypothesis that reductive elimination of the acyl fluoride may be facile is 
supported by Grushin’s stoichiometric study with (PPh3)2PdIIPhF. 39  In this report, 
subjecting (PPh3)2PdIIPhF to 1 atm of CO resulted in reductive elimination of benzoyl 
fluoride along with an observed (PPh3)2PdII(COPh)F intermediate at room temperature 
(Scheme 5.9). In contrast, reductive elimination of other benzoyl halides from analogous 
(PPh3)2PdII(COPh)X (X = Cl, Br I) was not observed, due to the high stability of 
Pd(acyl)halide complex (Scheme 5.15).40 
Scheme 5.15 Grushin’s Stoichiometric Study 
 
 
Another factor could be due to the thermodynamic stability of the benzoyl fluorides. Acyl 
fluorides have the strongest C–X bond and thus are the least electrophilic acyl halides 
amongst other acyl halides.41 Therefore, the reductive elimination of stable benzoyl 
fluoride readily occurs upon 1 atm of carbon monoxide, whereas the less stable benzoyl 
halides are thermodynamically unfavorable to form through reductive elimination from 
PdII(COPh)X complex.   
C–S Bond Formation. As part of our ongoing efforts toward the development of 
decarbonylative coupling methods, we sought to apply these optimized decarbonylative 





































studies targeted  diaryl sulfides because they are important scaffolds that are prevalent 
in natural products,42 materials,43 and pharmaceuticals44 (Figure 5.5). Such scaffolds 
are also widely utilized as useful intermediates in organic synthesis45 and as ligands in 
transition metal catalysis.46  Thus, the development of mild methods for their synthesis 
has attracted significant interest.  
Figure 5.5 Representative Organic Molecules Containing Diaryl Sulfides 
 
According to the Swain-Scott nucleophilicity parameters, nx the nucleophilicity of 
thiophenolate is 9.92, while Cl is 4.3. It suggests that our optimized conditions could be 
even more favorable for C-S coupling. 47  In 1987, Yamamoto demonstrated the 
decarbonylation of thioesters to form S-phenyl phenyl thioate with 5 mol % of Pd(PCy3)2  
(eq 1, Scheme 5.16) or with an equimolar amount of Wilkinson’s catalyst (eq 2) under 
negative pressure. In all cases, quantitative conversion of diaryl sulfides and vinyl(alkyl) 
sulfides were observed under the corresponding conditions by GC analysis.48 However, 
limitations of this system include a narrow substrate scope (3 examples for Pd) and 
reaction conditions (evacuation of the system). Weinert has subsequently demonstrated 
decarbonylative C–S bond formation using stoichiometric amounts of NiCl26H2O (2 
equiv). However, there has been no follow-up study of catalytic decarbonylative 
coupling for diaryl sulfide formation.49 Therefore, we decided to apply the optimized 
catalytic conditions for decarbonylative C–Cl coupling to the development of C–S cross 




























Scheme 5.16 Yamamoto’s Decarbonylative Thioetherification 
 
     Expansion of Decarbonylative Chlorination to Thioetherification. Our investigation into 
C–S bond formation started with S-phenyl benzene thiolate as the model substrate. 
Gratifyingly, 32% yield of phenyl sulfide was observed by GC analysis under the 
reaction conditions for decarbonylative chlorination (entry 1, Table 5.6). Using refluxing 
p-xylene (b.p. 138 °C) resulted in improved yield (up to 58% as determined by GC 
analysis). It is important to note that the original chlorination was conducted at 0.05 M 
concentration in aroyl chloride with set-up B. For the analogous C–S coupling reaction 
set-up E was found effective (yield differ by 1-2% lower) when the reaction 
concentration was increased to 0.2 M. Thus, for safety reasons, the rest of the 
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R3a  = Me; 100% GC yield
R3b  = Et; 100% GC yield





Table 5.6 Preliminary Investigation of Decarbonylative C–S Cross-Coupling Reactions 
for the Synthesis of Diaryl Sulfide (Set-Up B or E) 
 
Entry Solvent  Temperature (°C) GC Yield (%) 
1 Toluene 130 32 
2 p-Xylene 130 46 
3 p-Xylene 150 58 
Ligand Screen. Ligands were reevaluated to find optimal conditions for the 
thioetherification reactions. The use of JohnPhos (entry 1, Table 5.7) or XantPhos (entry 
2) gave appreciable yields of 20% and 52% yield of 21, respectively. The use of 20 mol 
% of bidentate ligands such as XantPhos (entry 3), rac-BINAP (entry 5), dppf (entry 6) 
and dppb (entry 7) increased the yields of phenyl sulfide 21. We hypothesized that bulky 
monodentate phosphine ligands would further promote this reaction. Indeed, P(Ad)2n-
Bu further improved the yield of the product (entry 9). Finally, the use of 20 mol % 
P(Ad)2Bn gave the best yield (78%, entry 10) of phenyl sulfide 21 under the reaction 
conditions. Therefore, we chose to use P(Ad)2Bn as a ligand for studying the scope of 
the decarbonylative thioetherification reactions.  
Table 5.7 Ligand Screen for Thioetherification 
 
Entry Ligand (L)  L mol%  GC Yield (%) 
1 JohnPhos 10 22 
2 Xantphos 10 52 
3 Xantphos 20 61 
4 tBu-Xantphos 20 15 
5 rac-BINAP 20 59 
6 dppf 20 61 
7 dppb 20 64 
8 dppe 20 19 
9 P(Ad)2n-Bu 20 67 
10 P(Ad)2Bn  20 78 
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Substrate Scope. With the optimized conditions in hand, the substrate scope of the 
decarbonylative thioetherification was next examined. Phenyl (21), p-OMe (22), p-CF3 
(23), o-Me (24) and 1-naphthoyl (26) substituents were tolerated and afforded moderate 
to good yields (Figure 5.6). Notably, the substrate containing the electron-rich 4-
methoxyl substituent led to poor yields, due to the formation of diphenyl sulfide as a by-
product. Pyridine substrate tolerated the reaction condition affording 54% of product 25. 
One limitation of this protocol is the persistent formation of phenyl sulfides as 
byproducts, which might occur via carbonyl C–S bond cleavage by the palladium 
catalyst.50 For instance, when S-phenyl 2-naphthoyl thiolate (27) was subjected to the 
reaction conditions, the formation of biaryl sulfide mixtures was observed (Scheme 5.17). 
This product distribution is attributed to C-S activation by Pd.51 Further mechanistic 
studies, including kinetics and more detailed studies on electronic and steric effects will 
be required to improve the reaction conditions.  

































Scheme 5.17 Current Limitations: C–S bond Cleavage 
 
Vinyl and Aliphatic Substrates. This work was further extended to non-aromatic 
substrates. For example, this protocol works with cinnamyl thioesters, affording 
phenyl(styryl)sulfane 24 (E:Z = 89:11) in 50% yield. However, isomerization occurs at 
during this reaction, resulting in a mixture of alkene stereoisomers. Interestingly, 
changing the catalyst from Pd(P(o-tol)3)2 to Ni(COD)2 led to the single E isomer 28 in 
28% yield, suggesting that isomerization as readily at the NiII center. Moreover, a 
benzylic substrate also underwent the desired decarbonylation reaction to form 29 in 
high yield (81%) (Scheme 5.18). Notably, we found that if the allylic substrate is also 
substantially activated, affording the desired product 30 in 49% yield. It is known that 
the decarbonylation of aliphatic aldehyde is stereospecific: the configuration of the 
stereocenter to which the formyl group is attached to is retained using Wilkinson’s 
catalyst.52 Such finding has been used in the total syntheses of several natural products 
including 7-(±)-deoxypancratistatin.53 Therefore, we envision that extension of scope to 
aliphatic substrates will find great synthetic applications because of the abundances of 
C–S bonds in important organic molecules.  




























81%With Pd(P(o-tol)3)2: 50% (E:Z = 89:11)




Competitive β-H Elimination Pathway. These preliminary results led us to further 
investigate the reactivity of aliphatic substrates. However, products attributed to β-H 
elimination were observed when S-phenyl 3-phenylpropanethioate was used as the 
substrate, resulting in no desired product (Scheme 5.19). The current substrate 
structure has a β-hydride that can be easily abstracted by a reactive PdII center leading 
to styrene formation. We propose that changing the sterics and electronics on the alkyl 
chain may slow down the rate of β-H elimination. For example, installing electron-poor 
arenes on the β-carbon has been shown to slow down β-H elimination.54 Chirik and 
Bercaw have performed systematic studies on the effect of β-carbon substituents on the 
rate of β-H eliminaton with zirconocene β-arylethyl complexes. They found that electron-
withdrawing substituents slowed down the rate of β-H elimination (ρ = – 1.8).55 We 
envision that electron-withdrawing groups should have the same effect in our system, 
slowing down the β-H elimination pathway and thus favoring the desired 
decarbonylative coupling. In addition, the rate of β–H elimination should also decrease 
with electron-withdrawing substituents at the α-carbon. Studies on the electronic effects 
toward decarbonylative thioetherification are a possible future direction.56  
Scheme 5.19 Outcome of Decarbonylative C–S Coupling with S-phenyl 3-
Phenylpropane Thiolate 
 
C–N and/or C–O Bond Formation. Having demonstrated the feasibility of C–S bond 
formation, decarbonylative amination and etherification to form C–N and C–O bonds 
would be a logical extension of this project. In particular, esters and amides are 
common functional groups in organic molecules. Despite the abundance of esters and 
amides functionalities, Cacyl–N  and Cacyl–O bond cleavage is challenging due to 
resonance stabilization of the amide functionality (Scheme 5.20).  





















Examples of decarbonylation via metal insertion into Cacyl–N57 or Cacyl–O58 bonds are 
scarce. Such transformations could be highly useful, as amides and esters could serve 
as protecting groups in complex organic molecule syntheses followed by removal of 
these protecting groups via late-stage decarbonylative coupling. Our first goal is to 
identify a good amide for systematically studying its reactivity toward Pd0. Three key 
factors for increasing the reactivity of amides towards oxidative addition/decarbonylative 
coupling are: (1) ground state destabilization of amide bonds, (2) high reaction 
temperatures, and (3) the use of labile ligands that promote decarbonylation.59 Three 
different amides were prepared as N-methyl-N-phenylbenzamide 60  and N-(4-
trifluroomethylbenzoyl)glutarimide57 have literature precedents for metal insertion into 
carbonyl-amide bonds. Unfortunately, the desired decarbonylative coupling reactions 
were not observed after our preliminary studies (Scheme 5.21).  
Scheme 5.21 Attempted Decarbonylative Amination Reactions 
 
Similarly, a series of esters were prepared and subjected to various reaction conditions 
for decarbonylative coupling. Unfortunately, no desired reactivity was observed under 
our initial conditions (Scheme 5.22). Future efforts will investigate various ligands, 
solvents, and transition metals to accomplish the transformation.  
Scheme 5.22 Attempted Decarbonylative C–O Coupling Reactions 
 
One alternative to the current attempts at Pd-catalyzed amination and etherification 



























X1= H, X2 = OMe, X3 = NO2
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and coworkers have shown that Ni can oxidatively add to a Cacyl-O bond followed by 
decarbonylation to form a NiII–alkoxy complex albeit in low yield (Scheme 5.23).58 In 
order to facilitate the decarbonylation process at Ni, an appropriate hemilable ligand will 
need to be identified that simultaneously leaves a coordination site open at NiII and 
provides steric bulk to promote reductive elimination.  
Scheme 5.23 Ni Insertion into Cacyl–O Bond Cleavage and Decarbonylation58 
 
One Pot CN, C-O, and C-C Bond Formation from C-Cl Decarbonylative Cross 
Coupling. As a side project to these decarbonylation studies, we sought to find a one 
pot method to convert acid chlorides to ethers and amines using the catalyst and ligand 
from our optimized decarbonylation conditions. In our first attempt, we were pleased to 
find that the original chlorination conditions could be used to form C–N, C–O and C–C 
bonds in high yields (Scheme 5.24). It is noted that the system was vented before 
nucleophiles were added to the reaction in order to release CO from the system, but the 
same catalyst could be further used to facilitate the next step. To the best of my 
knowledge, this is the first example of utilizing an acid chloride to form aryl–N, aryl–O, 
and aryl–C bonds. The scope of suitable substrates for this transformation will be 

































In summary, this chapter describes the development of transition metal catalyzed 
decarbonylative functionalizations to form a variety of carbon-heteroatom bonds. Using 
Pd(P(o-tol)3)2 as a precatalyst, decarbonylative chlorination and thioetherification were 
achieved under much milder conditions than previous reports. Attempts at developing 
decarbonylative coupling of aryl fluorides, esters and amides were not successful after 
extensive studies. However, as a preliminary result, starting from the aroyl halide, one 
pot decarbonylative C–N, C–O, and C–C cross coupling reactions with corresponding 


































5.4 PERSPECTIVE AND OUTLOOK 
As part of our continuous effort toward the development of more sustainable 
chemical transformations, carbonyl groups would be a highly desirable synthon for 
carbon-heteroatom coupling reactions. For future studies, a fundamental investigation of 
the mechanism of the decarbonylative chlorination and thioesterification reactions would 
be useful. In particular, kinetic studies (ex. Hammett studies) under the catalytic 
conditions would provide insight into the electronic effects of this system. In addition, 
stoichiometric studies aimed at synthesizing relevant intermediates could provide 
important insights for catalyst design. Furthermore, computational studies could help 
clarify or rationalize any ambiguity that could arise from our experimental results. Only a 
few literature reports on detailed mechanistic studies of catalytic decarbonylative 
coupling reactions have been disclosed.5 Thus, the work from this chapter and its 
preliminary results opens up the possibility for a number of new applications and 





Instrumental Information. NMR spectra were obtained on a Varian MR400 (400.52 
MHz for 1H; 100.71 MHz for 13C; 376.87 MHz for 19F), a Varian vnmrs 500 (500.10 MHz 
for 1H), or a Varian vnmrs 700 (699.76 MHz for 1H; 175.95 MHz for 13C) spectrometer. 
1H and 13C NMR chemical shifts are reported in parts per million (ppm) relative to TMS, 
with the residual solvent peak used as an internal reference. 1H and 19F multiplicities are 
reported as follows: singlet (s), doublet (d), triplet (t), quartet (q), and multiplet (m). 
Materials and Methods. S-phenyl arene thiolates were prepared according to a 
literature procedure. 61  Anhydrous DMF and P(Ad)2Bn were obtained from Aldrich. 
Pd[(P(o-tol3)2] was obtained from Alfa Aesar. 4-trifluoromethyl benzoyl chloride 1, 3,5-
bis(trifluroomethyl)benzoyl chloride, 4-anisoyl chloride, biphenyl-4-carbonyl chloride, 
phenylacetyl chloride were purchased from Acros. BrettPhos was purchased from 
Strem. All reactions were conducted under a nitrogen atmosphere or using standard 
Schlenk techniques unless otherwise stated. All reactions conducted at elevated 
temperatures were heated on a hot plate using an aluminum block. Temperatures were 
regulated using a thermocouple. 
Synthesis of Benzoyl Chloride  
 
General Procedure A: Ar(CO)Cl substrates were prepared by the following procedure 
adapted from the literature:62 the indicated carboxylic acid was suspended to anhydrous 
toluene (0.25M) and thionyl chloride (2.0 equiv) was added. The reaction was then 
refluxed overnight. Reaction was cooled and the crude mixture was distilled under 
reduced pressure to afford acid chlorides.   
General Procedure B: Ar(CO)Cl substrates were prepared by the following procedure 
adapted from the literature:63 Oxalyl Chloride (1.1 equiv) was added dropwise to a 
mixture of the carboxylic acid (1.0 equiv) and DMF (cat.) in dry CH2Cl2 under a N2 
atmosphere at 0 °C. The mixture was stirred at the same temperature for 5 h upon 
which it was allowed to warm up to ambient temperature. The reaction was 




General Procedure for Synthesis of S-phenyl Arene Thioate. S-Phenyl thioate was 
prepared by the following procedure adapted from the literature:61 A 25 mL two-neck 
flask was equipped with a Teflon-lined magnetic stir bar and a rubber septum. The flask 
was evacuated and back-filled with N2 and this cycle was repeated for three times. 
Thiophenol (1.0 equiv) and pyridine (1.0 equiv) was added with methylene chloride 
(0.1M) and cooled to 5°C. To the cooled mixture, was an acyl chloride (1.0 equiv) added 
by syringe over 5 minutes. The resulting suspension was stirred at 5°C for an additional 
5 minutes, and stirred at room temperature for 30 min to overnight (reaction was 
monitored by TLC). The reaction was then quenched by pouring over water (twice the 
volume of the solvent). The aqueous phase was separated and extracted with 
methylene chloride (x2), and the combined organic phases were dried over Na2SO4, 
filtered and concentrated. The crude mixture was purified by flash column 
chromatography to afford the desired thio ester.  
General Procedure for the Decarbonylative Chlorination/Thioetherification 
General Procedure (a): Pd-Catalyzed Reaction on Small Scale. In a glovebox, 
substrate (0.05 mmol, 1 equiv), Pd(P(o-tol)3)2 (2.9 mg, 0.005 mmol, 0.1 equiv), 
P(Ad)2Bn(3.6 mg, 0.2 equiv) , and MS 5A (thioetherification only) were combined with p-
xylene (0.3 mL) in a 4 ml vial. The vial was connected with a reflux condenser and 
capped with a rubber septum and the reaction mixture was taken out from the glovebox. 
Argon balloon was placed on the top of condenser (see picture below) and the reaction 
was refluxed for 20h at indicated temperature. After cooling to room temperature, the 
reaction mixture was diluted with CH2Cl2 (2 mL), and it was passed through a pad of 





General Procedure (b): Pd-Catalyzed Reaction on Larger Scale for Isolation. 
Reactions were conducted analogously to General Procedure a, but on a 0.3–0.5 
mmol scale as indicated. The reaction mixture was diluted with Et2O and absorbed into 
silica and concentrated by rotovap. The resulting crude residue was purified by flash 
column chromatography. The isolated product was re-dissovled in methylene chloride 
and CuCl (0.4 equiv) was added and stirred for 20 minutes at room temperature to trap 
P(o-tol3)2.64 The resultant precipitate was removed by passing through a plug of silica 
gel using 4:1 Hexanes/EtOAc eluent. The filtrate was concentrated to afford a desired 




A. Characterizations of Acid Chlorides and Chlorinated Products 
 
Aroyl Chloride 5. The aroyl chloride is prepared according to the following procedure. 
Methyl 4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carboxylate: To a round bottom flask 
charged with a stir bar, 4-bromobenzotrifluride (1.74g, 7.75 mmol), 4-methyl carbonyl 
boronic acid (1.46g, 8.1 mmol, 1.1 equiv), PPh3 (0.12 g, 0.47 mmol, 0.06 equiv), 
Pd(OAc)2 (0.035g, 0.16 mmol, 0.02 equiv) were added and dissolved in acetone/water 
(1:1) .  The reaction was refluxed for 5 hours. The reaction was then concentrated and 
re-dissolved in DCM:hexane (1:1) mixture. The solution was then passed through silica 
gel to remove Pd black. The filtrate was concentrated to afford methyl 4'-
(trifluoromethyl)-[1,1'-biphenyl]-4-carboxylatea white crystalline (0.85g, 40% yield). The 
product was taken onto a next transformation without further purification. 
4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carboxylic acid:65 To a solution of the ester (0.85g, 
3.1 mmol) in THF: H2O  (3:1, 0.2 M), LiOH (0.15g, 6.1 mmol, 2.0 equiv) was added as 
powder. Then reaction was stirred at 0oC for 3 hours. To the reaction mixture, 1 N HCl 
was added to acidify the aqueous layer. The aqueous layer was extracted with EtOAc. 
The combined organic layer was washed with brine and dried over Na2SO4. It was 
concentrated to receive a title compound in quantitative yield.  
4'-(trifluoromethyl)-[1,1'-biphenyl]-4-carbonyl chloride: 66  General Procedure A was 
followed to receive a title compound as a yellow powder (683mg, 2.4 mmol, 92%). 1H 
NMR (700 MHz, CDCl3): δ 8.23 (d, J = 7.0 Hz, 2H), 7.76-7.73 (m, 6H),13C NMR (176 
MHz, CDCl3): δ 167.7, 145.9, 142.5, 132.7, 132.1, 130.8 (q, J = 33 Hz). 127.8, 127.7, 
126.1, 126.0. 19F NMR (376 MHz, CDCl3): δ –62.7. HRMS EI [M+H]+ Calcd for 







Chlorinated Product 5. General Procedure b was followed using aroyl chloride 5 (0.5 
mmol) to receive a title compound in 89% yield. The 1H, 13C, and 19F NMR 
spectroscopic data were identical to that reported previously in the literature.67  19F NMR 
(376 MHz, CDCl3): δ –62.5. HRMS EI [M]+ Calcd for C13H8ClF3: 256.0267; Found 
256.0262  
B. Characterization of S-Phenyl Arene Thioate  
 
S-Phenyl Phenyl Thioate 1. General procedure is followed using benzoyl chloride (0.87 
mL, 7.5 mmol) and afforded a title compound as off-white crystalline (1.45g, 91% yd). 
The 1H, 13C, and 19F NMR spectroscopic data were identical to that reported previously 
in the literature.68 HRMS EI [M+H]+ Calcd for C13H10OS: 215.0452; Found: 215.0550. 
 
S-phenyl 4-Methoxyphenyl Thioate 2. General procedure is followed using 4-anisoyl 
chloride (853 mg, 5.0 mmol) and afforded a title compound as colorless crystalline 
needles (810 mg, 69% yd). The 1H, 13C, and 19F NMR spectroscopic data were identical 
to that reported previously in the literature.67 HRMS EI [M+H]+ Calcd for C14H12O2S: 












S-phenyl 4-trifluoromethylphenyl Thiolate 3. General procedure is followed using 4-
trifluoromethylbenzoyl chloride (1.40g, 5.0 mmol) and afforded a title compound as 
colorless crystalline needles (510 mg, 38% yd). The 1H, 13C, and 19F NMR 
spectroscopic data were identical to that reported previously in the literature.69 HRMS EI 
[M+H]+ Calcd for C14H9F3OS: 283.0326; Found: 283.0399. 
 
S-phenyl 2-tolyl Thioate 4. General procedure is followed using 4-toluoyl chloride (773 
mg, 5.0 mmol) and afforded a title compound as colorless oil (960 mg, 84% yd). The 1H 
and 13C NMR spectroscopic NMR spectroscopic data were identical to that reported 
previously in the literature.67 HRMS EI [M+H]+ Calcd for C14H12OS: 229.0609 ; Found: 
229.0682. 
 
S-phenyl (E)-3-phenyl-2-propene Thioate 5. General procedure is followed using (E)-3-
phenyl-2-propenoyl chloride (500mg, 3.4 mmol) and afforded a title compound as white 
crystaline (606mg, 74% yd). The 1H and 13C NMR spectroscopic data were identical to 
that reported previously in the literature. 70  HRMS EI [M+H]+ Calcd for C15H12OS: 











S-Phenyl Phenylthiol acetate 6. General procedure is followed using phenylacetyl 
chloride (1.54 g, 10 mmol) and afforded a title compound as yellow oil (959 mg, 78% yd). 
The 1H and 13C NMR spectroscopic data were identical to that reported previously in the 
literature.71 HRMS EI [M+H]+ Calcd for C14H12OS: 229.0609; Found: 229.0682. 
 
S-phenyl (E)-4-phenyl-3-butenethioate 7. General procedure is followed using (E)-4-
phenyl-3-butenoyl chloride (900 mg, 5 mmol). Aroyl chloride was prepared according to 
the general procedure B, afforded a title compound as yellow oil (260 mg, 25% yd). 1H 
NMR (700 MHz, CDCl3): δ 7.44-7.40 (m, 7H), 7.33 (t, J = 7 Hz, 2H), 7.26 (s, 1H), 6.60(d, 
J = 7 Hz, 1H), 6.33 (dt, J = 18, 7 Hz, 1H), 3.55 (d  J = 7 Hz, 2H). 13C NMR (176 MHz, 
CDCl3): δ 195.48, 136.6, 135.1, 134.5, 129.4, 129.2, 128.6, 127.8, 127.7, 126.4, 120.7, 
47.5. HRMS EI [M+H]+ Calcd for C6H14OS: 255.0838; Found: 255.0835. 
 
 
S-phenyl 3-phenylpropanethioate 8. General procedure is followed using 3-
phenylpropanoyl chloride (1.68g, 10 mmol) and afforded a title compound as white 
crystaline (2.07g, 85% yd). The 1H and 13C NMR spectroscopic data were identical to 
that reported previously in the literature. 72   HRMS EI [M+H]+ Calcd for C15H14OS: 










S-phenyl 1-naphthalyl Thioate 9. General procedure is followed using 1-naphthoyl 
chloride (500 mg, 3.0 mmol) and afforded a title compound as off-white powder (204 mg, 
77% yd). The 1H and 13C NMR spectroscopic data were identical to that reported 
previously in the literature.69 HRMS EI [M]+ Calcd for C17H12OS: 264.0609; Found: 
264.0609. 
 
S-phenyl 3-pyridyl Thioate 10.  The title compound is prepared according the literature 
procedure73 using 3-picolinic acid (370 mg, 3 mmol) and afforded a title compound as 
off-white powder (610 mg, 46% yd). The 1H and 13C NMR spectroscopic data were 
identical to that reported previously in the literature. 74  HRMS EI [M+H]+ Calcd for 
C12H9NOS: 216.0477; Found: 216.0478. 
 
 
S-phenyl 2-naphthalyl Thioate 11. General procedure is followed using 2-naphthoyl 
chloride (953 mg, 5 mmol) and afforded a title compound as off-white powder (610 mg, 
46% yd). The 1H and 13C NMR spectroscopic data were identical to that reported 
previously in the literature.68 HRMS EI [M+H]+ Calcd for C17H12OS: 265.0609; Found: 
265.0682. 











C-S coupled Product 1 General procedure b is followed using substrate 1 (64.2 mg, 
0.3 mmol) and afforded a title compound as colorless oil (47.7 mg, 85% yd).  1H NMR 
(700 MHz, CDCl3) δ 7.35−7.30 (m, 5H), 7.28−7.19 (m, 5H). 13C NMR (176 MHz, CDCl3) 
δ 135.8, 131.0, 129.2, 127.0. HRMS EI [M]+ Calcd for C12H10S 186.0503, Found 
186.0502.  
 
C-S coupled Product 2 General procedure b is followed using substrate 2 (73.2 mg, 
0.3 mmol) and afforded a title compound as colorless oil (17.5 mg, 27% yd). The 1H and 
13C NMR spectroscopic data were identical to that reported previously in the literature.75  
HRMS EI [M]+ Calcd for C13H12OS 216.0609, Found 216.0612.  
 
 
C-S coupled Product 3 General procedure b is followed using substrate 3 (84.7 mg, 
0.3 mmol) and afforded a title compound as colorless oil (60.1 mg, 79% yd). The 1H and 
13C NMR spectroscopic data were identical to that reported previously in the literature.75 











C-S coupled Product 4 General procedure b is followed using substrate 4 (68.4 mg, 
0.3 mmol) and afforded a title compound as colorless oil (60.1 mg, 79% yd). The 1H and 
13C NMR spectroscopic data were identical to that reported previously in the literature. 75 
HRMS EI [M]+ Calcd for  C13H12S 200.0660, Found 200.0664. 
 
 
C-S coupled Product 5 General procedure b is followed using substrate 5 (64.5 mg, 
0.3 mmol) and afforded a title compound as a colorless oil (30.2 mg, 54% yd). The 1H 
and 13C NMR spectroscopic data were identical to that reported previously in the 
literature.75   HRMS EI [M]+ Calcd for C11H9NS 188.0528, Found 188.0527. 
 
C-S coupled Product 6 General procedure b is followed using substrate 6 (79.3 mg, 
0.3 mmol) and afforded a title compound as white powder (47.9 mg, 68% yd). The 1H 
and 13C NMR spectroscopic data were identical to that reported previously in the 
literature. 75 HRMS EI [M]+ Calcd for C16H12S 236.0660 Found.236.0653 
 
 
C-S coupled Product 7 General procedure b is followed using substrate 7 (72.1 mg, 
0.3 mmol) and afforded a title compound as colorless oil (31.5 mg, 50% yd, E:Z = 89:11). 
The 1H and 13C NMR spectroscopic data were identical to that reported previously in the 










C-S coupled Product 8 General procedure b is followed using substrate 8 (68.4 mg, 
0.3 mmol) and afforded a title compound as white crystalline (48.6 mg, 81% yd). 1HNMR 
(700 MHz, CDCl3): δ 4.01 (s, 2H), 7.18-7.22 (m, 10H). 13C NMR (176MHz, CDCl3): δ 
39.1, 126.5, 127.3, 127.5, 128.5, 128.9, 129.4, 129.8, 136.9, 137.7.  HRMS EI [M]+ 
Calcd for C13H12S 200.0660, Found 200.0665. 
 
C-S coupled Product 9 General procedure b is followed using substrate 9 (76.3 mg, 
0.3 mmol) and afforded a title compound as white powder (32.9 mg, 49% yd). The 1H 
and 13C NMR spectroscopic data were identical to that reported previously in the 




C-S coupled Product 10 General procedure b is followed using substrate 10 (79.3 mg, 
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